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Abstract 
Spinal cord development has been studied extensively and is a model for embryonic 
patterning and cell differentiation. These processes are governed by extracellular and 
intracellular signaling and require gene transcription.  Wnt signaling has been shown to 
be involved in dorsal-ventral patterning of the spinal cord, where it affects cell 
proliferation and specification. Wnt ligands bind to Frizzled receptors and Lrp5/6 co-
receptors and initiate canonical, β-catenin-dependent, Wnt signaling. To determine 
important FZD receptors in chick spinal cord we analysed FZD expression patterns 
using in situ hybridization. In situ cryosections showed that FZD expression patterns are 
dynamic and specific along the dorsal-ventral axis of the spinal cord. Previous work in 
Xenopus showed that FZD10 acts through canonical Wnt signaling. However, which 
Wnt ligands activate FZD10 during neurogenesis remains unclear. Here, we investigate 
FZD10 expression, regulation and function in the chick developing spinal cord using in 
situ hybridization, in ovo electroporation and immunohistochemistry.  
 
FZD10 is expressed in the dorsal neural tube and overlaps with expression of Wnt1, 
Wnt3a, markers of dorsal progenitors and of interneurons. To examine Wnt1 and Wnt3a 
interactions with FZD10 in vivo, developing spinal cords were electroporated with 
Wnt1 and Wnt3a individually. Targeted mis-expression of Wnt1 up-regulated FZD10 
expression whereas Wnt3a did not. This may suggest that FZD10 exclusively interacts 
with Wnt1 to mediate its function during spinal cord development.   
 
Furthermore, the role of FZD10 was studied in vivo in developing spinal cords. FZD10 
regulated cell proliferation and differentiation, suggesting that it is required for Wnt1 
signal transduction and for spinal cord development.  
 
Lrp6 is involved in central nervous system development including spinal cord. In this 
study, in vivo experiments revealed that Lrp6 complements Wnt1/FZD10 mediated 
activation of dorsal markers during spinal cord neurogenesis.  This could explain how 
Wnt signalling regulates sensory neuron formation in the dorsal spinal cord.  
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1.Introduction 
1-1 Wnt signalling pathways: 
Wnt signalling regulates many embryonic and developmental processes in both 
invertebrates and vertebrates, from fruit flies to humans.  Wnt signalling has been 
shown to be involved in the regulation of a wide variety of biological processes, such as 
cell proliferation, cell polarity, cell differentiation, cell fate specification and cell death 
(Moon et al., 2004; Logan and Nusse, 2004).  It also plays several roles in the 
development of the central nervous system (CNS), such as in neural induction, 
neurulation, patterning, neural cortical migration, neuronal differentiation in the spinal 
cord, neural stem cells, axon guidance and synaptogenesis (Yoshikawa et al., 1997; 
Pöpperl et al., 1997; Muroyama et al., 2004; Muroyama et al., 2002; Lee et al., 2004; 
Chenn and Walsh, 2003; Lyuksyutova et al., 2003; Hall et al., 2000; Alvarez-Medina et 
al., 2008; Le Dréau and Martí, 2012). 
 
Development of the vertebrate CNS requires cell-to-cell communication, intracellular 
signalling and gene transcription.  Wnt signalling is also involved in these events 
because it can function as a morphogen, which means that it can regulate cell-to-cell 
communication and other processes that require extracellular signalling pathways 
(Zecca et al., 1996; Neumann and Cohen, 1997). 
 
The Wnt lignds belong to a family of secreted glycoproteins that bind to the N-terminal 
extracellular cysteine-rich domain of the Frizzled (FZD) receptor family of seven-pass 
transmembrane proteins (Komiya and Habas, 2008). Wnt ligands and their receptors are 
normally classified into those that activate canonical or non-canonical signalling 
pathways (Fig 1.1).  Canonical signalling is also called Wnt/β-catenin signalling 
because β-catenin is a major player in this pathway (Komiya and Habas, 2008).  The 
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non-canonical signalling pathways are divided into planar cell polarity (PCP) pathways 
and Wnt/Ca2+ pathways.  The division of Wnt signalling relies on the fact that 
canonical Wnts bind to FZDs and activate β-catenin, which then activates target genes 
of the signalling pathway, whereas the non-canonical Wnts bind to FZDs and activate 
small Rho GTPases but the pathways are independent of β-catenin activity (Saijun and 
Zongbin, 2012; Komiya and Habas, 2008).  It is worth mentioning that canonical and 
non-canonical Wnt signalling pathways are able to regulate each other (Saijun and 
Zongbin, 2012).  
 
	
Fig. 1.1 Wnt signalling pathways. (A) Canonical Wnt signalling without Wnt 
activation. (B) Canonical Wnt signalling with Wnt activation. (C) Non-canonical Wnt 
signalling (planar cell polarity (PCP) pathways and Wnt/Ca2+ pathways). (Adapted 
from Masckauchán and Kitajewski, 2006). 
		
 
 
In this study, I focus only on the canonical Wnt signalling pathway. 
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-Canonical Wnt signalling:   
The canonical Wnt signalling pathway consists of several components, including 
several ligands (Wnts) and receptors, FZDs (FZD1-10); a co-receptor, the low-density 
lipoprotein-related receptor protein (LRP5/6); dishevelled (Dvl), a cytoplasmic protein; 
β-catenin destruction complex; glycogen synthase kinase 3β (GSK-3β); adenomatous 
polyposis coli (APC); Axin proteins and casein kinase I (CKI) and nuclear transcription 
factors of the lymphoid enhancer factor/T-cell factor (LEF/TCF) family as well as Wnt 
target genes (Fig. 1).  In addition, canonical Wnt signalling is inhibited by antagonists 
such as sFRP, WIF-1, Cerberus and DKKs (Saijun and Zongbin, 2012). Furthermore, 
Kremen genes are known as inhibitors for canonical Wnt signalling (Mao et al., 2002).  
 
β-catenin is a key player in the canonical Wnt signalling pathway.  The stability of β-
catenin relies on the presence of Wnt ligands (He et al., 2004).  Without Wnt ligand 
binding to a cognate receptor, β-catenin is degraded by the destruction complex 
Axin/APC/GSK-3/CKI (Fig. 1.1A).  The destruction complex mediates β-catenin 
degradation through the proteasomal machinery (He et al., 2004), leading to the 
association of LEF/TCF transcription factors with transcriptional co-repressors in the 
nucleus, which represses Wnt target genes (Saijun and Zongbin, 2012; Komiya and 
Habas, 2008). 
 
β-catenin is stabilised when Wnt ligands bind to cell surface receptors FZD/LRP5/6, 
leading to inhibition of the destruction complex (Fig. 1.1B) (Masckauchán and 
Kitajewski, 2006).  The binding of Wnt ligands to FZD/LRP5/6 receptors leads to the 
activation of dishevelled (Dvl), a cytoplasmic protein containing three domains: a DIX, 
a PDZ and a DEP domain (Wallingford and Habas, 2005).  The DIX and PDZ domains 
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are required for canonical Wnt signalling and for the Dvl-mediated inhibition of the 
destruction complex Axin/APC/GSK-3/CKI (Wallingford and Habas, 2005).  When the 
destruction complex is inhibited by Dvl, the degradation of β-catenin is also stopped, 
resulting in the accumulation and stabilisation of β-catenin in the cytoplasm (Saijun and 
Zongbin, 2012; Komiya and Habas, 2008).  After accumulation, β-catenin enters the 
nucleus and then interacts with LEF/TCF DNA-binding transcription factors (Fig. 
1.1B). This results in the activation of Wnt target genes such as Twin and Myc (Reya 
and Clevers, 2005; Harland and Gerhart, 1997) (Fig. 1.1B). 
 
More than 18 Wnt ligands have been identified in vertebrates (Wang et al., 2006).  In 
this study, the Wnt ligands that are expressed in the dorsal neural tube will be examined, 
in particular Wnt1 and Wnt3a.  These are the best candidates to start with because of 
their important role in the development of the dorsal neural tube. However, their 
specific receptors have not been identified in the dorsal neural tube.   
 
Also, 10 FZDs receptors have been identified in vertebrates (Wang et al., 2006).  The 
FZD family consists of 7-pass transmembrane proteins, which are members of G-
protein-coupled receptors (Wang et al., 2006) (see below 1-5.) 
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1-2 Neural development: 
Development of the vertebrate nervous system is complex, requiring multiple 
interactions between tissues and signalling pathways.  The nervous system’s 
development starts during gastrulation, in which the embryo is rearranged into three 
germ layers, called the ectoderm, mesoderm and	endoderm.  These germ layers give 
rise to specific tissues. For example, the ectoderm gives rise to the epidermis, the neural 
tube and the neural crest.  During late gastrulation neural induction takes place, and this 
gives the dorsal ectoderm neural identity.  Neural induction is a key event for neural 
development, which is directed by Hensen’s node in chick embryos (equivalent of 
Spemann’s organiser) (Colas and Schoenwolf, 2001).  Hensen’s node is located at the 
anterior end of the primitive streak and plays an important role in neural induction, 
controlling the movement of cells during gastrulation and producing numerous signals 
that specify neural cells.  Rapid proliferation leads to expansion of the dorsal ectoderm, 
which then becomes a neural plate.  The neural plate gives rise to all central nervous 
system tissues, the brain and the spinal cord (Gilbert, 2010). Initially the neural plate 
will generate the neural tube.  The formation of the neural tube is called neurulation, 
and there are two types: primary and secondary neurulation (Fig. 1.2) (Gilbert, 2010; 
Colas and Schoenwolf, 2001).  In primary neurulation, the edge of the neural plate 
thickens and elevates, and the epidermal cells move toward the dorsal midline.  This 
leads to the formation of the neural folds (Fig. 1.2), which meet and fuse at the midline, 
forming a hollow tube.  The process of primary neurulation leads to the formation of the 
anterior neural tube, which is separated from the epidermis by the neural crest (Fig. 1.2) 
(Gilbert, 2010). The posterior end of the neural tube and tail bud are formed through the 
process of secondary neurulation.  In chick embryos, the closure of the neural tube 
begins at the level of the midbrain and zips up in both directions. Failure of neural tube 
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closure causes many malformations in the central nervous system, called neural tube 
defects (Greene and Copp, 2009).		
	
Fig. 1.2 Neural tube and neural crest formation. (A) Neural plate. (B) Neural groove. 
(C) Neural folds. (D) Neural tube. 1 to 4 illustrates the processes of neurulation from 
neural plate bending to neural tube closure. (Adapted from Gilbert, 2010). 
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Through the process of neurulation, the neural tube and crest are formed.  The neural 
tube gives rise to the forebrain, midbrain and hindbrain as well as the spinal cord, which 
in combination form the functional central nervous system in vertebrates.  The neural 
crest is formed during the process of neurulation from dorsal ectoderm, and it is first 
induced in the region of the neural plate border (Fig. 1.2).  After neural tube formation, 
the neural crest delaminates from the region between the dorsal neural tube and the 
epidermis and migrates out following a number of different routes.  Also, it gives rise to 
many types of cells, such as peripheral and enteric neurons and glia (Le Douarin and 
Kalcheim, 1999). 
 
Many signalling pathways play important roles in neural development in vertebrates.  
Bone morphogenic proteins (BMPs), fibroblast growth factors (FGFs) and the Wnts are 
the major players during neural induction and neurulation.  BMP signalling is blocked 
by the organiser activity (Hensen’s node in chicks), which generates BMP inhibitors 
from the dorsal mesoderm (chordin, noggin and follistatin) (Muñoz-Sanjuán and 
Brivanlou, 2002; Stern, 2005).  The inhibitory signals block BMP4 activity, leading to 
the activation of neural cell specification and inhibiting epidermal cells in the dorsal 
ectoderm (Piccolo et al., 1996; Zimmerman et al., 1996).  This process leads to the 
formation of the neuroectoderm, resulting in the formation of the neural plate.  This is 
called the default model of neural induction (Wilson and Edlund, 2001; Stern, 2005).  
 
As mentioned above, FGFs are involved in neural induction and neurulation.  Many 
studies have reported the involvement of FGF signalling in neural induction (Bertrand 
et al., 2003; Streit and Stern, 1999; Stern, 2005).  Streit et al. (2000) showed that FGF 
signalling is important for the initiation of neural induction before gastrulation in chick 
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embryos.  FGFs are also involved in secondary neurulation, which is the mechanism 
that generates the posterior end of neural tube and tail bud (Storey et al., 1998; Shamim 
and Mason, 1999). 
 
Wnt signalling pathways play a critical role in many developmental processes, 
including neural induction and neurulation.  In addition, Wnt signalling pathways have 
been shown to play a role in the formation of the dorsal Spemann–Mangold organiser in 
early Xenopus embryos, which mediates neural induction (De Robertis, 2000; Tao et 
al., 2005).  Also, it has been shown that activation of canonical Wnt signalling leads to 
formation of a secondary dorsal axis when RNA encoding components such as 
dnGSK3β, β -catenin, or Wnt1/3a is microinjected into the prospective ventral side of 
early Xenopus embryos (Du et al., 1995).  Moreover, canonical Wnt signalling can 
regulate anterior–posterior axis formation and neural patterning (De Robertis and 
Kuroda, 2004; Logan and Nusse, 2004; Yamaguchi, 2001; Kawano and Kypta, 2003). 
 
The integration of Wnt signals with FGFs and BMPs is important for the selection of 
cell fates during neural induction, through which embryonic ectoderm cells are directed 
to become neural or epidermal cells (Wilson and Edlund, 2001; Muñoz-Sanjuán and 
Brivanlou, 2002; Stern, 2005).  It has also been shown that Wnt activity is required for 
neural induction through β-catenin signals (Baker et al., 1999), and Wnt signalling is 
also involved in neural tube and neural crest formation (Muroyama et al., 2002; Ikeya et 
al., 1997; Dorsky et al., 1998; Calisto et al., 2005).  Moreover, many studies have 
shown that Wnt signalling plays a critical role in neural tube patterning along the 
anterior-posterior and dorsal-ventral axes (Baker et al., 1999; Robertis et al., 2000; 
Domingos et al., 2001; Kiecker and Niehrs, 2001; Ulloa and Martí, 2010; Le Dréau and 
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Martí, 2012).  Therefore, Wnt signalling is one of the key signals that pattern the central 
nervous system. 
 
1-3 Dorsal-ventral neural tube patterning and signalling pathways: 
The neural tube is the precursor of the central nervous system, which develops from the 
neural plate through the process of neurulation, giving rise to the brain and spinal cord.  
After neural induction, the neural tube differentiates and is patterned in anterior-
posterior (AP) and dorsal-ventral (DV) axes (Wilson and Maden, 2005).  The 
differentiation of the neural tube results in the formation of the forebrain, midbrain and 
hindbrain in the anterior portion of a developing embryo as well as the formation of the 
spinal cord in the posterior portion. The patterning of the AP neural tube is controlled 
by many developmental signals, including BMPs, FGFs, Wnts and retinoic acid (RA) 
(Blumberg et al., 1997; Wodarz and Nusse, 1998; Gamse and Sive, 2000; Holowacz and 
Sokol, 1999; Momoi et al., 2003; Villanueva et al., 2002).  
 
The DV patterning of the neural tube occurs after neural induction and during the 
elongation of the embryonic axis, while the organiser (Hensen’s node in chicks) is 
regressing (Wilson and Maden, 2005).  Through neurulation, the roof plate is formed on 
the dorsal side of the neural tube, where sensory neurons will form, and the floor plate 
is formed on the ventral side of the neural tube, where motor neurons will form  
(Zhuang and Sockanathan, 2006; Wilson and Maden, 2005).  The roof plate and floor 
plate act as signalling centres, which interact in a reciprocal fashion by secreting 
different morphogen proteins, to establish the DV neural tube pattern.  Also, the somites 
and the notochord are required for pattering the DV axis.   
The neural tube is divided into eleven domains of neural progenitor cell populations 
along the DV axis using transcription factors (TFs) [the home-domain (HD) and the 
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basic-helix-loop-helix (bHLH) families] as molecular markers for specific neural 
progenitors (Ulloa and Martí, 2010; Le Dréau and Martí, 2012; Wilson and Maden, 
2005).  The dorsal TFs divide the dorsal neural tube into six domains (dP1-dP6), and 
the ventral TFs divide the ventral half into five domains (p0, p1, p2, pMN and p3) 
(Ulloa and Martí, 2010) (Fig 1.3).  The expression of these TFs is controlled by several 
patterning signals, which are secreted from the tissues surrounding the neural tube. 
	
Fig.	 1.3	 Cross section of the developing spinal cord, at stage HH24 stained with 
DAPI; red circles mark six dorsal progenitor domains (dP1-dP6), while green circles 
represent five ventral progenitor domains (p0, p1, p2, pMN and p3).  VZ, the ventricular 
zone; MZ, the mantle zone. 	
Several extracellular signalling pathways are active in the DV neural tube, including 
FGFs, RA, BMPs, Wnts, and sonic hedgehog (Shh) (Fig. 1.4) (Ulloa and Martí, 2010; 
Le Dréau and Martí, 2012; Wilson and Maden, 2005).  These patterning signals are 
produced by different tissues; FGFs are generated by the mesoderm, RA is expressed by 
somites, BMPs and Wnts are expressed and secreted by the roof plate and Shh is 
produced by the notochord and then by the floor plate (Ulloa and Martí, 2010; Wilson 
and Maden, 2005).  In this study, the focus is mainly on Wnts, but I will briefly mention 
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BMPs and Shh because of their known interactions with Wnt signalling pathways.  All 
of these signals act as morphogens, specifying neural cell types along DV axis of spinal 
cord.  
	
Fig. 1.4 This Diagram shows a cross section of the developing spinal cord. The 
ventricular zone (VZ) is a layer of proliferative progenitor cells surrounding the lumen. 
The mantle zone (MZ) consists of differentiated neurons in specific order along DV 
axis. The neural tube is patterned by gradients of Wnts and Bmps, secreted by the roof 
plate (RP), and Shh, produced by the notochord (N) and the floor plate (FP). Retinoic 
acid (RA) is produced in somites  (Adapted from Ulloa and Martí, 2010). 
 
 
1-3-1 The ventral neural tube and Shh: 
The ventral neural tube is patterned by the notochord and the floor plate, which generate 
a Shh gradient, which in turn specifies ventral neural cell fates (Marti et al., 1995; 
Placzek et al., 1990).  The notochord is necessary for the specification of the ventral 
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neural tube and removal of the notochord results in a loss of the floor plate and motor 
neurons (Placzek, 1995).  Moreover, it is sufficient to induce the floor plate of the 
neural tube because grafting it beside the neural tube results in the induction of an 
ectopic floor plate and motor neurons (Placzek 1990).  Thus, the notochord is required 
for the formation of the floor plate, which acts as a signalling centre for Shh activity. 
Shh is generated by the notochord and then by the floor plate, and it controls the ventral 
patterning of the neural tube.  Shh is a member of the hedgehog (Hh) family of proteins 
and is involved in many developmental processes. For example, Shh is sufficient and 
necessary to specify the ventral neural tube (Martí et al., 1995; Roelink et al., 1995).  
The gradient concentration of Shh patterns the ventral neural tube by inducing and 
repressing particular homeo-domain (HD) proteins (Briscoe et al., 2000; Jessell, 2000).  
The HD proteins that are activated by high-level concentrations of Shh are called Class 
II and include Nkx2.2 and Olig2, and the HD proteins that are repressed by Shh are 
called Class I and include Pax3, Pax7, Pax6 and Irx3 (Briscoe et al., 2000; Dessaud et 
al., 2008; Jessell, 2000).  Cross-repression between Class I and Class II HD proteins 
refines their boundary domains and maintains their expression (Zhuang and 
Sockanathan, 2006; Briscoe et al., 2000; Wilson and Maden, 2005).  This in turn 
establishes five neural progenitors in the ventral neural tube: p0, p1, p2, pMN and p3 
(Le Dréau and Martí, 2012) (Fig 1.3). For example, cross-repressive interaction of the 
Olig2 and Nkx2.2 leads to the creation of the pMN and p3 progenitors boundary in the 
ventral half of the neural tube (Sun et al., 2003).  
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The Shh gradient activity is mediated through the Gli transcription factors (Stamataki et 
al., 2005).  Gli genes are expressed in the neural tube (Gli1, Gli2, Gli3) and the proteins 
exist in an activator (GliA) or a repressor form (GliR), which either activate or repress 
target genes of Shh (Ulloa and Martí, 2010).  Knockout of Gli2 led to many alternations 
in the ventral neural tube (floor plate and V3 progenitors were lost) (Matise et al., 
1998), and knockout of Gli3 led to a normal ventral pattern but intermediate dorsally 
expanded interneurons (Persson et al., 2002).  It has been proposed that Shh creates a 
balance between the Gli activator (Gli2) and repressor activities (Gli3R) in the neural 
tube (Ulloa and Martí, 2010). Furthermore, Gli3 transcription factor has been 
considered as an inhibitor for Shh activity (Wang et al., 2000; Jacob and Brisco, 2003).  
 
1-3-2 The dorsal neural tube and Wnt/BMP: 
The dorsal neural tube is patterned by the activity of the roof plate, which generates 
many extracellular signals, including BMPs and Wnts (Helms and Johnson, 2003; 
Zhuang and Sockanathan, 2006).  The dorsal neural tube is divided into six domains 
characterized by expression of dorsal TFs (dI1, 2, 3, 4, 5, 6) (Le Dréau and Martí, 
2012).  Also, dorsal interneurons are divided into two groups according to their 
dependency on the roof plate; dI1-3 are dependent on roof plate activity (called Class 
A) and dI4-6 are independent of roof plate activity (called Class B) (Zhuang and 
Sockanathan, 2006).  At least for Class A, the roof plate is required for the dorsal 
pattering of the neural tube.  Two studies have shown the requirement for the roof plate. 
The first showed that the lack of a roof plate in Dreher mutant mice, in which Lmx1a 
gene was affected, led to a loss of dorsal interneurons (Millonig et al., 2000). The 
second study showed that when the roof plate was genetically ablated in mouse embryo 
by introducing conditional expression of diphtheria toxin A subunit from the Gdf7 locus 
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in the roof plate cells resulted in a loss of dorsal interneurons (dI1-3) in the neural tube 
(Lee et al., 2000).   
The roof plate is essential for dorsal neuron specification, especially for Class A (dI1-3). 
It is a signalling centre that expresses many members of the BMP and Wnt families, 
which play important roles in the dorsal patterning of the neural tube (Timmer et al., 
2002; Ikeya et al., 1997; Le Dréau and Martí, 2012; Wilson and Maden, 2005). 
 
1-3-2-1 BMP signalling: 
BMPs are members of the transforming growth factor beta family (TGFβ). BMPs  play 
an important role throughout neural development, including the DV patterning of the 
neural tube.  Many TGFβ family members are expressed in the roof plate, including 
BMP4, BMP5, BMP7, Activin B, Dorsalin1 and GDF7 (Chesnutt et al., 2004; Zhuang 
and Sockanathan, 2006).  This suggests that BMPs are involved in dorsalizing the 
neural tube.  In fact, findings from in vitro and in vivo studies have demonstrated that 
BMP signalling is required for dorsal neural tube specification (Helms and Johnson, 
2003).  Two groups of researchers have demonstrated this requirement, and both studies 
were conducted on chick embryos using electroporation (Timmer et al., 2002; Chesnutt 
et al., 2004).  Timmer et al. (2002) showed that overexpression of BMP receptors 
(BMPR-Ia and BMPR-Ib) led to an expansion of dorsal interneurons (dI1-3), whereas 
inhibition of BMP signalling resulted in a loss or reduction of dI1-3.  They also showed 
that BMPs pattern the neural tube through the regulation of bHLH and HD proteins.  
The authors concluded that BMP signalling positively regulates dorsal expression of 
Pax7 and negatively regulates Pax6 in intermediate regions, both Pax7 and Pax6 are 
homeo- and paired-domain containing proteins.  This regulation leads to refinement of 
expression boundaries of these proteins in the dorsal neural tube. 
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In another study, Chesnutt et al. (2004) overexpressed noggin (BMP inhibitor) in chick 
neural tubes using electroporation, which led to a loss of roof plate and dorsal cell fates, 
indicating that BMP signalling is required for roof plate maintenance and dorsal 
interneurons.  Also, they showed that the dorsal neural progenitors that express bHLH 
proteins are required for BMP signalling.  Moreover, the study demonstrated that Wnt 
family members and FZD receptors that are expressed in the dorsal neural tube (Wnt1 
and FZD10) are positively regulated by BMP signalling, whereas those that are 
expressed on the ventral side (Wnt7a, FZD7, sFRP1) are negatively regulated.  Chesnutt 
et al. (2004) proposed that BMP signalling regulates dorsal neural tube patterning while 
Wnt signalling regulates proliferation.  In other words, BMP signalling controls 
patterning and growth in coordination with canonical Wnt signalling.  This means that 
canonical Wnt signalling is regulated by BMP signalling and acts as a mitogenic rather 
than a patterning signal.  Wnt ligands are downstream of BMP signalling, and their 
expressions are enhanced by BMP signalling, especially Wnt1/3a (Chesnutt et al., 
2004).  For example, Wnt1 is induced by BMPR overexpression.  
Recently, Le Dréau et al. (2012) demonstrated that BMP7 is required for dorsal neural 
tube neurogenesis (dI1-dI3-dI5) but it is not required for patterning in chick and mouse 
embryos.   
 
1-3-2-2 Wnt signalling: 
Wnt signalling is involved in dorsal neural tube patterning (see 1-4).  Many Wnt family 
members are expressed in the dorsal neural tube, including Wnt1/3a, which are 
expressed in the roof plate, which acts a signalling centre for BMP/Wnt. 
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In summary, the DV neural tube axis is established by interactions between Shh, BMP 
and Wnt.  Shh sets up the ventral side of the neural tube and functions against 
BMP/Wnt activity in that location.  BMP and Wnt establish the dorsal side of the neural 
tube and repress Shh activity on that side.  Shh, BMP and Wnt pattern the neural tube 
through the complex regulation of HD and bHLH transcription factors along the DV 
axis.  
 
 
1-4 Dorsal neural tube development and the canonical Wnt signalling pathway:  
Wnt genes are involved in the development of the central nervous system in vertebrates.  
Several Wnt genes are expressed in the neural tube, namely, Wnt1, Wnt3, Wnt3a, Wnt4, 
Wnt7a and Wnt7b (Parr et al., 1993).  Wnt1 and Wnt3a are known as canonical and 
exclusively expressed in the roof plate, and they are implicated in the DV axis 
development of the neural tube (Chesnutt et al., 2004; Dickinson et al., 1994; Megason 
and McMahon, 2002; Muroyama et al., 2002; Alvarez-Medina et al., 2008).  
 
In fact, many studies have reported a proliferative role for Wnt signalling in the neural 
tube.  Dickinson et al. (1994) showed that overexpression of Wnt1 led to an increase in 
proliferation in the CNS without pronounced changes in patterning, meaning that Wnt1 
acts as a mitogenic signal.  Megason and McMahon (2002) findings agreed with that 
study, concluding that Wnt1 and Wnt3a act as a mitogenic signal in neural progenitors.  
Chesnutt et al. (2004) data confirmed the mitogenic activity of Wnts using in ovo chick 
electroporation assays. They also proposed that Wnt activity is dependent on BMP 
activity (which couples growth with patterning). Ille et al. (2007) agreed with the model 
proposed by Chesnutt et al. (2004), suggesting an inhibitory crosstalk between 
Wnt/BMP signalling in the neural tube.  Wnt signalling induces proliferation and 
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inhibits differentiation, whereas BMP signalling induces differentiation and inhibits 
proliferation (Ille et al., 2007).  This inhibitory crosstalk links patterning and growth, 
whereby the dorsal half of the developing spinal cord is refined. 
 
However, several reports have suggested a patterning role for Wnt signalling in the 
neural tube.  Muroyama et al. (2002) showed that in the Wnt1/Wnt3a double mutant 
mouse, dorsal interneurons 1 and 2 were lost or reduced, whereas dorsal interneuron 3 
was expanded.  Also, they showed that Wnt3a protein is able to induce dI1 and dI2 
markers.  This suggests that Wnts are required for dorsal interneuron specification, at 
least for dI1-3.  Moreover, this phenotype is consistent with the phenotype of roof-
plate-ablated embryos, which show a loss of dI1-3 (Lee et al., 2000).  As a result, Wnt1 
and Wnt3a play an essential role in dorsal spinal cord patterning (Muroyama et al., 
2002).  
 
Additionally, it has been shown that canonical Wnt signalling is sufficient to induce the 
bHLH transcription factor Olig3, which is required for dI1-3 progenitors (Zechner et al., 
2007).  Zechner et al. (2007) demonstrated that Olig3 expression is lost from neural 
progenitors in β-catenin conditional mutant mice.  Also, they showed that Olig3 is 
ectopically expressed when β-catenin is constitutively expressed in the entire spinal 
cord axis.  Clearly, canonical Wnt signalling is involved in DV patterning. 
 
In a study using chick electroporation assays, the overexpression of Wnt1 and Wnt3a 
led to the expansion of dorsal genes (Pax6 and Pax7) and to the inhibition of ventral 
genes (Olig2 and Nkx2.2) (Alvarez-Medina et al., 2008).  On the other hand, the 
inhibition of the Wnt signalling pathway led to an opposite phenotype: the dorsal genes 
were inhibited, and the ventral genes were expanded dorsally (Alvarez-Medina et al., 
	 18	
2008).  Interestingly, Alvarez-Medina et al. (2008) reported that Wnt signalling could 
regulate DV neural tube patterning through the regulation of Gli3 expression, which 
represses Shh signalling.  They showed that Gli3 is expressed in dorsal spinal cord, and 
it was ventrally expanded when Wnt1/3a was overexpressed in the chick neural tube, its 
expression seemed to be directly regulated by canonical Wnt signalling.  Furthermore, 
in Wnt1/3a double mutant mice Gli3 expression was reduced. These results indicate that 
canonical Wnt signalling can regulate Gil3 expression in spinal cord. They have 
proposed that the patterning activity of canonical Wnt signalling is dependent on Gli3 
repressor form to antagonize Shh signalling in dorsal spinal cord.  Also, the authors 
showed that Wnt activity in DV patterning is independent of BMP activity.  Thus, Wnt 
signalling can control patterning in the DV neural tube through regulating Shh/Gli 
signalling. 
 
In addition, a ‘gain and loss of function’ study of zebrafish spinal cord concluded that 
Wnt signalling regulates patterning and proliferation: canonical Wnt signalling regulates 
patterning through TCF7 (transcriptional mediator) and proliferation through TCF3 
(Bonner et al 2008), indicating that canonical Wnt signalling plays roles in both 
proliferative and patterning activities. 
 
Recently, an in vivo experiment showed that β-catenin regulates the cell fate and 
polarity of the neuroblasts in chick neural tubes via atypical protein kinase C (aPKC) 
expression and localisation (Herrera et al., 2014).  Therefore, canonical Wnt signalling 
is required for proper development of the neural tube.  However, Wnt–FZD interactions 
in vivo in the neural tube have not been investigated. Hence, studying the FZD 
receptors of canonical Wnt signalling (Wnt1/3a) could provide an understanding of the 
	 19	
mechanism through which canonical Wnt signalling is able to regulate neural tube 
development. 
 
1-5 FZD receptors:  
  
FZDs are receptors for Wnts and other ligands. They are involved in the regulation of 
developmental processes such as cell polarity, neural patterning, cell proliferation and 
neural synapsis development (Clevers, 2006; Medina et al., 2000). The deregulation of 
FZDs causes many diseases including cardiac hypertrophy, cancer, neural tube defects 
and neural degeneration (Luo et al., 2007; Malaterre et al., 2007; Ueno et al., 2013; 
Wang et al., 2006). 
1-5-1 FZD structure and signalling:   
FZD receptors have been identified in both vertebrates and invertebrates. There are only 
four FZDs in Drosophila and C. elegans, whereas ten FZDs have been characterised in 
vertebrates, including mice and humans (Amerongen and Nusse, 2009). FZD receptors 
are classified into four groups based on amino acid sequence similarity (FZD1, 2 and 7; 
FZD3 and 6; FZD5 and 8; FZD4, 9 and 10) (Huang and Klein, 2004). 
FZDs are 7-pass transmembrane proteins and members of the G-protein-coupled 
receptor (GPCR) superfamily (Barnes et al., 1998; Wang et al., 2006) (Fig. 1.5). The 
length of FZD proteins is around 500–700 amino acids. FZDs consist of the N-terminal 
extracellular cysteine-rich domain (CRD), a linker region, the seven hydrophobic 
domains and C-terminal intracellular domain (MacDonald and He, 2012; Wang et al., 
1996; Barnes et al., 1998) (Fig. 1.4). The CRD length is around 120 amino acids, and it 
is conserved in all FZDs and binds to Wnts with great affinity (Bhanot et al., 1996; 
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Dann et al., 2001). The KTXXXW motif in C-terminal is necessary for activation of the 
canonical Wnt pathway (Umbhauer et al., 2000) (Fig. 1.5). 
	 		Fig. 1.5 Schematic illustration of FZD structure; CRD is extracellular domain where 
Wnts bind to FZDs followed by a linker region. 7TM are seven transmembrane 
domains. C-terminal is intracellular domain where KTXXXW motif is located.				
FZDs are expressed on the surface of Wnt-responsive cells and act as receptors for Wnt 
ligands (Bhanot et al., 1999). FZDs were first studied in Drosophila, in which dFZD1 
mutant flies exhibit cell polarity defects. The first evidence showing that FZDs bind to 
Wnts also came from studies of Drosophila: dFZD2 overexpression in non-sensitive 
Wnt cell cultures leads to Wnt binding and activation of canonical Wnt (Bhanot et al., 
1996). Furthermore, dFZD1/2 depletion mimics the Wingless mutant phenotype in 
Drosophila (Bhanot et al., 1999; Bhat, 1998). In addition, FZD receptors synergise with 
Wnts in axis duplication assays in Xenopus (Deardorff et al., 2001; Garcia-Morales et 
al., 2009; Yang-Snyder et al., 1996). Also, many reports have documented that FZD 
CRDs are required for Wnt binding (Hsieh et al., 1999; Wu and Nusse, 2002; Cadigan 
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et al., 1998; Rulifson et al., 2000; Zhang and Carthew, 1998). Furthermore, the crystal 
structure of FZD8-CRD and XWnt8-mFZD8CRD complex has confirmed and 
explained the mechanism of Wnt–FZD interactions (Hsieh et al., 1999; Dann et al., 
2001; Janda et al., 2012). Therefore, FZD receptors are needed for Wnt reception and 
signal transductions.  
FZDs mainly bind to Wnts, but they can also bind to other ligands including sFRPs and 
R-spondin (Rodriguez et al., 2005; Nam et al., 2006).  Binding of FZDs leads to Wnt 
signalling activation (Liu et al., 2003; Li and Bu, 2005).  Therefore, FZDs are able to 
activate both Wnt signalling pathways: the canonical (Wnt/β-catenin signalling) and the 
non-canonical (Wnt/PCP signalling and Wnt/calcium signalling). In FZD/β-catenin 
signalling, FZD binding with other co-receptors (LRP5/6) leads to the stabilisation and 
accumulation of β-catenin (Gordon and Nusse, 2006). In FZD/PCP signalling, this 
binding results in the activation of the c-Jun N-terminal kinase (JNK) pathway (Seifert 
and Mlodzik, 2007). In FZD/Ca2+ signalling, FZD binding leads to increased calcium 
levels inside cells, which results in the activation of calcium-responsive enzymes such 
as protein kinase C (PKC) (Kohn and Moon, 2005; Slusarski et al., 1997). 
1-5-2 FZDs and Wnt specificity:  
Wnt–FZD specificity is complicated and poorly understood for many reasons, including 
the ability of FZDs to activate multiple pathways. For example, FZD7 is able to mediate 
canonical Wnt and non-canonical Wnt signalling, as reported in chick somite and other 
systems (Medina et al., 2000; Gros et al., 2009).  Furthermore, Wnts can bind to 
multiple FZDs, and FZDs can engage with more than one Wnt ligand (19 Wnts– 10 
FZDs) (Hsieh et al., 1999b; Carmon and Loose, 2010). As an example, Wnt9a can bind 
to CRDs of FZD4, 7 and 9, as shown by immunoprecipitation assays in COS7 cells 
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(Matsumoto et al., 2008). Also, redundancy is common among FZD receptors, which 
makes it difficult to study an independent function for each FZD. In Drosophila, dFZD1 
and dFZD2 function redundantly, and both have to be mutant to produce a wingless-like 
phenotype (Chen and Struhl, 1999; Muller et al., 1999). Mouse genetic studies have 
reported that FZD1 and 2 exhibit redundancy in their function, as do FZD3/6 (Wang et 
al., 2006; Yu et al., 2010).  
However, several reports have documented the specificity of certain Wnts and their 
receptors. For example, in Drosophila, dFZD2-CRD has stronger binding affinity for 
Wg (ten-fold) than dFZD1-CRD (Rulifson et al., 2000). In addition, dFZD1 has a 
primary role in PCP signalling, whereas dFZD2 does not have a role in polarity 
(Rulifson et al., 2000).  
In Xenopus, axis duplication assays have shown many examples of Wnt–FZD 
selectivity. For instance, XWnt5a can only induce axis duplication when it is co-
injected with FZD5, but other examined FZDs do not have this effect (He et al., 1997). 
This suggests that FZD5 is a receptor for XWnt5a and mediates its activity in axis 
induction.  FZD10 shows interaction with Wnt1 but not Wnt3a, as reported in axis 
duplication assays (Garcia-Morales et al., 2009). Also, FZD8 has the ability to synergise 
with XWnt8, leading to induction of complete axes in Xenopus (Deardorff et al., 1998). 
Moreover, XWnt8 protein can interact with FZD8 protein, and FZD8-CRD binds to 
XWnt8 with higher affinity compared to other FZDs (Janda et al., 2012).  
In zebrafish, FZD3a interacts with Wnt8b and regulates the formation of forebrain 
commissures, and their independent knock-down leads to the same phenotype; 
commissural defects (Hofmeister and Key, 2013). 
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Luciferase assays have been used to dissect Wnt–FZD interactions in different cell 
lines.  FZD9 (Rfz9) strongly activates TCF transcription (Wnt/β-catenin reporter) when 
it is co-expressed with Wnt2, but not when it is co-expressed with other Wnts, as shown 
in 293T cells (Karasawa et al., 2002). This indicates that FZD9 is a receptor for Wnt2 
and mediates its function through canonical Wnt signalling.  Additionally, a recent 
study using the same cell line showed that Wnt2 can increase TCF activity more than 
fifteen-fold when it is co-transfected with FZD8 or 9, but not with the other eight FZDs 
(Bravo et al., 2013).  
Recently, Dijksterhuis et al. (2015) characterised a novel cell line called the mouse 
myeloid progenitor (32D). This cell line does not express FZD receptors, but it 
expresses LRP5 and 6. Therefore, the authors generated an overexpressing cell line for 
each individual FZD (FZD2, 4 and 5) and investigated their function and selectivity 
with multiple Wnts (Wnt3a, Wnt4, Wnt5a and Wnt9b). Interestingly, only Wnt3a could 
increase β-catenin stability and induce LRP6 phosphorylation (PS) in a dose-dependent 
manner in 32D/FZD2, 4 and 5 cells. However, a high concentration of Wnt5a was able 
to induce β-catenin stability in 32D/FZD5-expressing cells, but not in 32D/FZD2 or 
32D/FZD4 cells. This suggests Wnt5a prefers binding to FZD5. The authors also 
showed that phosphorylation (PS) of DVL2/3 was affected by Wnt–FZD selectivity. For 
instance, stimulation of Wnt3a and Wnt5b led to the formation of PS-DVL3 but not PS-
DVL2 in 32D/FZD5 cells. Obviously, Wnt–FZD pair binding has a different biological 
activity, as reported in this cell line. Therefore, this cell line and other approaches could 
help dissect receptor–ligand interactions and explain the downstream effects of each 
Wnt–FZD pair. Additionally, studies of Wnt–FZD signalling are necessary to tackle 
Wnt-related diseases, such as cancer, neural tube defects and neurodegenerative 
diseases.   
	 24	
1-5-3 Wnt/FZD signalling and diseases: 
1-5-3-1 FZDs and cancer: 
Wnt signalling is known to regulate cell Proliferation and reportedly, Wnt components 
are highly expressed in human cancers, such as lung, breast and colon cancer 
(Amerongen and Nusse 2009; Bravo et al., 2013; Gurney et al., 2012; Ueno et al., 
2013). Moreover, FZDs are overexpressed and involved in several human cancer types 
(Ueno et al., 2013). For example, FZD1 is overexpressed in colon cancer (Holcombe et 
al 2002), and a high expression of FZD3 has been found in chronic lymphocytic 
leukaemia cells and in lymphoma cells (Lu et al., 2004; Qiang et al., 2003). Also, FZD5 
overexpression is seen in kidney and prostate cancer (Janssens et al., 2005; Thiele et al., 
2011). FZD7 is highly expressed in more than six colorectal cancer lines (Ueno et al., 
2008) while FZD8 is upregulated in several types of lung cancer (Bravo et al., 2013). 
FZD10 is strongly expressed in colon, lung and sarcoma cancer (Terasaki et al., 2002; 
Nagayama et al., 2005).  
FZD knockdown approach was used in different cell lines.  FZD7-siRNA reduced 
invasion activity and cell viability in colorectal cancer lines (Ueno et al., 2008). In lung 
cancer cell lines, the targeting of FZD8 by shRNA resulted in a significant reduction in 
proliferation (Wang et al., 2012). Moreover, FZD8-shRNA inhibited tumour growth in 
vivo, as seen in xenograft mouse models. Notably, both studies showed that knockdown 
of either FZD7 or FZD8 reduced the canonical Wnt signalling. In addition, FZD10-
siRNA suppressed tumour growth in synovial sarcomas cell lines (Nagayama et al., 
2005). Therefore, FZDs are involved in many cancer types, so targeting these receptors 
could be a valuable tool for treating cancer. 
	 25	
Additionally, antibodies can be used against FZDs in cancerous cells. MAb 92-13 
antibody is specifically bound to FZD10-overexpressing tumours, allowing these 
tumours to be targeted by radio-immunotherapy (Fukukawa et al., 2008). Another 
antibody called OMP-18R5 (a human IgG2 isotype) has been identified that can bind to 
five different FZDs (FZD1, 2, 5, 7 and 8) through a conserved epitope (Gurney et al., 
2012). OMP-18R5 inhibits the canonical Wnt signalling by preventing Wnt ligands 
from binding to FZD receptors.  This antibody suppresses several kinds of human 
tumours including breast, colon and pancreatic cancer. Furthermore, it has shown strong 
synergy with many chemotherapy drugs, such as taxol. 
It has also been shown that microRNAs are able to regulate FZD expression (Ueno et 
al., 2013). For instance, FZD1 is inhibited by miR-204 overexpression (Li et al., 2011), 
and miR-23b regulates FZD7 in colon cancer cells (Zhang et al., 2011). Thus, 
microRNAs can be used to suppress tumour growth that result from overexpression of 
Wnt pathway components, including FZDs. 
 
1-5-3-2 Wnt/FZD signalling and neural tube defects: 
Neural tube is formed through the process of primary and secondary neurulation. 
Primary neurulation leads to neural tube formation and closure, while in secondary 
neurulation the interior of a solid precursor is hollowing out to form the caudal end of 
the neural tube. Most neural tube defects (NTDs) are a result of the failure of neural 
tube closure during primary neurulation in the brain or spinal cord (Greene and Copp, 
2009).   
Both canonical and non-canonical Wnt signalling are implicated in NTDs. Disruption of 
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non-canonical Wnt (PCP) components leads to NTDs, as shown in mutant mice of 
Vangl2, Celsr1 and Scrb1 (Curtin et al., 2003; Murdoch et al., 2003). Also FZDs, Wnt 
receptors, are involved in neural tube closure, as FZD1/2 and FZD3/6 mutant mice 
exhibited NTD phenotypes (Yu et al., 2010; Wang et al., 2006). In addition, DVL is 
involved in neural tube closure, as Dvl1–Dvl2 double-knockout mice show severe NTD 
phenotypes in which the neural tube fails to close along the anterior–posterior axis  
(Hamblet et al., 2002). 
A recent study showing the importance of canonical Wnt signalling (Wnt/β-catenin) in 
neural tube closure reports that spina bifida aperta, a NTD, was observed in β- catenin 
conditional knockout in Pax3-expressing cells in the dorsal neural tubes of mice (Zhao 
et al., 2014). Caudal axis bending and tail truncation were present in this mutant. Pax3 
and Cdx2 play a very important role in caudal neural tube closure, and their expression 
was repressed in this mutant (Zhao et al., 2014).  
In addition, the gain or loss of function of LRP6 (FZD co-receptor) affects neural tube 
closure, resulting in NTDs (Allache et al., 2014; Gray et al., 2013; Pinson et al., 2000). 
In both mutants, LRP6-dependent NTDs are linked to disruption of apical–basal cell 
polarity in the neural folds through RhoA activity (Gray et al., 2013). Recently, three 
mutations in LRP6 orthologs were found in NTDs in humans (285 patients were studied 
that have different forms of open and closed phenotypes of NTDs such as 
Myelomeningocele) (Allache et al., 2014). These mutations have an effect on Wnt 
pathways (Allache et al., 2014). Thus, Wnt signalling plays a crucial role in the process 
of neural tube development, including closure during neurulation.   
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It is worth mentioning that the dysregulation of Wnt signalling is also implicated in 
neurodegenerative diseases such as Huntington’s, Alzheimer’s and Parkinson’s disease 
(Galli et al., 2014; Inestrosa and Toledo, 2014; Salinas, 2012). In Alzheimer’s disease 
(AD), it was found that β-catenin levels are reduced in AD brains, whereas Wnt/β-
catenin inhibitors (GSK-3β) are active (Pei et al., 1999). The activation of Wnt/β-
catenin signalling can stop β-amyloid peptide (Aβ)-induced neurotoxicity in cultured rat 
hippocampal neurons (De Ferrari et al., 2003; Alvarez et al., 2004). In addition, it was 
reported that Wnt3a can activate Wnt/β-catenin signalling through FZD1 (not FZD2) 
and has a protective effect against Aβ toxicity in hippocampal neurons and PC12 cells 
(Chacon et al., 2008). FZD1 overexpression along with Wnt3a leads to a significant 
increase in cell survival and prevents caspase-3 activation and degradation of β-catenin 
in the same cell line. This protective effect seems to be a result of Wnt/β-catenin 
signalling activation which in turn down-regulates Wnt inhibitors such as DKK1 and 
GSK-3β.  These inhibitors are found to be overexpressed in AD brains (Galli et al., 
2014; Inestrosa and Toledo, 2014). 
Furthermore, DKK1 expression level is upregulated in AD brains (Caricasole et al., 
2004). Interestingly, the blockade of DKK1 suppresses Aβ-induced synaptic 
degeneration (Purro et al., 2012). On the other hand, inducible expression of DKK1 in 
the striatum of adult mice leads to a Wnt/β-catenin signalling blockade as well as 
synaptic defects and degeneration (Galli et al., 2014). Therefore, sustained Wnt/β-
catenin signalling is important for adult neurogenesis. Also, targeting Wnt inhibitors 
such as GSK-3β and DKK-1 could be a useful approach for the treatment of 
neurodegenerative diseases (Purro et al., 2012; Inestrosa and Toledo, 2014; Salinas, 
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2012). 
 
1-6 Expression and function of FZDs during development: 
FZDs are expressed in different embryonic tissues and are implicated in many 
developmental processes. In Drosophila, dFZD1 expression has been found in the 
epidermis and other tissues, such as the wing (Adler and Lee, 2001). dFZD2 expression 
has been reported during embryogenesis in many cell types, such as in the epidermis 
and mesoderm. In late stages, dFZD2 expression was seen exclusively in the hindgut, 
dorsal vessel and the CNS (Bhanot et al., 1996).  
The function of FZDs has been investigated in flies via genetic screens and RNA 
interference.  The loss of dFZD1 function affects cell polarity in the sensory bristles, 
dorsal epidermis and wings (Vinson and Adler, 1987; Gubb and Garcia-Bellido, 1982). 
Also, flies lacking both dFZD1 and dfZD2 show abnormalities in embryo patterning, 
neuroblast specification and heart formation (Bhat, 1998; Muller et al., 1999).  
In zebrafish, Nikaido et al. (2013) preformed a comprehensive expression analysis, and 
studied the function of zFZD genes during embryogenesis. They identified thirteen FZD 
members and showed that their expression patterns are dynamic and overlapping in 
zebrafish embryo. For example, zFZD3a/9b/10 expression is overlapping in the dorsal 
neural tube, and zFZD7b/10 are expressed in the neural plate border. In this study, it 
was reported that zFZD7a/7b knockdown affected convergent extension movement 
during gastrulation.  Also, the inhibition of zFZD7a, zFZD7b and zFZD10 by 
morpholino leads to severe defects in mesodermal convergent extension.  
In Xenopus, xFZDs show dynamic expression in the early and late stages of developing 
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embryos. They are involved in different cellular processes including axis formation, 
patterning and neurogenesis. Some xFZDs are expressed while neurogenesis takes 
place, for example: xFZD2/3/4/7/10 are expressed in developing neural tissues 
(Deardorff et al., 2001; Moriwaki et al., 2000; Shi and Boucaut, 2000; Wheeler and 
Hoppler, 1999); xFZD2 expression is found in the otic vesicle, the somite and the eye 
(Deardorff and Klein, 1999); and xFZD3 is detected in the neural plate, the neural tube 
and the eye (Shi et al., 1998), where it is able to regulate eye formation during 
development. The overexpression of xFZD3 results in ectopic eye formation, whereas 
the overexpression of a dominant negative form of xFZD3 inhibits the expression of eye 
markers such as Pax6 and Otx2 and eyes were malformed in Xenopus  embryos 
(Rasmussen et al., 2001). It has also been shown that xFZD3 knockdown by morpholino 
inhibits neural crest induction (Deardorff. et al., 2001). In addition, xFZD4 is expressed 
during gastrulation and in the forebrain (Shi and Boucaut, 2000).  
 FZD2 FZD3 FZD4 FZD7 FZD8 FZD10 
Spemann organiser     X  
Neural tissues X X X X X X 
Otic Vesicle  X      
Eye  X X     
Somite  X      
Heart     X   
Table. 1.1 Summary of FZDs expression in Xenopus. 
The expression of xFZD7 was found to be expressed in many tissues, including the 
neural tube, the neural crest and the heart (Wheeler and Hoppler, 1999), and it plays 
roles in early patterning, proliferation and morphogenesis (Medina et al., 2000; Zhang et 
al., 2013). Furthermore, xFZD7 overexpression or knockdown affects neural crest 
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development and neural tube patterning (Abu-Elmagd et al., 2006; Carla-Morales, 
2008). xFZD8 is expressed in early developing cells including the Spemann organiser. 
The injection of xFZD8 RNA into ventral blastomeres leads to secondary axis 
formation, and it also synergises with XWnt8 (Deardorff et al., 1998). This report 
concluded that xFDZ8 is a receptor for Wnts and is involved in the morphogenesis of 
developing embryos.  
In chickens, FZDs are expressed in the developing embryo in different tissues including 
the eye, somite, limb bud and neural tube (for more details see Chapter 3).  
 
In mice, mFZDs are expressed during embryogenesis and adulthood and show specific 
and complex expression patterns (Borello et al., 1999; Summerhurst et al., 2008). Their 
expression is detectable by in situ hybridisation during the early stage of development 
(5.5 days). For example, mFZD5/8 are expressed in the visceral endoderm, and mFZD7 
is expressed in the epiblast during gastrulation  (Lu et al., 2004; Kemp et al., 2007).  
Borello et al. (1999) performed a complete expression profile for mFZDs during the 
segmentation stage by in situ hybridisation. They showed that mFZDs are expressed in 
different tissues including somites, neural tube and limb bud. For instance, 
mFZD1/3/6/7/8/9 are present in developing somites as well as in the neural tube, except 
for mFZD6. Notably, mFZD3 is expressed in the dorsal neural tube while mFZD7 
expression is restricted to the intermediate-ventral region of the neural tube. mFZD4/5 
are detected  in  the ventral telencephalon. Moreover, Borello et al. (1999) reported that 
some mFZDs (1/3/5/6) are expressed during eye development, suggesting a role for 
these receptors in eye formation.  
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mFZD 3, 5 and mFZD8 were shown to be expressed in the mouse developing 
hippocampus (Davis et al., 2008). Therefore, the dynamic and specific expressions of 
mFZDs in different embryonic tissues suggest important roles for these receptors during 
development.  
 FZD1 FZD3 FZD4 FZD5 FZD6 FZD7 FZD8 FZD9 FZD10 
Visceral 
endoderm 
   X   X   
The 
epiblast 
     X   X 
Somite X X   X X X X  
Eye X X  X X    X 
Neural 
tube 
 X    X X X X 
Hippocampus  X  X   X   
Table. 1.2 Summary of FZDs expression in mouse. 
FZD knockout produces different developmental defects. mFZD1/2 mutant exhibits 
developmental defects in the ventricular septum and the palate closure (Yu et al., 2010). 
Furthermore, the loss of mFZD2 in developing lung epithelium causes defects in 
branching morphogenesis (Kadzik et al., 2014). mFZD3 knockout mice show severe 
defects in axon development in the central nervous system (Hua et al., 2014; Wang et 
al., 2001; Wang et al., 2006). The loss of mFZD4 leads to abnormalities in the 
cerebellum, retina and cochlea (Xu et al., 2004; Wang et al., 2001). mFZD5 knockout 
causes yolk defects, leading to embryonic lethality (Ishikawa et al., 2001). Moreover, 
mFZD5 conditional loss-of-
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increased cell death in the ventral retina (Liu et al., 2008). The loss of mFZD6 results in 
a polarity defect in which hair is mis-orientated  (Guo et al., 2004). mFZD3/6 double 
mutant leads to defects in tissue closure, where the neural tube and eyelid fail to close 
(Wang et al., 2006). Also, the patterning and polarity of inner-ear sensory hair cells are 
affected by the mFZD3/6 double mutant. The loss of mFZD9 produces abnormal B-
cells, which implies that mFZD9 controls B-cell development (Ranheim et al., 2005).  
Thus, these phenotypes indicate that mFZDs plays many important roles during mouse 
embryo development. However, which specific Wnt ligands bind to which of these 
FZDs must still be investigated in vivo. 
 
 
In this project, we used chick embryo as a model system. Chick embryos allow 
researchers to study genes expression and function at the molecular level during 
development (Mok et al., 2015).  The chick neural tube is a widely used model system 
to study tissue patterning and in particular spinal cord development and to perform 
transient genetic manipulations. Spinal cord model allows researchers to study many 
biological events during neural development such as proliferation, patterning, 
specification and neural tube closure (Becker and Corral, 2015). Therefore, we used 
chick neural tube as a model system to study Wnt/FZD signalling during dorsal-ventral 
spinal cord neurogenesis.  
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1-7 The project background and aims:  
 
FZD10 is expressed in the dorsal neural tube in Xenopus, chicken, zebrafish and mouse 
(Wheeler and Hoppler, 1999; Yan et al., 2009; Kawakami et al., 2000; Nasevicius et al., 
2000).  This could suggest a role for FZD10 during spinal cord development. Previous 
studies on FZD10 in the Wheeler lab in Xenopus showed that FZD10 is expressed in 
the dorsal neural ectoderm and neural folds in the region where primary sensory 
neurons develop (Garcia-Morales et al., 2009).  Their studies into loss of function in 
Xenopus showed that FZD10 is required for sensory neurons to form. Also, FZD10 
mediates canonical Wnt signalling and interacts with Wnt1 and Wnt8 but not Wnt3a, as 
shown in synergy assays. Therefore, they proposed that FZD10 functions through 
canonical Wnt signalling and may mediate Wnt1 activity to determine sensory neural 
differentiation in Xenopus.  
 
However, further study is needed to examine the role of FZD10 in proliferation and 
differentiation of neurons and investigate its interaction with Wnts, FZDs and the FZD 
co-receptor (Lrp6) in vivo during spinal cord neurogenesis.  
 
So, this project aimed to study FZDs expression in chick neural tube and to investigate 
the regulation of FZD10 by dorsal Wnts. Wnt1 and Wnt3a are co-expressed in the roof 
plate and they show a complete overlapping expression pattern.  Many studies have 
shown that Wnt1 and Wnt3a are required for neural tube development (e.g., Chesnutt et 
al., 2004; Dickinson et al., 1994; Megason and McMahon, 2002; Muroyama et al., 
2002; Alvarez-Medina et al., 2008).  
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We also aimed to determine whether FZD10 only interacts with Wnt1 and not with 
Wnt3a in vivo, similar to what had been observed in Xenopus laevis.  
 
-The objectives of the project were: 
1-To characterise FZDs expression in chick neural tube. 
2- To establish FZD10 expression pattern using in situ hybridisation. 
3-To compare FZD10 expression to dorsal Wnt ligands expression (Wnt1, Wnt3a) 
during chick neural tube development.  
4-To investigate the regulation of FZD10 by dorsal Wnts (Wnt1/3a) in the spinal cord 
using electroporation and in situ hybridization. 
5-To study the function of FZD10 in spinal cord. In vivo approaches (electroporation) 
were used. 
6-To investigate Wnt1, FZD10 and Lrp6 interactions in vivo during spinal cord 
neurogenesis using electroporation.   
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Materials and Methods 
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2- Materials and Methods:   
2-1-RNA extraction and purification:  
Chicken eggs (White leghorn) were obtained from Henry Stuart and Co. Lincolnshire. 
They were incubated at 38oC until desired stages and the embryos were staged 
according to Hamburger and Hamilton (1992). 
After three (HH18) or four days (HH24) of development, embryos were dissected in 
cold DEPC-PBS. Then, the dissected embryos were transferred into Eppendorf tubes 
containing 1ml of Trizol on ice, tubes were then vortexed  until all embryonic tissues 
were completely dissolved in Trizol.     
 
To purify the RNA, 200µl of chloroform was added to 1ml of Trizol. The mixture was 
incubated for 5mins, then centrifuged at 4ºC for 25 minutes. The upper phase of the 
mixture was transferred into a new tube and 500µl of isopropanol was added.  This was 
followed by adding 1.2M of NaCl and tubes were incubated for 15mins at room 
temperature after which the mixture was centrifuged for 20mins at 4ºC. The supernatant 
was discarded and the pellet was washed with 100µl of fresh 70% EtOH. Tubes were 
centrifuged for 10mins and the supernatant was discarded. The pellet was left to dry at 
room temperature or in a heat-block at 37 oC. The pellet was dissolved in 20ul of Sigma 
water. To check the RNA concentration, the nanodrop spectrophotometer was used.  
Purified RNA was stored at -20ºC for short storage (up to 3 days) or at -80ºC for long-
term storage.  
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2-2-cDNA synthesis: 
To prepare 20µl of cDNA for PCR cloning, SuperScriptTM II Reverse Transcriptase 
protocol was followed: 
-1ng of RNA 
-1µl of Oligo dTs 
-1µl of dNTPs 
-9µl of Sigma H2O 
Incubate the mixture at 65ºC or 75ºC for 5mins using the PCR machine, then place the 
tube on ice. Then add: 
 -4µl of  5X FSB (5x First strand buffer) 
-2µl of DTT 
-1µl of RNasin 
Incubate at 47ºC for 2mins in the PCR machine. Then add 
- 1µl of SSII (SuperScript II)  
Incubate at 42ºC for 50mins, followed by 15mins  at 70ºC in the PCR machine. Store 
the 20µl of cDNA at -20ºC and check successful synthesis using GAPDH primers in a 
PCR reaction. A product of the correct size was obtained.  
2-3-Cloning of full length of FZD10: 
The full length cDNA sequence for FZD10 was obtained from the National Center for 
Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov) with accession 
numbers (NM_204098.2).  Also, FZD10 full sequence is available from The Ensembl 
database (http://www.ensembl.org/index.html).  Two pairs of primers were designed 
using online software such as Primer3Plus.  
2-4-Primer design to clone FZD10:  
-Forward primer: Not1+FZD10 
FW: 5’GCGGCCGCATGTGCGAGTGGAAGAGGTG 3’ 
-Reverse primer: EcoR1+ HA tag +FZD10 
	 38	
RW: 5’GAATTCTCAAGCGTAATCTGGAACATCGTATGGGTA-
TCATACACAGGTGGGTGGTTG 3’ 
 
2-5-PCR reaction and conditions: 
-PCR reaction-mix (30µl): 
  2µl cDNA 
  20µl BioMix (BioMix™ Red) (http://www.bioline.com/uk/biomix-red.html) 
  1µl 10µM Forward primer 
  1µl 10 µM reverse primer 
  1µl DMSO 
  5µl H2O 
 
-PCR condition: 
  1-95ºC 1min 
  2-95ºC 1min 
  3-65ºC 2mins 
  4-72ºC 1min 
  5-go to step 2 for 29 more times 
  6-72ºC for 10 mins. 
 
After that, PCR product was checked using agarose gel electrophoresis. 
 
2-6-Agarose gel electrophoresis:  
0.5g of agarose was mixed with 50ml of TAE buffer in a flask. The agarose was 
dissolved using a microwave for 1-2mins. Then the agarose was left to cool down and 
3.5µl of Ethidium bromide was added to the agarose, mixed and then poured in a gel 
tank containing well comb and left to set for 5mins. TAE buffer was added until the 
agarose gel was covered. All samples, 20 ul of PCR product, were mixed with loading 
buffer, containing dye, before being run in the gel at 75V, electrophoresis for 30mins.  
(https://www.addgene.org/plasmid-protocols/gel-electrophoresis/) 
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2-7-DNA extraction from agarose gel: 
Agarose gel was run for 30mins until DNA fragments were separated. DNA was 
visualized using UV illumination (around 210-285nm). The agarose gel containing the 
DNA fragment (PCR product) was extracted using a clean razor blade and was purified 
following GeneJET Gel Extraction Kit protocol (Life Technologies). The agarose gel 
containing the DNA band was placed into a pre-weighed 1.5 mL tube then the tube was 
weighed with the agarose gel. 1:1 volume of Binding Buffer was added to the agarose 
gel. The gel:buffer mixture was incubated at 50-60°C for 10 min. The tube was 
vortexed every few minutes to mix and dissolve the gel then 800 µl of the mixture was 
loaded into the GeneJET purification column. The column was centrifuged for 1 min 
and the flow through was discarded. 100 µl of Binding Buffer was added to the column 
and centrifuged for 1 min. The flow through was discard and the column was placed 
back into the same collection tube. 700 µl of Wash Buffer was added to the column and 
centrifuged for 1 min. The flow through was discard and the column was placed back 
into the tube. The empty column was centrifuged for an additional 1 min to completely 
remove residual wash buffer. The column was transferred to a clean 1.5 ml Eppendorf 
tube. 20-50 µl of Elution Buffer or dH2O was added to the centre of the purification 
column membrane. The column was incubated for 1min then centrifuged for 1 min. The 
column was discarded and the purified DNA was stored at -20°C.  
(https://tools.lifetechnologies.com/content/sfs/manuals/MAN0012661_GeneJET_Gel_E
xtraction_UG.pdf). 
2-8-Cloning of FZD10 into plasmid vector: 
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FZD10 fragment was first ligated into pGEM-T easy vector and was then subcloned 
into pCAB-IRES-GFP vector.  
 
 
2-8-1-Ligation of FZD10 into pGEM-T easy vector: 
pGEM-T easy vector is commonly used in cloning and makes the PCR product ligation 
efficient and quick because of   3’-T overhangs at the insertion site (Promega). FZD10 
fragment was ligated into pGEM-T easy vector by assembling the following reaction 
mix: 
 
-Ligation reaction (10µl): 
0.5µl of pGEM-T easy vector (25ng) 
2µl of FZD10 
5µl 2X rapid ligation buffer  
1µl T4 DNA ligase 
1.5µl H2O 
-Incubate for 2-4hours at room temperature.  
The ligated DNA was transformed into competent DH5α E-Coli (see 2-9). We took 
advantage of blue/white screening that is available for the  pGEM-T easy vector system. 
For this, X-gal and IPTG were added to LB-CARB plates. Successful ligation of the 
insert will disrupt the production of β-galactosidase enzyme so the colonies’ colour will 
be white. Unsuccessful ligation will result in blue colonies. After 24hours of incubation 
at 37°C, the LB plates were checked and then white colonies were picked up to do 
colony PCR, which was performed using FZD10 primers to screen many colonies. The 
colonies that contained FZD10 fragment were grown in LB-CARB media for future 
use. Mini prep was performed (see 2-10-1) in order to purify FZD10 DNA. The plasmid 
insert was confirmed by sequencing and pGEM-T-FZD10 was used to generate in situ 
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probe for FZD10. After that, the full length sequence of FZD10 was subcloned into 
pCAB-IRES-GFP for functional studies.  
 
2-8-2-Ligation of FZD10 into pCAB expression vector: 
The full length of FZD10 was digested with restriction enzymes (Not1+EcoRI) from 
pGEM-T easy vector. The expression vector (pCAB-IRES-GFP) was cut with the same 
enzymes to generate compatible ends.   
 
-Digestion reaction (20µL):  
1µg DNA (pGEM-T-FZD10 or pCAB-IRES-GFP) 
1µl of Not1 
1µl EcoRI 
4µl 10x Buffer 
X µl dH2O up to 20 µL 
-Incubate for 4 hour at 37ºC or overnight. 
 
Then both, the full length of FZD10 and the linearized plasmid were run on an agarose 
gel (see 2-6) the relevant bands were extracted and purified from the gel (see 2-7). 
After purification of FZD10 and pCAB-IRES-GFP, ligation was performed at a vector 
to insert ratio of 1:1 or 1:3. To determine the volumes needed the Ligation Calculator 
was used (http://www.insilico.uni-duesseldorf.de/Lig_Input.html). 
 
-Ligation reaction (10µl):  
X µl of pCAB-IRES-GFP 
X µl of FZD10 
5µl 2X rapid ligation buffer  
1µl T4 DNA ligase 
X µl H2O up to 10µl 
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-Incubate for 2-4hours at room temperature or O/N.  
Ligated plasmid was transformed into competent DH5 E-Coli (2-9). 
 
 
 
2-9-Plasmid transformation:  
 
1µl of DNA plasmid was added to 200µl of competent E. coli cells and incubated on ice 
for 30mins.  The cells were heat-shocked for 5mins at 37oC to take up the plasmid, and 
then they were incubated on ice for 5mins.  600µl of SOC medium was added and the 
cells were incubated for 1hour at 37oC to recover.  The transformants were spun down 
briefly and most of the supernatant was removed.  The bacterial pellet was suspended 
by pipetting and was plated out on a LB agar plate containing the appropriate antibiotic 
(i.e. Carbenicillin).  The plate was incubated overnight at 37oC. 
2-10-DNA purification and preparation:  
A single colony of transformed cells was picked and used to inoculate 5 or 50ml of 
LB/antibiotic medium to be incubated in a shaker (approx. 300 rpm) overnight at 37oC.  
The LB/antibiotic medium was then transferred to a 15 or 50ml tube to be spun down 
for 10/30 mins at 4oC.  The DNA plasmid was purified using Plasmid Mini/Midi Kits.  
The concentration of the purified DNA was measured using a Nanodrop and checked on 
an agarose gel (electrophoresis). 
 
2-10-1-Mini preparation of DNA plasmid: 
DNA purification was performed according to the manufacturer’s instructions of the 
reSource Plasmid Mini Kit protocol.  Briefly, a single colony was picked from a LB 
medium plate and was incubated in 5 ml LB medium/antibiotic in a 20ml tube. The tube 
was incubated over night at 37°C with shaking. The bacterial cells were harvested by 
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centrifugation for 10 mins at 4°C. the supernatant was removed and the bacterial cells 
pellet was re‐suspend in 250µl Buffer1+RNaseA then was transferred to a clean 
Eppendorf tube. The cell pellet was completely suspended by vortexing. 250 µl of 
Buffer2 was added that lysed the bacterial cells and mixed by inverting the tube 4–6 
times. 350 µl of Buffer3 was added that  led to DNA precipitation and the mixture was 
inverted 4–6 times. The tube was centrifuged for 10mins at 13,000 rpm. The spin 
column was placed in 2ml collection tube. The supernatant was transferred to the spin 
column by pipetting in the collection tube. Then, it was centrifuged for min and the 
supernatant was discarded. The spin column was washed with 0.5ml buffer B and was 
spun for 1min. after discarding the supernatant, the spin column was washed by adding 
0.75ml bufferE (ethanol ???) and was centrifuged for 1min. The supernatant was 
discarded and the spin column was centrifuged again to get rid of residual ethanol.  
The spin column was placed in a clean 1.5 ml  Eppendorf tube. DNA was eluted by 
adding 50µl Elution Buffer or 50µl water to the centre of the column. After 1min, the 
Eppendorf tube was centrifuged for 1min and  the column was discarded. The eluted 
DNA was stored at -20ºC for further use 
(http://www.lifesciences.sourcebioscience.com/clientupload/productinfo/sbs27104.pdf). 
2-10-2-Midi preparation of DNA plasmid: 
Electroporation  requires highly purified and concentrated DNA. For this, we used Midi 
prep kit (NucleoBond Xtra Plasmid Plus). The DNA purification was performed 
according to NucleoBond Xtra Plasmid Midi Kit protocol.  A single colony was picked 
from a LB medium plate containing antibiotic and was incubated in 5 ml LB medium+ 
appropriate antibiotic in a 20ml tube overnight. Then, 1ml of LB medium was 
transferred to 50ml LB medium+ appropriate antibiotic in a flask and then was 
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incubated over night at 37°C with shaking. The LB medium was transferred to 50ml 
tube. The tube was centrifuged for 15min at  4°C to harvest the  bacterial cells. Then the 
LB medium was discarded and the  bacterial cell  pellet remained in the tube. 
The pellet was completely re-suspended in 8ml Resuspension Buffer (RES) + RNaseA 
by pipetting and vortexing. 8ml Lysis Buffer (LYS) was added and mixed by inverting 
many times. The mixture was incubated for 5min at room temperature. While 
incubating, a NucleoBond® Xtra Column was equilibrated by adding 12ml  
Equilibration Buffer (EQU) and the column was allowed to empty by gravity. 
After the incubation, 8ml Neutralization Buffer (NEU) was added to the mixture and 
suspended by inverting until the mixture turned colorless, indicating that the completion 
of precipitation of SDS, protein, and genomic DNA. After that, the mixture was 
transferred to the NucleoBond® Xtra Column. The column was allowed to empty  by 
gravity. 
The NucleoBond® Xtra Column Filter and Nu- cleoBond® Xtra Column was washed 
with 5ml Equilibration Buffer (EQU). The NucleoBond® Xtra Column Filter was 
removed and the Nu- cleoBond® Xtra Column was washed with 8ml Buffer WASH. 
DNA was eluted by adding 5ml Elution Buffer (ELU) and was collected in a 15ml tube.  
To concentrate eluted DNA, 3.5ml isopropanol was added to the DNA at room-
temperature. The mixture was vortexed and left for 2min. The plunger of a 30ml syringe 
was removed and NucleoBond® Finalizer  was attached to the syringe. The 
precipitation mixture was loaded into the syringe, then the plunger was inserted. The 
plunger was used to push the mixture slowly through the NucleoBond® Finalizer. The 
NucleoBond® Finalizer was removed and the plunger was pulled out from the syringe. 
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The NucleoBond® Finalizer was reattached to the syringe and 2ml of freshly prepared 
70% ethanol was loaded into the syringe. Then, the plunger was inserted and pressed to 
discard the supernatant. The NucleoBond® Finalizer was dried by inserting the plunger 
into the syringe many times.  
To elute DNA, The NucleoBond® Finalizer was removed from the 30ml syringe and 
attached to a 1ml syringe after removing the plunger. 100-200ul of Buffer TRIS or 
water was loaded into the syringe. Then the plunger was inserted to press DNA into the 
collection tube. The eluted DNA concentration was measured using the nanodrop 
spectrophotometer and was stored at -20ºC for electroporation. (NucleoBond Xtra 
Plasmid DNA Purification User Manual (PT4011-1)_Rev_12-2.pdf) 
2-11-cloning of short fragments of FZD receptors: 
Frizzleds sequence was obtained from NCBI; (NCBI; http://www.ncbi.nlm.nih.gov) 
with the following accession numbers: 
-FZD2 (NM_204222) 
-FZD3 (NM_001271940) 
-FZD6 (NM_001271931) 
-FZD7 (NM_204221) 
-FZD10 (NM_204098.2) 
 
 
2-11-1- designed primers for FZD cloning: 
N Name Forward Reverse 
1 FZD2 CTGGAAAAGCTGGAAATGGA TAACGTGAGCTGATGGCTTG 
2 FZD3 GCGGCCGCATGGCTGTTAGCTGGATGTTCTGC ACTGCCAGCCATGGTAAAGA 
3 FZD6 CACTGCTCCTGTAACCACCA TGACCCACCATATTGTTCCTG 
4 FZD7 CAGAGCGACCCATCATCTTC TGCGGAACAAGGACACAAAG 
5 FZD10 CCTCAGCGTTTCAAGTACCC GGCCACAAAACCAGAAAGAA 
6 M13 GTAAAACGACGGCCAG CAGGAAACAGCTATGAC 
7 pCaB GGCAGGAAGGAAATGGGCGGGGA GGCCCTCACATTGCCAAAAGACG 
8 GapDH CCTCTCTGGCAAAGTCCAAG CATCCACCGTCTTCTGTGTG 
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Table 2-1: Primers were used for cloning and sequencing.  
 
 
 
2-11-2-PCR reaction and condition: 
Chick FZD receptors were amplified by PCR from cDNA made from 3 or 4 days old 
chick embryos (see 2-1 and 2-2). 
 
-PCR reaction (20ul): 
 1µl cDNA 
 10µl BioMix (Sigma) 
 1µl Forward primer 
 1µl Reverse primer 
 7µl H2O 
 
-PCR condition: 
    1- 95ºC 3mins 
    2- 95ºC 1min 
    3- 56ºC 1min 
    4- 72ºC 1min 
    5- go to step 2 for 29 more times 
    6- 72ºC 8mins. 
Then the PCR products were purified (see 2-6 and 2-7) and cloned into pGEM-T easy 
vector (see 2-8-1). All FZD receptor fragments were confirmed by sequencing and then 
in situ probes were made (see 2-14).  
 
2-12-Electroporation: 
After Nakamura et al (2004), the white eggs were incubated at 38oC until the embryos 
reached the desired Stage HH12-14.  The eggs were opened at the broad end and 
ink/PBS/ penicillin/streptomycin mix was injected underneath the embryo to improve 
contrast and ease targeting.  Embryos were injected by micro-injector into the neural 
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tube with the plasmid DNA mixed with 1% fast green. After injection, electroporation 
was performed by placing the electrodes on both sides of the embryo (i.e., the positive 
electrode on the right-hand side of the embryo and the negative one on the left) (Fig. 2-
1B).  The conditions for electroporation 20 or 24Voltage, Pulse number: 5, Pulse length: 
50msec, Pulse interval: 100msec. After the electroporation, PBS/P/S was added onto the 
top of the embryos and the eggs were sealed with clear tape. They were then re-
incubated for 24 or 48 hours at 38oC.  Lastly, the electroporated embryos were dissected 
and GFP/RFP expression was visualised (Fig. 2-1C-D).  
Number Name  Obtained from  
1 pCiG-Wnt1-IRES-GFP Elisa Martí.  
(Megason and McMahon, 2002)  
2 pCiG-Wnt3a-IRES-GFP Elisa Martí 
(Megason and McMahon, 2002) 
3 pCaB-dnWnt3a-IRES-GFP Andrea Münsterberg lab 
4 pCaB-FZD10-IRES-GFP PCR 
5  pCS2-GFP Andrea Münsterberg lab 
6 FZD10 shRNAs (A, B and C) see 2-13 Origene 
7 Scrambled shRNA see 2-13 Origene 
8 pCiG-IRES-GFP (Megason and McMahon, 2002) 
9 pCAB-IRES-GFP Andrea Münsterberg lab 
10 pCS2-hLrp6 Addgene  
Table 2-2: Plasmids used for electroporation.   
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Figure 2-1: Electroporation approach in chick neural tube. (A) Showing equipment 
used for electroporation such as dissecting microscope and micro-injector. (B) Shows 
electrode position during electroporation. (C-D) Whole mount picture of electroporated 
embryo showing GFP expression. (E) Cross section of chick neural tube stained with 
DAPI. (F) GFP expression in one half of electroporated neural tube.  
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2-13- FZD10 knockdown using shRNA: 
To knock down FZD10 in the neural tube, we obtained three short hairpin RNAs 
(shRNA) that were designed and inserted in expression plasmid (pRFP-C-RS), which 
has U6 promoter (ORiGene). U6 promoter works in chick and is able to generate a 
small RNA transcript by RNA polymerase III (Islam et al., 2013;Katahira and 
Nakamura, 2003).  
The shRNA expression was designed as follow, a 29 bp target gene specific sequence, a 
7 bp loop, and another 29 bp reverse complementary sequence, all under U6 promoter. 
A termination sequence (TTTTTT) was located downstream of the second 29 bp reverse 
complementary sequence to terminate the transcription by RNA Pol III. All three 
shRNA expression plasmids were confirmed by sequence (ORiGene). 
 
- Exact-ShRNA chick FZD10: 
A- GTACAACATGACGAGAATGCCGAACCTGA 
B- TGGATTGCCATCTGGTCCATTCTGTGCTT 
C- GCAAGCGTTATTACCAGTAGTGGAATCTA 
 
After obtaining the shRNA expression plasmids, electroporation was performed (Fig. 2-
2) and FZD10 knockdown was checked for each shRNA plasmid by in situ 
hybridization (see 2-14). B and C shRNA plasmids showed better knockdown. So, B+C 
were used in all experiments and are referred to as (FZD10 shRNA). 
Also scrambled  shRNA was used as control and it did not show any effect of FZD10 
expression after electroporation. 
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Figure 2-2: RFP expression was detected after electroporation of scrambled 
shRNA (control) and FZD10 shRNA (A, B, C) in chick neural tube (24hrs).  
 
 
2-14- Whole mount in situ hybridization (WISH): 
 
2-14-1-Probe synthesis:  
 
(PCR method): 
 DNA template preparation: Some plasmids have M13 forward and M13 reverse 
sequences together with T3, T7 or SP6 promoter sequences on either side of the insert 
of interst. We took advantage of that to generate template by PCR.  The PCR reaction 
was made up of 5µl of BiO mix, 1µl of M13 forward primer, 1µl of M13 reverse 
primer, 1µl of plasmid DNA and 2µl of Sigma water.   
-The PCR reaction conditions: 
1- 95oC for 3 minutes,  
2- 95oC for 1 minute,  
3- 55oC for 1 minute,  
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4-72oC for 1 minute,  
5- go to step 2 for 24 more times for 1min 
6- 72oC for 10 minutes.   
1/10th of the PCR reaction was run on an agarose gel to ensure that a single sharp PCR 
product of the right size was obtained.  
 
2-14-2- Antisense transcription:  
The PCR product was transcribed using the appropriate RNA polymerase.  The 
transcription reaction was in 50µl volume, containing the following mixture: 1µl PCR 
product (=DNA template), 10µl Promega transcription buffer, 5µl DTT, 5µl DIG or 
FITC-UTP plus NTP labelling mix, and 1µl RNasin, 2µl T3 or T7 or SP6 polymerase.  
The transcription reaction was incubated for 2-4 hours at the appropriate temperature 
for the polymerase used (T3/7 at 37oC, SP6 at 40oC).  The DNA template was degraded 
by adding 1µl of RQ DNase and incubated for 30 minutes at 37oC.  1/20th of the 
transcription reaction was run on an agarose gel to examine the probe. 
 
2-14-3-Probe purification:  
The volume of the transcription reaction was made up to 80µl with Sigma water and 
precipitated by adding 220µl of 100% EtOH and 8µl LiCl, after which the reaction was 
incubated overnight at -20oC.  This was centrifuged for 20 mins at 4oC and the 
supernatant was removed.  The pellet was washed with 300µl 70% EtOH and 
centrifuged for 5mins.  It was washed with 50µl 100% EtOH and spun down; then, the 
pellet was allowed to dry at room temperature, following which it was dissolved in 
100ul Sigma water by incubating for 15mins at 65oC.  The probe was denatured for 
3mins at 95oC and quickly cooled on ice for 5mins.  The probe was diluted by 10 
volumes of hybridization buffer and stored at -20oC. Sometimes, G50 column used to 
purify the probe. 
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-illustra™ MicroSpin™ G-50 column: 
 
The Column Preparation; the resin was resuspended in the column by vortexing.  The 
cap of the column was loosened and then the column was placed in the collection tube. 
The collection tube was spun for 1min at 735 × g. The column was placed in a 1.5ml 
Eppendorf tube and the probe was applied to  the top centre of the resin. The Eppendorf 
tube was spun for 2mins at 735 x g.  The purified probe was collected in the Eppendorf 
tube and stored at -20°C (http://www.gelifesciences.com). 
 
N Name Vector Sense Antisense Source  
1 Wnt1 pBS  T3 T7 Andrea Münsterberg lab 
2 Wnt3a pGEM-T T7 SP6 PCR (Qaioyun Yue) 
3 FZD1 pBS-KS T3 T7 C. Tabin 
4 FZD2 pGEM-T Sp6 T7 PCR 
5 FZD3 pGEM-T T7 Sp6 PCR 
6 FZD4 pBS T7 T3 C. Tabin 
7 FZD5 pBS-Sk+ T7 T3 Sabine Fuhrmann 
8 FZD6 pGEM-T T7 Sp6 PCR 
9 FZD7 pGEM-T T7 Sp6 PCR 
10 FZD8 pBS T3 T7 C. Tabin 
11 FZD9 pBS T7 T3 C. Tabin 
12 FZD10 pGEM-T T7 Sp6 PCR 
13 Ngn1 pBS-sk T7  Cristina Pujades 
Table 2-3: In situ probes were made and used in this project. 
 
2.14-4 Embryo preparation and staging: 
White fertilized chicken eggs were obtained from local farms and incubated at 37oC 
until the desired stages had been reached.  The embryos were staged according to 
Hamburger and Hamilton (1951) and harvested in PBS under a dissecting microscope.  
The embryos were then fixed in 4% PFA for 1hour at room temperature or overnight at 
4oC, following which they were washed twice PBST for 5mins per wash.  After that, 
they were dehydrated by passing them through ascending grades of MeOH (25%, 50% 
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and 70% MeOH in PBST), finishing at 100% MeOH, after which they were stored at –
20oC. 
 
2.14-5 Rehydration: 
The embryos were rehydrated from 100% MeOH by passing them through descending 
grades of MeOH (70%, 50% and 25% MeOH in PBST) for 5mins each, followed by 2 
washes with PBST; all of these steps were performed at room temperature with gentle 
rocking. 
 
2-14-6 Proteinase K treatment: 
Embryos younger than HH25 do not need to be treated with proteinase K (PK), but 
embryos older than HH25 were treated with 10µg/ml PK for different times depending 
on the embryo’s stage.  Then, the embryos were washed twice in PBST, and then fixed 
in 4% PFA containing 0.1% glutaraldehyde for 20 minutes with rocking.  After that, the 
embryos were washed twice in PBST for 5mins per wash.  
 
2-14-7 Hybridisation: 
PBST was removed and 1:1 PBST/hybridisation buffer was added to the embryos.  The 
embryos were kept until they sank in the solution, after which they were rinsed in 
hybridisation buffer for 15mins at room temperature.  The embryos were incubated in 
the hybridisation buffer for 2hours at 65oC.  Following this, the embryos were incubated 
in the probe of interest overnight at an appropriate temperature (65oC).  
 
2-14-8 Post-hybridisation: 
After hybridisation, the probes were removed and stored at -20oC.  Then, the embryos 
were washed with hybridisation buffer for 10mins and washed in wash buffer twice for 
30mins per wash.  The embryos were then washed in 1:1 wash buffer/MABT for 
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10mins (all these washes were done at 65oC).  After these steps, embryos were rinsed 
with 2x MABT at room temperature for 30mins per wash and washed in MABT/2% 
BBR solution for 1hour; this was followed by one wash in MABT/2% BBR/20% goat 
serum for 2hours to block non-specific binding.  The embryos were incubated overnight 
in the cold room with rocking in MABT/2% BBR/20% goat serum/ant-digoxgenin-AP 
(1:2000) or anti-fluorescin-AP (1-1000).  
 
2-14-9 Post-antibody washes and colour reaction: 
The antibody solution was removed and the embryos were rinsed in MABT 5 times for 
1hour each at room temperature with rocking, and then incubated in MABT overnight at 
4oC.  The following day, embryos were washed twice in freshly made NTMT buffer for 
10mins each; they were then incubated in 7ul BCIP/9ul NBT/1ml NTMT or in fast red 
solution in the dark in order to develop the colour.  The colour reaction was halted when 
the background had started to develop by washing many times in 5x TBST detergent 
mix.  After background removal, embryos were fixed in 4% PFA and then washed twice 
in PBS in order to be photographed.  
2-14-10 Double in situ hybridisation: 
For double in situ hybridisation, embryos were incubated with two different labelling 
probes (1:1ml DIG labelling probe/FITC labelling probe).  After this, the same protocol 
was followed, but after the first colour was developed the embryos were fixed in 4% 
PFA for 1hour at room temperature and then washed twice in PBS for 5mins each.  
Following this, embryos were incubated in MAPT for 1hour at 65oC followed by two 
washes in MABT for 10mins each at room temperature.  To block unspecific binding, 
embryos were treated in MABT/2% BBR solution for 1hour followed by one wash in 
MABT/2% BBR/20% goat serum for 2hours.  Lastly, the embryos were incubated with 
the second antibody overnight in the cold room with rocking (in MABT/2% BBR/20% 
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goat serum/ant-fluorescin-AP (1-1,000)).  The second colour was developed as 
mentioned earlier (see subsection 2.5.5) but with fast red. 
 
Embryos were photographed as whole-mount double in situ hybridisation or sectioned 
to see the two different colours. 
 
2-15- Cryosectioning: 
The embryos were fixed in 4% PFA for 1 hour at room temperature and then washed 
twice in PBS for 5 minutes each.  The embryos were incubated with 30% sucrose for 4 
hours at room temperature or overnight at 4oC.  After this, they were mounted in OCT 
compound in plastic capsules then left for 2 hours at room temperature.  Then, the 
embryos were positioned with needles, frozen by dry ice and then stored at -20oC for 
sectioning.  The embryos were sectioned with a Leica cryostat and the sections’ 
thicknesses were between 20 and 30 um.  The sections were collected in TESPA slides 
and left to dry at room temperature.  The sections were washed twice in PBS for 5 
minutes, after which they were covered with coverslips using a hydromount.  The slides 
were kept overnight at room temperature to dry.  Finally, the sections were imaged with 
a Zeiss CCD upright microscope using a colour camera.  The pictures were imported 
from AxioVision Rel 4.8 to Adobe Photoshop CS for adjustment and labelling.    
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2-16-Immunostaining: 
 
Embryos were fixed in 4% PFA for 1 hour at room temperature, or overnight at 4ºC. 
Different fixatives and fixation times may be needed for different antigens.  The 
embryos were washed well with PBS to remove fixative.  Then, They were transferred 
to 30% sucrose in PBS and kept for 2 hours at room temperature or at 4°C overnight. 
After that, they were embedded in OCT and sectioned using cryostat as normal. The 
cryosections were collected in slides. Fixo Gum was used to make a ring around 
sections. The Sections were rinsed in a jar of PBST (PBS 0.1%Triton).  Sections were 
treated with a blocking buffer for 1 hour at room temp, or overnight at 4ºC (blocking 
buffer: PBS + 5% BSA + 0.1% Triton + 5% Serum).  After blocking, primary 
antibodies were prepared by diluting into blocking buffer to give the appropriate 
concentration. This was determined for each antibody. Sometimes, two different 
antibodies were combined together if they were raised in different species. 50-100ul 
antibody solution was applied to the slide, and then incubated at 4 ºC overnight in a 
humidified chamber to prevent the sections from drying out.  Next step, slides were 
washed 3 x 5 mins in a jar of PBST (PBS Triton). Suitable secondary antibodies and 
DAPI were Prepared and applied to the slides. The slides were incubated at room temp 
for 1 or 2 hours in a dark humidified chamber. Then the slides were  washed 3 x 5 
minutes or longer in a jar of PBST (PBS Triton) in the dark. A Final wash with PBS 
only for 2 x 5 mins and then the ring was removed before mounting.  The slides were 
mounted with hydromount  and kept  overnight at 4°C in the dark. After that, the 
sections were imaged using Widefiled microscope Zeiss AxioPlan 2ie. Then, the images 
were analysed.       
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Number	 Name		 Species	raised	in	 Dilution		 Company		
1 Pax3 Mouse  1:50 DSHB 
2 Pax6 Mouse 50:1000 DSHB 
3 Pax7 Mouse 1:50 DSHB 
4 Nkx2.2 Mouse 1:50 DSHB 
5 Lhx1/4 Mouse 1:50 DSHB 
6 Islet1 Mouse 1:50 DSHB 
7 Tuj1 Mouse 2:1000 Covance  
8 RFP Rabbit  2:1000 Abcam 
9 DAPI  1:2000 Life Technolongies 
10 H3 Rabbit 5:1000 Abcam 
11 Anti-mouse Alexa 
Fluor 568 
Goat 4:1000 Life Technologies 
12 Anti-Rabbit 
Alexa Fluor 568 
Goat 4:1000 Life Technologies 
13 Anti-mouse Alexa 
Fluor 488 
Goat 2:1000 Life Technologies 
14 Anti-Rabbit  
Alexa Fluor 488 
Goat 2:1000 Life Technologies 
15 Anti-mouse Alexa 
Fluor 350 
Goat 5:1000 Life Technologies 
16 Alexa Fluor 568 
Phalloidin  
 1:500 Invitrogen 
17 Laminin Mouse 1:500 DSHB 
Table 2-4: Antibodies used in this project	
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Expression of chick 
Frizzled receptors (cFZD)  
during spinal cord development															
 
	 59	
3-1 Introduction 
Frizzleds (FZDs) are known as receptors for Wnt ligands. They have been shown to be 
involved in regulation of several embryogenesis events such as, cell proliferation, neural 
patterning, and neural synapse development (Clevers, 2006; Medina et al., 2000).  
In chicken, ten Frizzled receptor genes have been identified and numbered from 1 to 10. 
Expression of FZDs is dynamic during chick embryogenesis and is found in different 
developing tissues (Chapman et al., 2004; Fuhrmann et al., 2003; Stark et al., 2000; 
Quinlan et al., 2009; Theodosiou and Tabin, 2003). Most of the cFZDs are expressed in 
early stages of development during pattering and neural specification.  Six cFZD 
receptors show overlapping expression in the primitive streak and Hensen's node, 
including cFZD1, 2, 4, 7 and cFZD9 (Chapman et al., 2004). cFZD8 is exclusively 
expressed in Hensen's node.  
Moreover, all cFZDs, with the exception of cFZD10, are expressed in the developing 
eye and their expression is specific in different parts of the eye (Fuhrmann et al., 2003). 
It was found that, cFZD1, 2 and 7 are present in the cranial placodes and in the somite 
during development (Stark et al., 2000). Their expression patterns are shown in early 
forming somites and overlap with myogenic markers such as MyoD (Linker et al., 
2003). This group reported that in vivo, blockade of FZD signalling by cFZD7-CRD 
electroporation reduces MyoD expression, indicating the importance of   FZDs during 
myogenesis. Also the same group showed that, cFZD7 mediates Wnt6 function through 
the canonical Wnt signalling in the dorsal part of the somite (linker et al., 2005). 
Another study by Gros and colleagues, 2009 documented that FZD7 inhibition in vivo 
affects cell polarity and elongation of myocytes in the myotome of chick somites. This 
was not dependent on canonical mechanisms and suggested that FZD7 might act as 
	 60	
Wnt11 receptor through non-canonical Wnt signalling  (PCP). 
A number of cFZDs, including cFZD1, 2, 4 and 7, are expressed strongly in the limb 
bud at different stages of development (Kengaku et al., 1997; Nohno et al., 1999; Stark 
et al., 2000). cFZD2 is found in in the proximal limb mesenchyme and cFZD4 exhibits 
a specific expression pattern  in the apical ectodermal ridge of the limb (Nohno et al., 
1999). By stage HH30, cFZD4 shows high expression in the cartilage and in the 
interdigital spaces (Stark et al., 2000). cFZD1 and 7 expression is dynamic and distinct; 
cFZD1 expression is located on the ventral side of ectoderm and mesenchyme, whilst 
cFZD7 is expressed in the proximal-distal axis of the limb bud  (Kengaku et al., 1997). 
cFZD1 and 7 are expressed during chondrogenesis in the limb and their misexpression 
in chick wing reduces  chondrogenesis (Hartmann and Tabin, 2000). This study 
suggested that cFZD7 mediates Wnt4 signal in the articular chondrocytes. Another 
study showed that cFZD7 misexpression reduced chondrogenesis in chick limb culture 
(micromass), but cFZD1 misexpression did not have any effects (Tufan et al., 2002).  
Some cFZD receptors have been shown to be expressed in kidney, liver and the gut 
during the development of chick embryo (Theodosiou and Tabin 2003; Matsumoto et al 
2008; Stark et al 2000). cFZD4 shows a striking expression pattern in chick kidney and 
colocalizes with Wnt4 and other kidney markers (Stark et al 2000). FZD1, 4, 7 and 9 
expression is detected in the chick liver, and FZD7/9 expression overlaps with Wn9a 
expression and they seem to transfer its signal as shown by co-immunoprecipitation in 
COS7 cells (Matsumoto et al 2008).  
cFZDs are expressed during the development of the central nervous system (Chesnutt et 
al., 2004; Kawakami et al., 2000; Galli et al., 2014; Quinlan et al., 2009). It has been 
reported that cFZDs exhibit complex and dynamic expression patterns in different 
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regions of the developing brain (Quinlan et al., 2009). For example, cFZD1, 2 and 7 
show strong expression in the ventral of midbrain, while cFZD4 and 8 are expressed in 
the forebrain. In addition, cFZDs expression patterns overlap with many Wnt ligands in 
the mid and forebrain including Wnt1, Wnt3a, Wnt5A, and Wnt8B. This illustrates that 
Wnts and their receptors are present during the development of the brain.   
In addition, cFZDs are expressed in the developing spinal cord (Chesnutt et al., 2004; 
Kawakami et al., 2000) and in this project we analyzed the expression patterns of all 
known FZDs during chick neurogenesis.    
-Aims of this chapter:  
- To clone and generate in situ probes for all chick FZDs (see chapter2). 
- To establish a complete expression profile for all cFZDs in spinal cord.  
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3-2-FZDs are expressed in the chick developing spinal cord: 
To identify which FZDs mediate Wnt signalling that may be involved in the 
development of the spinal cord, an analysis of the expression patterns of these receptors 
was performed in chick embryos. To study the spatial expression of FZDs specific 
antisense RNA probes were generated for each FZD then whole mount in situ 
hybridization was used followed by cryo-sections as mentioned in materials and 
methods. FZD1 expression was seen in the dorsal spinal cord covering the roof plate 
and was graded dorsal to ventral at stage HH14-15 (Fig. 3.1D,E). FZD2 transcripts were 
detected in the intermediate ventral spinal cord and high level of expression was 
observed in the floor plate (Fig. 3.1F). FZD3 was strikingly expressed throughout the 
dorsal ventral spinal cord and it was restricted in the ventricular zone (Fig. 3.1G). 
FZD4, 5 and 6 were not present in the developing spinal cord at stage HH14-15 but they 
were expressed in other tissues (Fig. 3.1 H,I,J). For example, FZD4 is expressed in 
head, limb bud and nephrogenic ridge (Fig. 3.2). FZD6 was detected in the developing 
somite (Fig. 3.3A,A’). FZD7 showed specific and strong expression in the intermediate 
and ventral spinal cord (Fig. 3.1H). FZD8 did not appear to be expressed in the 
posterior neural tube, but it was found in nephrongenic ridge and limp bud (Fig. 3.1I 
and Fig. 3.3B,B’,B”). FZD9 was ubiquitously expressed and seemed to be strongly 
expressed around the lumen of the chick spinal cord (Fig. 3.1J). FZD10 transcripts were 
specifically expressed in the dorsal spinal cord and strong signal was seen in the dorsal 
neural progenitors (Fig. 3.1K). 
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Fig. 3.1.  Expression patterns of cFZDs in the developing spinal cord were 
detected by in situ hybridization at stage HH14-15.  
(A and D) Cross section of spinal cord with three domains of neural progenitors 
indicated. (B) Pax7 stained 6 dorsal progenitors (C) Pax6 is a marker for intermediate 
progenitors. (E) Expression of FZD1. (F) FZD2 expression in the ventral spinal cord. 
(G) FZD3 expression throughout the spinal cord. (H,I J, L) FZD4, 5, 6 and 8 are not 
expressed in the spinal cord. (K) Expression of FZD7. (M) FZD9 expression. (N) 
FZD10 expression in the dorsal spinal cord.  
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Fig. 3.2 Whole mount in situ shows expression patterns of FZD4 at different stages. 
FZD4 is expressed in head, limb bud and nephrogenic ridge. Cross sections show that 
FZD4 transcripts are found in nephrongenic ridge and limb bud.  	
			
	 65	
		
Fig. 3.3 Whole mount in situ shows expression patterns of FZD6 and 8. FZD6 was 
detected in somite. ridge. (A) FZD6 expression at stage HH18+. (A’) FZD6 is expressed 
in developing somite. (B) FZD8 expression at stage HH24, it was found in the head and 
limb buds. (B’) FZD8 was found nephrongenic ridge. (B”) cryosection shows that 
FZD8 transcripts were seen in limp bud.  	
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3-3-FZD7 and FZD10 are expressed during spinal cord neurogenesis: 
FZD7 and FZD10 are expressed during early neural specification and their expression 
continues throughout embryogenesis (Chapman et al., 2004).  We showed that they are 
strongly expressed in specific domains in the spinal cord at stage HH14-15 during the 
initiation of neurogenesis (Fig. 3.1HK).  
It was reported that almost half of all neurons were generated after 4days of 
development in chick spinal cord (HH24) (Le Dréau et al., 2012). Thus, we investigated 
the spatial and temporal expression of FZD7 and 10 in this stage of development (Fig. 
3.4). FZD7 transcripts were found to be highly expressed in the intermediate and ventral 
spinal cord where the intermediate and ventral progenitors are located and its expression 
pattern correlated with Pax6 and Nkx2.2 expression (Fig. 3.4B,C,E). A strong signal for 
FZD10 expression was detected in the dorsal domains of neural progenitors and its 
expression correlated with Pax7 (Fig. 3.4A and F). Both, FZD7 and 10 expression 
seems to be restricted to the proliferative progenitors whilst neurogenesis takes place 
and their expression was not detected in differentiating neurons (Fig. 3.4D,E,F). Also, 
we studied their regulation by dorsal Wnts in the spinal cord (see Chapter5). Also other 
FZDs such as FZD1 need to be investigated but because of time limitation it was not 
possible to do further analysis.  
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Fig. 3.4 Expression patterns of FZD7 and FZD10 corralate with neural 
progenitors markers in the spinal cord at stage HH24. (A) Pax7 stained 6 dorsal 
progenitors. (B) Pax6 marked intermediate progenitors. (C) Nkx2.2 is a marker for 
p3 ventral progenitors. (D) Cross section of the developing spinal cord at stage 
HH24 stained with DAPI; red circles mark six dorsal progenitor domains while 
green circles represent five ventral progenitor domains.  VZ, the ventricular zone; 
MZ, the mantle zone.  (E) FZD7 expression in the intermediate ventral progenitors 
and excluded from MZ. (F) FZD10 expression in the dorsal domain of the spinal 
cord during neurogenesis.  
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3-4- summary: 
We established a complete expression profile of cFZD receptors in chick spinal cord 
and identified FZDs that could be involved in spinal cord development in either dorsal 
or ventral domains (Fig. 3.1 and Table. 3.1). By taking advantage of using in situ 
hybridization we observed that six out of ten FZDs are expressed in the spinal cord and 
showed specific and different expression patterns at stage HH14-15. FZD1 and FZD10 
expression was found in the dorsal neural tube and FZD10 was strongly and specifically 
detected in the dorsal neural progenitor domains. Whereas FZD2 and FZD7 were 
expressed in the intermediate ventral spinal cord and their expression seems to be 
overlapping, but FZD7 showed stronger expression in the neural progenitors. FZD3 and 
FZD9 transcripts were found throughout the dorsal-ventral spinal cord. FZD3 
expression was specific in the ventricular zone where proliferation occurs while FZD9 
expression was ubiquitous. Also, we showed that FZD7 and FZD10 were expressed 
during spinal cord neurogenesis. The expression profile of cFZDs suggests potential 
roles for these receptors during spinal cord development. Also, it could be proposed that 
dorsal FZDs such as FZD10 may mediate signaling in response to Wnt ligands that are 
expressed in the dorsal spinal cord.  
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 FZD expression in the Spinal cord 
Frizzleds Dorsal Ventral 
1 Yes No 
2 No Yes 
3 Yes Yes 
4 No No 
5 No No 
6 No No 
7 No Yes 
8 No No 
9 Yes Yes 
10 Yes No 
Table. 3.1 Summary of FZD receptor expression in the spinal cord. Red colour 
represents the dorsal FZDs whereas green colour represents ventral FZDs.  
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Expression pattern of FZD10 
during spinal cord Development 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 71	
4-1 introduction  
FZD10 is one of the FZD family receptors and it has been detected in different species 
including zebrafish, Xenopus, chick and mouse (Kawakami et al, 2000; Moriwaki et al., 
2000; Wheeler and Hoppler, 1999; Nikaido et al., 2013; Yan et al., 2009). In zebrafish, 
FZD10 expression was found in neural plate at 1-somite stage, in the neural tube and in 
the tail bud (Nikaido et al., 2013). In Xenopus, FZD10 is expressed in the neural 
ectoderm and in the neural fold at early stages of development (Wheeler and Hoppler, 
1999). FZD10 is detected in the central nervous system where it is strongly expressed in 
the midbrain and hindbrain and in the dorsal neural tube (Moriwaki et al., 2000; 
Wheeler and Hoppler, 1999). Using double in situ hybridization, it was reported that 
FZD10 expression is partially overlapping with neural markers such as Sox2 and N-
CAM, while it shows strong co-localizations with the differentiated neuron marker N-
tubulin (Garcia-Morales et al., 2009).  
In chick, FZD10 is expressed at early stages of development as it was found in pre-
streak stages and by stage 4 was detected in the posterior of the primitive streak 
(Chapman et al., 2004). FZD10 expression continues throughout embryonic 
development and it was detected by in situ hybridization in several developing tissues 
such as the central nervous system, limb bud and branchial arches (Kawakami et al, 
2000). Chick FZD10 and human FZD10 have more than 85% identity in the amino acid 
sequence (Kawakami et al, 2000; Koike et al., 1999). Moreover, human FZD10 shares 
65.7% amino-acid similarity with FZD9 (Koike et al., 1999). 
In mouse, FZD10 expression is detected in the posterior epiblast at 7dpc and in the 
primitive streak at 7.5 dpc (Kemp et al., 2007). Also, it is strongly expressed in different 
parts of the developing central nervous system including midbrain, hindbrain and the 
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spinal cord (Kemp et al., 2007; Yan et al., 2009). FZD10 expression is also found in the 
limb bud and the tail bud during mouse development (Yan et al., 2009). 
Furthermore, FZD10 was cloned and described in human, and expressed in multiple 
human tissues including brain, heart, lung, skeletal muscle, and fetal kidney (Koike et 
al., 1999). Also, It was reported that FZD10 is highly expressed in a variety of cancer 
tissues such as synovial sarcoma, colon and lung (Nagayama et al., 2009; Terasaki et 
al., 2002).  
 
Chapter aims: 
- To characterize FZD10 expression during chick embryo development. 
- To follow FZD10 expression during spinal cord neurogenesis and compare it to 
neural marker gene expression. 
- To compare Wnt1, Wnt3a and FZD10 expression in the developing spinal cord.  
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4-2- FZD10 expression pattern during chick embryo development: 
 
To study when and where FZD10 is expressed during embryogenesis, we cloned full 
length of cFZD10 was cloned and antisense RNA probe was generated and then used 
for whole mount in situ hybridization. In this study, FZD10 expression was investigated 
from stage HH9 to HH24 (Fig. 4.1A). FZD10 transcripts were found in the developing 
midbrain and hindbrain during neural tube closure (Fig. 4.1A’) as well as in the 
posterior region where secondary neurulation occurs (Fig. 4.1A’’). By stage HH13, 
FZD10 expression was detected in the developing brain and spinal cord (Fig. 4.1B). 
Notably, FZD10 was strongly expressed in the spinal cord in all examined stages (Fig. 
4.1C,D,E,F,G,H,I). Also, it was found in the tail bud throughout development (Fig. 
4.1C,D,E,K). FZD10 expression was found in the branchial arch 1 and 2, and in the 
developing limb (Fig. 4.1’,I).  It was exclusively expressed in the dorsal posterior of the 
limb bud (Fig. 4.I,I’’). By stage HH28, FZD10 expression was seen in different parts of 
the limb mesenchyme including in the proximal region (Fig. 4.1LM). Our data is 
consistent with previous study documented by Kawakami et al (2000a).  
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Fig.	4.1	Whole	mount	in	situ	
hybridization	of	FZD10	expression	
during	chick	embryo	development	in	
HH9-28	embryos.		(A-H)	Dorsal	views	of	different	stages	of	development.	(I)	FZD10	expression	in	HH24;	I’,	the	branchial	arch;	I’’,	Limb	bud.	(K)	Dorsal	view	of	tail	bud	at	HH28.	(L)	Dorsal	view	of	the	stage	28	hindlimb	bud	and	distal	view	(M).	
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4-3-FZD10 is expressed in the dorsal domain of the spinal cord during 
neurogenesis: 
 
It was previously shown that FZD10 is expressed in specific domains in the dorsal 
spinal cord at stage HH14-15 and HH24 (Chapter3). It has been shown that 
neurogenesis of dorsal neurons has begun at stage HH18 and half of neurons are formed 
by stage HH23 in the spinal cord (Le Dréau et al., 2012).  Therefore, we followed 
FZD10 expression during neural tube development at different times; before the onset 
of neurogenesis, during neurogenesis initiation and during formation of dorsal neurons. 
Before the onset of neurogenesis FZD10 expression seems to be graded from dorsal to 
ventral as seen by stage HH12 (Fig. 4.2A). It continued to be expressed in the spinal 
cord but expression was more dorsally restricted during the initiation of neurogenesis 
(Fig. 4.2B,C.D). During neurogenesis, FZD10 was highly expressed in the dorsal half of 
the spinal cord while dorsal progenitors were being formed (Fig. 4.2D,E,F). Also, a 
high level of FZD10 expression was found in the ventricular zone where progenitors 
were still in proliferative mode and during neurogenesis. Because of time limitation, it 
was not possible to perform immunostaining (Pax7 or Lhx1/5) after FZD10 in situ at 
stage HH12 or HH24. 
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Fig. 4.2 FZD10 expression in the dorsal spinal cord during 
dorsal neurogenesis. Transverse sections of chick spinal cords at 
different stages HH12-24. (A-F) In situ hybridization shows the 
dorso-ventral extend of FZD10 expression. 
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4-4-FZD10 expression overlaps with dorsal neural progenitors markers:  
 
The dorsal ventral axis of the spinal cord can be divided into eleven domains based on 
the expression of specific transcription factors (Le Dreau and Marti, 2012). For 
example, Pax3/7 expression marks six dorsal progenitors (dp1-6), whereas Pax6 is a 
marker for three dorsal progenitors (dp4-6) and one intermediate ventral progenitor 
(p0). Thus, as FZD10 is strongly expressed in dorsal domains of the spinal cord, the 
FZD10 expression pattern was compared to these well-characterized transcription 
factors during dorsal neurogenesis at stage HH24 (Fig. 4.3). To achieve this we used in 
situ hybrizidation and immunestaining in chick embryos as mentioned in Materials and 
Methods (Chapter2). FZD10 expression was found in 5 progenitor domains and showed 
a complete overlap with Pax3/7 expression (Fig. 4.3A,B,C,E). Also, FZD10 and Pax7 
were expressed in the roof plate but Pax3 was not (Fig. 4.3B,C,E). FZD10 has some 
overlap with Pax6 expression in the dorsal domain where Pax6 was weakly expressed 
(Fig. 4.3A,B,D). FZD10 expression showed some overlap with Ngn1 expression in the 
dorsal progenitor 2 (Fig. 4.3G,H). Additionally, FZD10 expression was compared to 
dorsal differentiated neurons markers such as Lhx1/5 and Islet1, and FZD10 was 
expressed during the formation of dorsal interneurons (Fig. 4.3F,G,I,J). Therefore, 
FZD10 is specifically and strongly expressed in the dorsal domains of the spinal cord 
and overlaps with dorsal progenitors markers.  
 
 
 
 
	 78	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4.3 Comparison of the expression patterns of FZD10 and neural 
markers at stage 24HH:  (A) Dorsal–ventral sections of the developing spinal 
cord at stage HH24 stained with DAPI; red circles represent 6 dorsal progenitor 
domains (dp1-6) whereas green circles represents 5 ventral progenitor domains 
(p0-2, pMN, p3). (B and G) In situ section shows FZD10 expression. (C and E) 
Pax3/7 proteins are markers for all 6 dorsal progenitors (red colour in A). (D) 
Pax6 protein is weakly expressed in the dorsal domain, but the expression was 
stronger in the intermediate and it is a marker for dp4,5,6 and p0 (ventral 
progenitor). (F) Schematic representation of differentiated neurons markers 
expression at HH24; yellow circles (Lhx1/5); white colour (Islet-1). (H) Ngn1 
is a proneural basic-helix–loop–helix factor, and a marker for dp2 and dp6-p2 
(blue colour in F). (I) Lhx1/5 is a marker for differentiated interneurons dI2,4,6 
and V1. (J) Islet-1 is a marker for dI3 in the dorsal spinal cord and it is also a 
marker for motorneurons (MN) in the ventral spinal cord (white colour in F). 
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4-5- FZD10 expression overlaps with dorsal Wnts (Wnt1 and Wnt3a) in the spinal 
cord: 
FZD10 is expressed in the dorsal neural tube including the roof plate where some Wnts 
are expressed such as Wnt1 and Wnt3a (Fig. 4.4). Wnt1 and Wnt3a are co-expressed in 
developing spinal cord in chick and mouse, and they are involved in proliferation, 
neural specification and dorsal-ventral neural tube patterning (Alvarez-Medina et al., 
2008; Megason et al., 2002; Muroyama et al., 2002). Here, we attempted to compare 
and contrast the expression patterns of Wnt1, Wnt3a and FZD10 in chick embryo and in 
the dorsal spinal cord. Accordingly, the Wnt1 and Wnt3a anti-sense probes were 
generated and labeled with DIG-UTP and whole mount in situ was preformed as 
mentioned in materials and methods (Chapter2). Then, Wnt1 and Wnt3a expression 
patterns were analysed in chick embryos by completing an expression profile for each 
Wnt from stage HH14 to stage HH25 (Fig. 4.4 and appendix. B1,2,3). From whole 
mount in situ, FZD10 was co-expressed with Wnt1 and Wnt3a in the neural tube at 
stage HH14 and HH20 (Fig. 4.4A-F and appendix. B1). Also, Wnt3a expression was 
found in the limb bud and in the tail bud (Fig. 4.4B,C and appendix. B1.2).  From whole 
mount in situ hybridization, it was difficult to observe expression patterns in the dorsal-
ventral axis of the spinal cord so the embryos were sectioned using the cryostat and then 
the sections were mounted, imaged and analyzed (Fig 4.4 and appendix. B1,2,3).  At 
stage HH14, FZD10 showed strong overlapping expression with Wnt1 and Wnt3a in the 
dorsal domain of the neural tube (Fig. 4.4a,b,c). By stage HH20, Wnt1 and Wnt3a 
expression patterns were dorsally restricted but FZD10 expression still covered the 
dorsal part of the spinal cord (Fig. 4.4d,e,f and appendix. B2,3). From the FZD10 
expression profile, it is apparent that FZD10 overlaps with Wnt1 and Wnt3a. This data 
is consistent with a previous report, which was published while this study was under 
investigation (Galli et al., 2014).  
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Fig. 4.4 Expression profile of 
Wnt1, Wnt3a and FZD10 in 
chick embryo at HH14 and 
HH20.  
(A to F) Dorsal views of whole 
mount embryos  after in situ 
hybridization to show expression 
patterns of Wnt1, Wnt3a and 
FZD10 in chick at stage HH14 and 
HH20. (a-c) Transverse sections of 
chick neural tube showing Wnt1, 
Wnt3a and FZD10 expression in 
the dorsal part of the developing 
spinal cord at stage HH14 and 
HH20.  (d-f) transverse sections of 
chick neural tube showing the 
expression patterns of  Wnt1, 
Wnt3a anf FZD10 at stage HH20. 
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4-6 Summary: 
 
In this chapter, FZD10 expression was characterized during chick embryo development. 
At stage HH9, FZD10 is expressed in the midbrain while the neural tube is closing as 
well as in the posterior region during neurulation. FZD10 expression was found in the 
developing central nervous system; in the midbrain, the hindbrain and the spinal cord in 
all stages examined throughout development (Fig. 4.1). In addition, at stage HH24, FZD 
transcripts were found in the limb bud and the branchial arch 1 and 2. Also, it showed 
very strong expression in the tail bud throughout the developmental stages. We showed 
that FZD10 is expressed in the dorsal spinal cord and it continued to be expressed 
during different time of neurogenesis. FZD10 expression was detected in the dorsal 
spinal cord and overlapped with well known dorsal progenitor markers such as Pax3/7. 
FZD10 is also expressed during dorsal interneuron formation as shown by these 
markers; Islet1 and lhx1/5.  
Importantly, we preformed a careful observation for the expression patterns of Wnt1, 
Wnt3a and FZD10 during spinal cord development. Results show that the expression 
profiles of Wnt1 and Wnt3a is similar. FZD10 expression overlapped with Wnt1 and 
Wnt3a in the dorsal spinal cord. These dorsal Wnts are required for spinal cord 
development (Alvarez-Medina et al., 2008; Megason et al., 2002; Muroyama et al., 
2002). The expression profile of Wnt1, Wnt3a and FZD10 could suggest that FZD10 
has a potential function and interaction with these ligands in the developing spinal cord. 
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Canonical Wnt signalling regulates FZD10 expression 
during spinal cord development 
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5-1 Introduction: 
Wnt/FZD signalling is involved in embryonic development through regulating cell 
proliferation, cell polarity, cell differentiation and cell fate specification (Moon et al., 
2004; Logan and Nusse, 2004). Canonical Wnt signalling members are required for 
several developing tissues during embryogenesis. For example, Wnt1 and Wnt3a can 
regulate induction of myogenesis in somites, neural crest formation, and spinal cord 
growth and patterning (Galli et al., 2004;Ikeya et al 1997;Le Dréau and Martí, 2012; 
Münsterberg et al., 1995). Secreted Wnt1 and Wnt3a are supplied from roof plate and 
they are implicated in roof plate-dependent specification of interneurons (dI1-3) as seen 
in Wnt1/Wnt3a double mutant mice (Le Dréau and Martí, 2012;Muroyama et al., 2002). 
They are also required for neural tube development as seen from several studies; 
Megason and McMahon (2002), using in ovo chick electroporation approaches, 
reported a mitogenic effect of Wnt1 and Wnt3a on neural progenitors. Many other 
studies using gain or loss of function in chicken, mice, zebrafish and mice showed a 
proliferative role of Wnt1 and Wnt3a (Dickinson et al., 1994; Zechner et al., 2003; 
Chesnutt et al., 2004; Ille et al., 2007; Bonner et al., 2008). Additionally, they have a 
role in patterning as reported in chick, electroporation assays, co-overexpression of 
Wnt1 and Wnt3a resulted in the expansion of expression of dorsal genes, while 
ventrally expressed genes were repressed which indicates the involvement of these 
ligands in DV patterning (Alvarez-Medina et al., 2008). To date Wnt1 and Wnt3a 
receptors have not been studied in vivo to determine a specific receptor mediating their 
biological activities in the spinal cord. Therefore, Studying FZD receptors that are 
expressed in the dorsal neural tube and have a potential interaction with Wnt1 or/and 
Wnt3a, could lead to the identifycation of their receptors. This will then allow to 
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separate their functions and to investigate the mechanism behind their biological 
activities. 
 
In this study, we examined Wnt1 and Wnt3a expression patterns during neural tube 
neurogenesis and we found that they are highly expressed during the initiation of 
neurogenesis in the dorsal neural tube and they have similar expression patterns 
(Appendix B).  
We next analysed FZD10 expression in chick embryos by in situ hybridisation. FZD10 
is expressed in the dorsal spinal cord, its expression appears to correlate with dp1-5 
progenitor regions and overlaps with expression domains for progenitor markers 
including Pax3, Pax6 and Pax7. It overlaps with Wnt1 and Wnt3a expression patterns in 
the dorsal part of the early developing spinal cord. Moreover, it was previously shown 
that FZD10 acts through canonical Wnt signaling pathway and is required for sensory 
neuron formation in Xenopus (Garcia-Morales et al., 2009). Therefore, we investigated 
Wnt1/3a and FZD10 interactions in the chick spinal cord by performing in ovo 
electroporation experiments using microinjection of Wnt1/3a expression vectors into the 
neural tube.  
Chapter aims: 
-To investigate the effects of Wnt1/3a mis-expression on regulation of FZD7 and 10 in 
developing spinal cord.   
-To study individual roles for Wnt1 and Wnt3a in patterning and in FZD10 regulation. 
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5-2 Wnt1 and Wn3a regulate FZDs expression in the dorsal-ventral axis of the 
spinal cord:  
We showed previously FZD10 is expressed in the dorsal domain of the developing 
spinal cord and FZD7 expression is found in the intermediate-ventral domain 
(Chapter3). Here, we investigated how Wnt1 and Wnt3a   regulate the expression of 
both FZDs in the developing spinal cord, thus we used in ovo electroporation, 
immunohistochemistry and in situ hybridization as explained in Methods and Materials 
(chapter2). Electroporation allowed us to overexpress Wnt1 and Wnt3a ectopically, 
along the dorsal-ventral axis of the chick spinal cord.  We electroporated Wnt1 or 
Wnt3a construct individually  (chapter2) in chick neural tube at stage HH11-12. 
Embryos were dissected after 24 hours post electroporation and then screened for GFP, 
with GFP expressed from the same plasmid. Both constructs resulted in GFP expression 
after electroporation as seen in dorsal view of whole mount pictures of injected embryos 
(Fig. 5.1A,B).  Then, we co-electroporated Wnt1 and Wnt3a in chick neural tube at 
stage HH11-12. After 24 hours embryos were dissected, fixed and cryosectioned to 
visualize GFP in transfected side of the neural tube before immunostaining (Fig. 5.1C).  
To analyse the effects of Wnt1/3a co-overexpression in neural tube we used neural 
markers such as Pax7 and Nkx2.2. Pax7 is a marker for six dorsal progenitors and it was 
ventrally expanded on the transfected side after Wnt1/3a misexpression compared to the 
control side (Fig. 5.1C). Nkx2.2 is expressed in the ventral neural tube and it was 
severely repressed in the transfected side compared to control side (Fig. 5.1C). These 
results are consistant with a previous report showing that Wnt1 and Wnt3a co-
electroporation in neural tube affect neural progenitors patterning  (Alvarez-Medina et 
al., 2008).  
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We next investigated FZD10 and 7 expression following Wnt1/3a overexpression; 
embryos showed strong GFP expression after co-electroporation were proceeded for 
whole mount in situ to analyse changes in the expression patterns. We found that 
FZD10 expression was strongly upreglated and ventrally expanded on the 
electroporated side of neural tube (Fig. 5.1D). Suggesting that dorsal Wnts activate 
expression of FZDs such as FZD10 in the dorsal spinal cord. Conversely, FZD7 
expression was lost in the intermediate domain and ventrally restricted on the 
electroporated side of neural tube compared to the control side (Fig. 5.1E). This 
indicates that expression of ventrally expressed FZDs (FZD7) is repressed by dorsally 
expressed Wnts (Wnt1/3a) in the developing spinal cord.   
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Fig. 5.1 Wnt1 and Wn3a affect FZD10 and 7 expression in chick spinal cord 
(24hours PE). (A,B) Dorsal views of  whole mount pictures of electroporated embryos 
show GFP expression in chick neural tube. (A’,B’)  Green colour  shows GFP 
expression after Wnt1 and Wnt3a electroporation indicating successful transfection. (C) 
Cross section of the neural tube shows GFP expression (green) in the electroporated 
side, Pax7 expression is ventrally expanded (red), Nkx2.2 expression was repressed in 
the ventral (red) (n;). (D) FZD10 expression is ventrally expanded. (D) FZD7 
expression is lost in the intermediate region and repressed in the ventral neural tube. 
GFP staining after FZD7/10 in Situ was perfomed, but GFP antibody did not work, it 
may be important to be repeated in the future.  
Embryos number, (C, n=8/9), (D, n=13/15), (E. n=12/15).  EP side will always be 
shown on the right in this experiment. 
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5-3 Wnt1 and Wnt3a affect spinal cord pattering and Wn1 overexpression up-
regulates FZD10 expression: 
We found that FZD10 is expressed during spinal cord neurogenesis and its expression 
overlaps with Wnt1 and Wnt3a (Chapter 4). It has been shown that Wnt1 and Wnt3a are 
required for proper development of spinal cord (Le Dréau and Martí, 2012).  Here, we 
examined the role for each individual Wnt in patterning and in FZD10 regulation.  To 
do this, we electroporated Wnt1 and Wnt3a individually in chick neural tube at stage 
HH11-12 and then re-incubated the embryos for 48hours. The embryos were screened 
for GFP, fixed and cryosectioned (Fig. 5.2A,B,C).  
GFP was visualised in all sections before staining, and we observed that electroporated 
side of spinal cord was bigger than control side in Wnt1 or Wnt3a electroporeated 
embryos (Fig. 5.2D,E,G). This could be a result of high rate of proliferation on the 
electorporated side as shown in a pervious report (Megason and McMahon, 2002). 
Then, we used immunohistochemistry to analyze the effects of Wnt1 and Wnt3a 
misexpression in pattering and neurogenesis. We found that ectopic expression of 
Wnt1or Wnt3a led to expansion of dorsal progenitor cell domains. This was evidenced 
by the expression domains of Pax6 and Pax7, which were ventrally extended on the 
transfected side when compared to the control side (Fig. 5.3A,B and Fig. 5.4A,B). 
Conversely, the Nkx2.2 expression domain was repressed and restricted to the ventral 
part of the spinal cord (Fig. 5.3C and Fig. 5.4C). These results demonstrate that both 
Wnts produce same phenotype which affect neural progenitor patterning in the spinal 
cord.   
We next investigated the effect of Wnt1 or Wnt3a misexpression on formation of dorsal 
interneurons. Therefore, we analyzed the expression pattern of Islet-1, a marker for 
dorsal interneurons 3 (chapter4). We found that Islet-1 expression domain was broader 
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on the transfected side, indicating that more differentiated neurons were being generated 
after Wnt1or Wnt3a electroporation (Fig. 5.3D and Fig. 5.4D). This suggests that Wnt1 
and Wnt3a promoted neurogenesis of dorsal interneurons 3.  
Then, we analyzed the effect of dominant-negative (dn) Wnt3a electroporation in spinal 
cord. We previously generated chicken dnWnt3a by deleting C-terminal and subcloned 
it into IRES-GFP expression vector (Yue et al., 2008). Dominant-negative Wnts are 
presumed to function extracelluarly and to block Wnt signaling through preventing 
Wnts from binding to their receptors and/or directly inhibit wild-type Wnt ligands 
(Hoppler et al., 1996). Therefore, we examined whether dnWnt3a electroporation in the 
neural tube would affect proliferation and patterning. dnWn3a was electroporated into 
neural tube at HH11-12 and the embryos were dissected after 48 hours to analyze the 
phenotype. The embryos had strong GFP expression were fixed and cryosectioned 
(Appendix B. Fig. 1A,B). We found that the size of the spinal cord was severely 
reduced on the electroporated side, suggesting that rate of cell proliferation was reduced 
(Appendix B. Fig. 1C). To investigate the effect of dnWnt3a on pattering, 
immunohistochemistry for Pax7 was used. We observed that Pax7 expression was 
repressed and its domain was reduced (AppendixB. 1C,D). Because of time limitations 
the dnWnt phenotype was not characterized further.   
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Fig. 5.2 Wnt1 and Wn3a electroporation in chick spinal cord after 48hours. (A,B) 
Whole mount picture of electoporated embryo showing GFP expression after Wnt1 or 
Wnt3a electroporation in spinal cord. (C) A dorsal view of electroporated embryo. 
(D,E) Cross section of transfected spinal cord with Wnt1 or Wnt3a plasmid. Embryos 
number, (D, n=5), (E, n=4). (G) Measurement of un-electroporated and electroporated 
half side of neural tubes after Wnt1 or Wnt3a transfection.  
0	10000	
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Fig. 5.3 Analysis of protein expression patterns after Wnt1 misexpression in spinal 
cord. (A) Shows GFP expression in the transfected side (green), Pax7 expression and 
its expansion in experimental side of the spinal cord. (B) Pax6 is ventrally extended in 
the transfected side following  ectopic expression of Wnt1 as marked by GFP. (c) 
Nkx2.2 is ventrally shifted and repressed. (D) Islet-1 expression domain is increased in 
the transfected side. Embryos number was 12/14.  
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Fig. 5.4 Analysis of protein expression patterns after Wnt3a misexpression in 
spinal cord. (A) Shows GFP expression in the electroporated side (green), Pax7 
expression is expanded  following ectopic expression of Wnt3a. (B) Pax6 is ventrally 
extended in the transfected side. (c) Nkx2.2 is ventrally shifted and repressed. (D) Islet-
1 expression domain is increased in the transfected side when compared to the control. 
Embryos number was 11/14. 
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-As FZD10 is expressed in dorsal spinal cord and its expression was strongly expanded 
ventrally after Wnt1/3a co-electroporation. To determine the individual effects of Wnt1 
and Wnt3a electroporation on FZD10 expression, the neural tube was electroported at 
stage HH11-12 and the embryos were re-incubated for 48hours. The embryos were 
dissected and screened for GFP and only strongly transfected embryos were hybridised 
with FZD10 probe to assess potential changes in expression pattern.  We observed that 
FZD10 expression was broader and extended ventrally after Wnt1 overexpression on 
the electroporated side when compared to non-electroporated side (Fig. 5.5A,B). Also, 
we noticed that FZD10 expression was strongly increased in the roof plate (Fig. 5.5B). 
Interestingly, FZD10 expression was not affected after Wnt3a electroporation (Fig. 
5.5C,D). These data suggest that Wnt1 overexpression led to up-regulation of FZD10 
expression in the dorsal neural tube.      
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Fig. 5.5 FZD10 expression is up-regulated following Wn1 misexpression. (A) GFP 
expression in the electroporated side indicating   Wnt1 is ectopically expressed. (B) 
FZD10 expression is ventrally expanded and increased in the roof plate region.  (c) GFP 
expression shows Wnt3a misexpression along the dorsal-ventral axis of the spinal cord. 
(D) FZD10 expression was not changed after Wnt3a missexpression. (B,D) Green 
arrows points to a curve in the ventral spinal cord that always presents following Wnt1 
or Wnt3a electroporation as result of overgrowth.  Embryos number, (B, n=13/15), (D, 
n=12/15). 	
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5-4 Summary: 
In this chapter, we investigated the effects of dorsally expressed Wnts on pattering and 
on FZDs regulation in spinal cord. We found that co-misexpession of Wnt1 and Wnt3a 
led to expansion of dorsal genes as shown by Pax7 immunostaining (Fig. 5.1C). By 
contrast, the ventrally expressed gene Nkx2.2 was repressed (Fig. 5.1C). These date are 
in agreement with other studies, which reported the same observations (Alvarez-Medina 
et al., 2008). We also showed that FZD10 expression was expanded to the ventral spinal 
cord following Wnt1/3a co-electroporation, indicating that FZD10 expression is 
positively regulated by canonical Wnt signaling. Conversely, FZD7 expression was lost 
in the intermediate-ventral spinal cord. This suggests that the expression of FZD7 and 
potentially other ventrally expressed FZD receptors is inhibited by secreted Wnts from 
the dorsal spinal cord.  
It has been shown that electroporation of Wnt1 or Wnt3a increases   proliferation in 
spinal cord through controlling cell cycle regulators (Megason and McMahon, 2002). 
Also, Wnt1/3a co-electroporation affects pattering by antagonizing Shh activity through 
controlling Gli3 transcription (Alvarez-Medina et al., 2008). Here, we elctroporated 
Wnt1 and Wnt3a individually into the neural tube and we found that both Wnt1 and 
Wnt3a are able to regulate patterning of neural progenitors along dorsal-ventral axis and 
stimulate neurogenesis of dorsal interneurons 3 (Fig. 5.3 and Fig. 5.4).  
 
Moreover, we attempted to determine which Wnt affects FZD10 regulation; embryos 
were electroporated with Wnt1 and Wnt3a individually. We found that FZD10 
expression was upregulated and ventrally extended after Wnt1 overexpression but its 
expression pattern was not affected following Wnt3a overexpression. This suggests that 
the FZD10 promoter may react to a Wnt1 signal and may indicate that this receptor 
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mediates Wnt1 function in the dorsal spinal cord, potentially creating positive feed-back 
interaction. Also, FZD10 promoter regions could be analysed using bioinformatics tools 
to identify cis-elements, such as transcription factor binding sites. These data 
encouraged us to examine Fzd10 function and interactions during spinal cord 
development (Chapter6). Wnt3a may activate the expression of other different FZD 
receptors in the spinal cord such as FZD1 and FZD3. For example, it has been shown 
that Wnt3a can mediate canonical Wnt singling through FZD1 in hippocampal neurons 
and PC12 cells (Chacon et al., 2008). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	 97	
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investigating FZD10 function and its interactions 
with Wnt1 and Lrp6 during spinal cord 
development 
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6-1 Introduction  
 
FZD10 is expressed in the neural tube in many species, including Xenopus and chicks 
(Galli et al., 2014; Garcia-Morales et al., 2009; Wheeler and Hoppler, 1999; Kawakami 
et al., 2000a). FZD10 expression has been found in the limb buds of chick embryos 
(Chapter 4; Kawakami et al., 2000a). It appears to interact with Wnt7a and overlaps 
with Shh expression in the dorsal-posterior-distal mesenchyme in the limb bud, where it 
was also shown that Shh and Wnt7a induce and maintain FZD10 expression. These 
results suggest that FZD10 interacts with Wnt7a and plays a positive role in limb bud 
development. Furthermore, in Xenopus animal cap assays, FZD10 synergises with 
Wnt7a but not with Wnt3a and induces Wnt-target genes, such as Siamios (Kawakami 
et al., 2000b).  
Furthermore, Nikaido et al. (2013) found that FZD10, FZD7a and FZD7b are involved 
in the regulation of epiboly movements and mesoderm differentiation in zebrafish.  
Work from the Wheeler lab on Xenopus, showed that FZD10 is expressed in the dorsal 
neural ectoderm and neural folds in the region where primary sensory neurons develop 
(Garcia-Morales et al., 2009). Their investigation into loss of function in Xenopus 
showed that FZD10 is required for the formation of sensory neurons. Furthermore, in 
mouse P19 cells, retinoic acid was used to induce neural differentiation; overexpression 
of Xenopus FZD10 leads to an increase in the number of neurons generated, while 
siRNA knockdown of endogenous mouse FZD10 inhibits neurogenesis. FZD10 
injection results in partial axis formation and interacts with Wnt1 and Wnt8 but not with 
Wnt3a, as shown in synergy assays. Clearly, these data indicate that FZD10 functions 
through canonical Wnt signalling and is a potential receptor for Wnt1. They, therefore, 
indicate that FZD10 mediates canonical Wnt signalling to determine sensory neural 
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differentiation in Xenopus and neuron development in mouse P19 cells (Garcia-Morales 
et al., 2009). 
 In the present study, we found that Wnt1 overexpression up-regulated FZD10 
expression in the spinal cord (Chapter 5). Therefore, we investigated FZD10 function in 
dorsal-ventral patterning of the spinal cord as well as its interactions in vivo with 
Wnt1/3a and Lrp6; using loss and gain of function experiments in chick neural tubes. 
 
Chapter aims: 
-To study the role of FZD10 during spinal cord development by using loss and gain of 
function approaches. 
-To examine the requirement of FZD10 for Wnt1 and/or Wnt3a in the spinal cord in 
vivo using rescue experiments. 
-To investigate Lrp6 function and potential interaction with FZD10 and Wnt1 in the 
spinal cord using gain of function studies. 
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6-2 Knockdown of FZD10 led to a decrease in cell proliferation in the spinal cord 
  
To study the function of FZD10 in spinal cord development, we obtained three short-
hairpin vectors (sh-RNA) that were specifically designed against chick FZD10 (Chapter 
2). FZD10 sh-RNA plasmids (pRFP-C-RS) were electroporated into chick neural tubes 
at stage HH11-12. After 48 hours following electroporation, embryos were screened for 
RFP expression and processed for in situ hybridization in order to assess FZD10 
knockdown. Each sh-RNA vector was electroporated individually. Electroporation of 
FZD10 sh-RNA vectors B and C resulted in a strong reduction in FZD10 expression on 
the electroporated side of the spinal cord when compared to the unelectroporated side 
(Fig. 6.1 D, E, F). This indicates that endogenous FZD10 transcripts were knocked 
down. Also, RT-PCR or qRT-PCR could be useful to detect FZD10 knockdown, and 
rescue FZD10 knockdown with mouse or  Xenopus FZD10 in the future. 
Electroporation of the scrambled sh-RNA vector did not affect FZD10 expression, so it 
was used as a negative control (Fig. 6.1 A, B, C).  
 
Next, we analysed the effects of FZD10 knockdown on the spinal cord. We observed 
that the electroporated side of the spinal cord was often smaller and thinner following 
knockdown of FZD10 by sh-RNA (Fig. 6.2 D, E). This suggested that proliferation 
could be affected in the ventricular zone where neural progenitors are located. 
Therefore, we used immunostaining for phosphor-histone H3 (pH3), which is a marker 
for mitotic cells, to assess proliferation along the dorso-ventral axis of the spinal cord 
after FZD10 knockdown. The number of pH3 positive cells in the spinal cord was 
counted on the experimental and control sides of embryos electroporated with FZD10 
sh-RNAs or scrambled sh-RNA, and statistical analysis was performed using Excel and 
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a Student’s t-test (paired). The statistical analysis showed that the number of mitotic 
cells was significantly decreased 1.42-fold (p < 0.01, Student's t-test) on the 
experimental side of the spinal cord (Fig. 6.2 F). Conversely, scrambled sh-RNA 
electroporation did not lead to a significant change in the number of pH3 positive cells 
on either side of the spinal cord (Fig. 6.2 C). Thus, FZD10 knockdown led to a 
reduction in cell proliferation in the ventricular zone of the spinal cord. 
 
 
Fig. 6-1 FZD10 was knocked down after electroporating FZD10 sh-RNA vectors in 
the spinal cord. (A) RFP expression in the electroporated side of the spinal cord. (B, C) 
FZD10 expression was not affected after scrambled sh-RNA electroporation. (D) RFP 
expression after electroporating FZD10 sh-RNA vectors. (E, F) FZD10 expression was 
strongly inhibited on the experimental side of the spinal cord in electroporated embryos. 
RFP was detected by RFP antibody in cryosections after in situ hybridization.  
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Fig. 6-2 Knockdown of FZD10 led to a reduction in spinal cord size and a decrease 
in proliferative cells. (A, B) Cross sections of spinal cord stained with DAPI and 
phosphor-histone H3, showing that the sizes of the experimental and control sides of the 
spinal cord were not affected after electroporating scrambled sh-RNA vector, as shown 
by RFP expression. (D, E) the size of the electroporated half of the spinal cord was 
smaller than the control, as shown by DAPI staining in the spinal cord electroporated 
with FZD10 sh-RNA vector: blue, DAPI; green, pH3; red, RFP.  
Proliferative cells were stained with pH3 and counted in the experimental and control 
sides of the spinal cord electroporated with scrambled sh-RNA or FZD10 sh-RNA. 
Statistical analysis was performed using Excel and a Student’s t-test. (C) The average 
number of pH3 positive cells per section on both sides of the spinal cord electroporated 
with scrambled sh-RNA; there was no significant difference between the experimental 
(column 1) and control (column 2) sides of the spinal cord. There were 5 embryos and 
32 sections were analysed. (F) The average number of pH3 positive cells per section in 
the spinal cord electroporated with FZD10 sh-RNA vector; enumeration of the pH3 
positive cells showed a statistically significant decrease in proliferative cells on the 
electroporated side (column 1) when compared to the control side (column 2) of the 
spinal cord after FZD10 knockdown. 7 embryos and 53 sections were analysed.  
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6-3 Knockdown of FZD10 affected neurogenesis in the spinal cord 
Next, we investigated the effect of FZD10 knockdown on the dorsal-ventral patterning 
and neurogenesis in the spinal cord by using neural markers that overlap with FZD10 
expression (Chapter 4). To achieve this, FZD10 sh-RNA vectors were introduced by in 
vivo electroporation in the neural tubes at HH11-12, and the electroporated embryos 
were cryosectioned at 24 or 48 hours. The sections were screened for RFP expression 
and then the phenotypes were assessed by immunochemistry for Pax6 and Pax7. After 
24 hours PE, we observed that the Pax7 expression domain had shifted slightly dorsally 
in the experimental side of the embryos transfected with FZD10 sh-RNA vector, 
whereas it was not affected in the control side (Fig. 6.3E). Scrambled sh-RNA 
electroporation did not exhibit any effect on Pax7 expression in either side of the spinal 
cord (Fig. 6.3B).  
After 48 hours Post-electroporation of FZD10-shRNA, we did not observe a 
consistent effect on the expression domains of Pax6 and Pax7 following FZD10 
knockdown (Fig. 6.4A-D’). However, we noticed that the expression domains of Pax6 
and Pax7 were smaller in the electroporated side as compared to the control side (Fig. 
6.4A-D’). This could be a result of a reduction in proliferation, as previously shown.  
Subsequently, we assessed whether FZD10 knockdown would affect neurogenesis in 
the spinal cord. To investigate the effect of FZD10 on neurogenesis, embryos were 
electroporated into neural tubes at stage HH11-12 with a vector encoding sh-RNA 
against cFZD10 and expressing RFP as a reporter. The embryos were analysed after 48 
hours and immunostained for Lhx1/5 and Tuj-1, markers for differentiated neurons. 
Lhx1/5 expression was strongly reduced on the electroporated side of the spinal cord 
compared to the control (Fig. 6.4F,F’). 
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After 24 hours, Tuj-1 expression was reduced along the dorsal-ventral sides of the 
spinal cord in the embryos electroporated with FZD10 sh-RNA (Fig. 6.3H). After 48 
hours post-electroporation, we still observed a reduction in Tuj-1 expression on the 
electroporated side of spinal cord especially in the dorsal domain when compared with 
the control (Fig. 6.4H,H’). In contrast, scrambled sh-RNA electroporation did not affect 
expression of any neural markers used (Fig. 6.4). Therefore, knockdown of FZD10 
inhibited neurogenesis in the spinal cord.  
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Fig. 6.3 FZD10 knockdown affects neural markers in spinal cord (24hours PE). 
Scrambled sh-RNA vector was introduced into neural tubes at stage 11-12 and the effect 
was analysed after 24 hours using dorsal marker; Pax7, (A-C) shows that the expression 
domain of Pax7 was not affected in either side of the spinal cord. (D-F) Pax7 expression 
was slightly reduced in the experimental half of spinal cord eletroporated with FZD10 
sh-RNA vector. (G-I) Tuj-1 expression was severely repressed in the experimental half 
of spinal cord, suggesting that FZD10 is required for the differentiation of interneurons 
in chick.  Number of embryos was 3 and more than 10 sections were analysed for each 
markers. 
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Fig. 6.4 Effects of FZD10 knockdown on neural marker expression after 48hours post-
electroporation. Scrambled and FZD10 sh-RNA vectors were electroporated into neural tubes 
and these vectors expressed RFP as reporter for successful transfection. (A,A’) Pax7 expression 
after Scrambled shRNA-vector electroporation. (B,B’) Pax7 expression domain was moderately 
reduced on the electroporated side of the spinal cord. (C,C’) Pax6 expression was not affected 
after scrambled sh-RNA, but it was slightly shifted dorsally on the electroporated side of the 
spinal cord after electroporation with the FZD10 shRNA-vector. (E,E’) Lhx1/5 expression in 
embryos electroporated with scrambled shRNA. (F,F’) Lhx1/5 expression was repressed after 
FZD shRNA-vector electroporation. (G,G’) Tuj-1 expression. (H,H’) Tuj-1 was inhibited in the 
dorsal domain of spinal cord electroporated with FZD10 shRNA-vector. Embryos number (N) 
(Pax6/7=12/13) (Lhx1/5 and Tuj-1=7/8). If time had allowed, these sections would have been 
analysed by ImageJ software to count cells or measure area. 
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6-4 Knockdown of FZD10 rescued the Wnt1 overexpression phenotype: 
FZD10 was shown to function through canonical Wnt signalling as injection of Xenopus 
FZD10 into the ventral marginal zone (VMZ) results in partial axis formation in early 
Xenopus embryos and the phenotype of FZD10 knockdown can be rescued by β-catenin 
in Xenopus embryos (Garcia-Morales et al., 2009). Therefore, we further investigated 
FZD10 integration in canonical Wnt signalling and its involvement in spinal cord 
development, we tested the requirement of FZD10 for Wnt1 and/or Wnt3a in the spinal 
cord using in vivo electroporation. We performed rescue experiments by co-
electroporating Wnt1 or Wnt3a with shRNA vectors (scrambled shRNA or FZD10 
shRNA) in neural tubes at stage HH11-12 (Fig. 6.5). The embryos were analysed after 
48 hours and neural markers (Pax6/7) that are regulated by canonical Wnt signalling 
were used to assess the phenotypes (Fig. 6.6). Co-electroporation of scrambled shRNA 
with Wnt1 did not result in any change in the Wnt1-induced phenotype; Pax6 and Pax7 
were ventrally expanded as before (Fig. 6.6 A, C and Fig. 5.3). In contrast, co-
electroporation of FZD10 shRNA with Wnt1 attenuated the effect of Wnt1 
overexpression; expression domains of Pax6 and Pax7 on the electroporated side were 
comparable to the control side in the spinal cord (Fig. 6.6 B, D). Also couting cells 
would be good but the time had not allowed. Moreover, the Wnt1 phenotype was 
rescued from the majority of embryos (80%) (Fig. 6.8). These data suggest that FZD10 
knockdown rescues the Wnt1-induced phenotype and that the Wnt1 signal is mediated 
through FZD10 in the spinal cord.  
We next examined whether FZD10 knockdown would affect the phenotype induced by 
Wnt3a overexpression. We applied the same experimental conditions used with Wnt1 to 
remain consistent and to avoid variability due to differences in the approach (Fig. 6.5). 
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We found that the co-electroporation of scrambled shRNA or FZD10 shRNA with 
Wnt3a did not seem to affect the phenotype of Wnt3a overexpression as the expression 
domains of Pax6 and Pax7 were ventrally expanded in both experiments  (Fig. 6.7 A, B, 
C, D). In addition, Wnt3a-induced phenotype was not affected in a majority of the 
embryos examined (81%) after FZD10 knockdown (Fig. 6.8). These results indicate that 
FZD10 knockdown did not interfere with the Wnt3a-induced phenotype and that Wnt3a 
may function through different FZD receptors, such as FZD1 and FZD3, in the spinal 
cord. Consistent with this hypothesis, Wnt3a is capable of activating canonical Wnt 
signalling through FZD1 in P12 cells (Chacon et al., 2008). 
			
 
Fig. 6-5 Schematic illustration of rescue experiments in the spinal cord. To 
investigate the requirement of FZD10 for Wnt1 biological activity, embryos were 
electroporated with pCiG-Wnt1-IRES-GFP/ pCiG-Wnt3a-IRES-GFP on their own or 
with and shRNA- RFP vectors (scrambled shRNA or FZD10 shRNA) at HH11-12. 
Embryos were analysed and cryosectioned after 48 hours. Then, neural markers were 
used to assess the effects on the expression patterns of the neural markers, Pax6 and 
Pax7. We ensured the consistency of experimental conditions in all experiments. 
Therefore, experiments were preformed in parallel on the same days.  
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Fig. 
Fig. 6.6 FZD10 knockdown by shRNA rescues the Wnt1-induced phenotype. 
Scrambled shRNA electroporation with Wnt1 did not affect the phenotype; Pax6 and 
Pax7 were ventrally expanded (A, C), whereas FZD10 sh-RNA electroporation with 
Wnt1 inhibited the Wnt1-induced phenotype and prevented (B) or reduced (D) the 
ventral expansion of the expression domains of Pax6 and Pax7 in the electroporated side 
of the spinal cord (B, D). 
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Fig. 6-7 Knockdown of FZD10 did not affect the phenotype of Wnt3a 
overexpression. Scrambled shRNA or FZD10 shRNA co-electroporation with Wnt3a 
did not affect the ventral expansion of Pax6 or Pax7 on the electroporated side of the 
spinal cord (A-D). 
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Fig. 6.8 Summary of rescue experiments that shows numbers of embryos and their 
phenotypes.  
																					
 
 
 
 
 
 
Wnt1+	Scrambled	sh-RNA	 Wnt1+FZD10	sh-RNA		 Wnt3A+scrambled	sh-RNA	 Wnt3a+FZD10	sh-RNA	no	rescue	 8	 0	 6	 13	rescue	 0	 14	 0	 1	
0%	10%	
20%	30%	
40%	50%	
60%	70%	
80%	90%	
100%	
	 112	
 
6-5 Overexpression of FZD10 affected the patterning of neural progenitors and 
inhibited neurogenesis  
 
To further study FZD10 function, we cloned full-length chick FZD10 and subcloned it 
into expression vector pCAB-IRES-GFP (Chapter 2). FZD10 was introduced into the 
chick neural tube at stage HH11-12 by in vivo electroporation. Embryos were analysed 
after 48 hours and screened for GFP expression (Fig. 6.8 A, B). They were subsequently 
hybridized with an FZD10 probe to ensure that FZD10 was ectopically expressed along 
the DV axis of the electroporated half of the spinal cord (Fig. 6.8 C). Indeed, 
cryosections revealed that FZD10 transcripts were misexpressed on the experimental 
side of the electroporated embryos, suggesting that FZD10 was successfully 
overexpressed in the spinal cord (Fig. 6.8 D). Interestingly, we observed that the 
electroporated side was smaller in size (Fig. 6.8 D). 
We next examined whether FZD10 misexpression would affect neural progenitor 
patterning. We assessed the expression domains of Pax6, Pax7 and Nkx2.2 after 48 
hours post-electroporation. FZD10 overexpression affected patterning cell-
autonomously; the expression domains of Pax6 and Pax7 were shifted to the dorsal 
domain of the spinal cord in the electroporated embryos, whereas the Nkx2.2 domain in 
the ventral part of the spinal cord was broader in the electroporated half compared to the 
control half of the spinal cord (Fig. 6.9 B, E, H). This suggests that dorsal progenitor 
domains were reduced whilst ventral progenitors were expanded dorsally.  
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Fig. 6-8 Ectopic expression of FZD10 is detected in the spinal cord after 
electroporation. (A) A dorsal view of an embryo electroporated with an expression 
construct encoding full-length cFZD10 and GFP from the same vector backbone. (B) 
Cross section of a spinal cord showing GFP expression in the electroporated embryos. 
(C) Dorsal view of an embryo hybridized with a FZD10 probe. (D) Ectopic FZD10 
expression along the dorsal-ventral axis of the spinal cord was detected by in situ 
hybridization after electroporation. N=3/3. 		
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Fig. 6.9 FZD10 overexpression affects neural progenitor pattering the in D-V axis 
of the spinal cord. (A, D, G) The green colour represents GPF expression on the 
transfected side of the spinal cord, indicating that FZD10 is ectopically expressed. (B, 
C) The Pax7 expression domain is more dorsally restricted on the electroporated side. 
(E, F) The Pax6 expression domain is dorsally shifted. (H, I) The Nkx2.2 expression 
domain is dorsally expanded on the electroporated side of the spinal cord. N=11/13.  
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We further investigated the effect of FZD10 overexpression on neurogenesis of the DV 
of the spinal cord. Neural markers, such as Lhx1/5, Islelt-1 and Tuj-1, were used to 
assess their expression in electroporated embryos (48 hours post-electroporation). 
Lhx1/5 expression was repressed along the dorsal half of the electroporated spinal cord 
and it was missed in the interneuron V1 region (Fig. 6.10 A, B, C). Islet-1 positive cells 
were reduced in the dorsal interneuron 3 region on the electroporated half of the spinal 
cord compared to the control (Fig. 6.10 D, E, F). Tuj-1 is a marker for differentiated 
neurons along the DV spinal cord and its expression was moderately affected in the 
dorsal domain after 48 hours post-electroporation (Fig. 6.10 G, H, I). We also analysed 
the effect of FZD10 overexpression after 72 hours of electroporation; the phenotype 
was weaker compared to the phenotype after 48 hours. However, we observed that the 
elctroporated side was still smaller when compared with the control side of spinal cord 
electroporated with full-length FZD10 (Fig. 6.11). Boundaries between the interneurons 
(dI2, dI4, dI6, V0 and V1) were reduced on the experimental side of spinal cord, as seen 
by Lhx1/5 staining (Fig. 6.11 A, B). Fewer differentiated neurons were noted in the dI3 
domain as marked by Islet-1, whereas the motorneurons were not affected, as assessed 
by the Islet-1 expression in the ventral spinal cord (Fig. 6.11 C, D). Tuj-1 expression 
was more repressed in the experimental side of the spinal cord in electroporated 
embryos (Fig. 6.11 E, F). Interestingly, we observed that most GFP positive cells 
accumulated along the DV spinal cord in the MZ where the differentiated neurons were 
located (Fig. 6.11 B, D, F). These findings indicate that FZD10 is involved in spinal 
cord development and that it regulates neurogenesis.  
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These results also demonstrate inhibitory effects for FZD10 overexpression in neural 
progenitors and in neurogenesis in the spinal cord. It is not clear how FZD10 causes 
these effects, but there are a number of possibilities; full length FZD10 may act in a 
dominant negative fashion by sequestering (other) Wnt ligands and preventing them 
from binding to their receptors in the spinal cord (see summary 6). Alternatively, 
overexpressed FZD10 may disrupt non-canonical Wnt signalling by depleting co-factors 
(see 6-6), or FZD10 may require the Lrp6 co-receptor to activate canonical Wnt 
signalling (Wnt1). Availability of Lrp6 may be rate-limiting and therefore FZD10 
overexpression impairs rather than activates the pathway (see also 6-7). 
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Fig. 6.10 FZD10 overexpression leads to inhibition of neurogenesis of the spinal 
cord 48 hours post-electroporation. (A, D, G) The green colour represents GPF 
expression on the electroporated side of the spinal cord, indicating that FZD10 is 
ectopically expressed along the DV axis of the spinal cord. Expression of differentiated 
neuron markers was inhibited in the electroporated half of the spinal cord, (B, C) 
Lhx1/5 expression (E, F) Islet-1 expression, (H, I) Tuj-1 expression. N=11/13. 
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Fig. 6.11 FZD10 overexpression reduces neurogenesis of the spinal cord 72 hours 
post-electroporation. Markers for differentiated neurons were inhibited in the 
electroporated half of the spinal cord, (A) Lhx1/5 expression, (C) Islet-1 expression, 
whereas Islet-1 expression in motor neurons was not affected, (E) Tuj-1 expression. (B, 
D, F) Most of GFP positive cells were present along the DV axis of the spinal cord in 
the mantle zone (MZ) (G), where differentiated neurons are formed. Embryos number 
was 2/2 and multiple sections were analysed for each marker.  		
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6-6 Overexpressed FZD10 affected the actin cytoskeleton on the apical side of the 
spinal cord  
FZD receptors are involved in cell polarity and tissue closure. For example, FZD1 
and/or FZD2 mutations lead to defects in neural tube closure in mice (Yu et al., 2010). 
Also, FZD3–/–; FZD6–/– mutations result in neural tube defects, which is a failure of 
neural tube closure along the anterior-posterior axis (Wang et al., 2006). FZD7 regulates 
convergent extension movements in Xenopus embryos (Djiane et al., 2000). All these 
effects have been linked to a disruption in non-canonical Wnt signalling (PCP). 
Recently, it has been shown that FZD10 affects convergent extension in the mesoderm 
of zebrafish embryos (Nikaido et al., 2013). 
Therefore, we examined here whether overexpressed FZD10 would affect cell polarity 
in the DV spinal cord. To test this hypothesis, we used phalloidin to stain filamentous 
actin (F-actin) in the spinal cord after cryosectioning embryos electroporated with 
FZD10. We observed that phalloidin staining was reduced in the injected half of the 
spinal cord (Fig. 6.11 C, D). Moreover, phalloidin staining was also disrupted in the 
apical surface of the lumen following FZD10 overexpression, suggesting that F-actin 
failed to accumulate on the cells’ apical side (Fig. 6.11 D’). 
We also used Laminin antibody to assess the effect of FZD10 overexpression on  the 
cells’ basal side. We found that Laminin staining was not affected in the electroporated 
side of the spinal cord and it was comparable to the control (Fig. 6.11 E, F, G). These 
data indicate that overexpressed FZD10 affected the polarity of cells in the spinal cord, 
particularly their apical side. This might also suggest that overexpressed FZD10 may 
disrupt non-canonical Wnt signalling. Consistent with this, FZD10 has been shown to 
activate the JNK pathway and regulate RhoA activity in different cell lines (Fukukawa 
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et al., 2009). 
	
Fig. 6.12 FZD10 affected the actin cytoskeleton on the apical surface of the spinal 
cord 48 hours post-electroporation. (A) DAPI stained nuclei in a cross section of the 
spinal cord. (B, E) GFP expression in the transfected side of the spinal cord. (C, D) 
Phalloidin stained F-actin; its accumulation was reduced in the electroporated side of 
the spinal cord, indicating that the structure of the cytoskeleton was disrupted. (D’) 
Phalloidin staining was inhibited and disrupted in the apical cells in the luminal face of 
the spinal cord. (F, G) Cross section of spinal cord stained with DAPI and Laminin; 
Laminin-stained basal cells in the spinal cord. N=4/5. 
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6-7 Co-overexpression of Lrp6 and FZD10 enhanced the Wnt1-induced phenotype, 
leading to overgrowth and dorsalization in the spinal cord 
Next, we wanted to test whether FZD10 overexpession caused inhibition of canonical 
Wnt signalling potentially due to a ‘dominant-negative’ sequestration of important co-
factors with limited availability. In particular, we examined the requirement of Lrp6 for 
the function of Wnt1 and FZD10 in vivo in the spinal cord. Lrp6 is a FZD co-receptor; 
it binds Wnt1 and is necessary for the activation of Wnt signalling (He et al., 2004; 
MacDonald and He et al., 2012; Tamai et al., 2000). Importantly, it is expressed in 
neural tube and its mutations result in neural tube defects including a failure of neural 
tube closure and disruption in cell polarity (Allache et al., 2014; Gray et al., 2013; 
Houston and Wylie, 2002). We blasted human Lrp6 sequences against the chick 
genome and found that the predicted chick Lrp6 protein shares more than 92% identity 
in its amino acid sequence with hLrp6 protein (Appendix C). 
Therefore, we co-electroporated human Lrp6 (pCS2-hLrp6) with pCiG (pCiG-IRES-
GFP) as a tracer into neural tubes at HH11-12 and analysed the embryos after 48 hours. 
To assess the effect on dorso-ventral patterning, Pax3 and Pax7 antibodies were used. 
The Pax3/Pax7 expression domains did not appear to be affected in the experimental 
side of the spinal cord in embryos electroporated with hLrp6+pCiG or with empty pCiG 
alone (Fig. 6.12). These data suggest that hLrp6 on its own did not affect the dorsal-
ventral patterning of the spinal cord, and it may require the formation of active 
complexes bound by Wnt ligand to be activated. In agreement with our findings, it has 
been shown in a study in mice that dorsal-ventral patterning is not affected in Lrp6 gain 
of function (Lrp6Cd/Cd) (Gray et al., 2013).  
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Fig. 6.13 LRP6 misexpression does not affect dorsal progenitor patterning in the 
spinal cord. Pax3 (A-D) and Pax7 (I-L) expression domains are not affected after 
electroporation of the empty pCIG vector alone (N=3). Pax3 (E-H) and Pax7 (M-P) 
expression patterns were not altered in either side of spinal cords co-electroporated with  
pCIG and the hLRP6 vector (N=6/6).  														
A																												B																												C																												D													
E																												F																												G																													H	
I																												J																															K																												L	
M																										N																												O																													P	
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Next, we tested the interactions between Wnt1, hLrp6 and FZD10 in the spinal cord. 
First, hLrp6 was co-electroporated with FZD10 into the neural tube at HH11-12 and the 
phenotype was examined using the dorsal marker Pax7. We found that in the presence 
of hLRP6 the more dorsal restriction of dorsal markers observed after electroporation of 
FZD10 alone (see 6-5) was reverted and the dorso-ventral expanse of Pax7 expression 
was rescued (Fig. 6.14 A-D). This suggests an interaction between FZD10 and Lrp6, 
but may indicate limited availability of the relevant ligand. Interestingly, we also found 
that FZD10 electroporation together with Wnt1 seemed to inhibit the Wnt1-induced 
phenotype. Assessment of dorso-ventral patterning showed that the ventral expansion of 
Pax7 was reduced compared to what had been seen following Wnt1 electroporation 
alone (see for example Fig. 6.5). In addition, the kink-related to Wnt1 overexpression in 
the ventral part of the spinal cord was missed (Fig. 6.14 E-H).  Finally, the effects of 
FZD10, hLrp6 and Wnt1 co-electroporation into the spinal cord were investigated. The 
embryos were dissected after 48 hours post-electroporation to be cryosectioned and 
analysed. We found that Pax7 expression was expanded ventrally on the electroporated 
side of the spinal cord (Fig. 6.14 I-L). This expansion was more dramatic than what had 
been observed after electroporation of Wnt1 or Wnt3a alone (see chapter5; Fig.5.3 and 
Fig.5.4). Furthermore, the experimental side was larger than the control, possibly due to 
overgrowth although we have not directly measured the number of proliferating cells in 
this scenario (Fig. 6.14 I). We found that the ventral expansion of Pax7 expression 
doubled in size and significantly increased 1.9-fold after Wnt1 co-electroporation with 
FZD10 and Lrp6 compared to Wnt1 electroporation alone (Fig. 6.15). These findings 
are consistent with the idea that FZD10 interacts with Lrp6 to transduce a Wnt1 signal 
in vivo in the spinal cord. 
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Fig. 6.14 FZD10 interacts with Lrp6 to mediate Wnt1 activity in vivo in the spinal 
cord. (A, E, I) DAPI staining. (B, F, J) GFP expression in the electroporated side of the 
spinal cord as a reporter for ectopically expressed FZD10, Lrp6 and Wnt1. (C, D) The 
Pax7 expression domain is almost restored to wild type expression after Lrp6 co-
electroporation with FZD10 (N=8/10). (G, H) FZD10 co-electroporation with Wnt1 
attenuates the phenotype of Wnt1 overexpression; the kink in the ventral spinal cord 
was missed and ventral Pax7 expansion was reduced (N=4/5). However, there is a slight 
enlargement restricted to the dorsal domain of the spinal cord where endogenous and 
ectopic FZD10 are expressed. (I-L) Electroporation of FZD10, Lrp6 and Wnt1 in 
combination results in overgrowth of the electroporated side of the spinal cord (I, J) and 
a dramatic  ventral expansion of the Pax7 expression domain (K, L) (N=5/5). 			
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Fig. 6.15 The degree of ventral expansion of Pax7 48 hours  after electroporation of 
Wnt1 alone compared to Wnt1, FZD10 and Lrp6. (A) Pax7 expression after Wnt1 
electroporation. (B) Pax7 expression after co-electroporation of Wnt1 with FZD10 and 
Lrp6. The white bracket in A, B indicates the ventral expansion that was measured. (C) 
The average length of Pax7 expansion in both experiments; ventral expansion of Pax7 
was strongly enhanced after introducing both FZD10 and Lrp6 together with Wnt1 into 
the spinal cord, indicating that the dorsal domains of the six neural progenitors were 
expanded along the DV spinal cord and these receptors mediates Wnt1 activity in vivo.  
The measurement was done using AxioVision (Rel.4.8.2) software and the 
measurement unit was micron (µm). Statistical analysis was performed using Excel and 
a Student’s t-test. 4 embryos and 20 sections were analysed for each experiment.  
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6-8 Summary  	
To study how FZD10 is involved in spinal cord development and in Wnt signal 
transduction, different approaches were applied using in vivo loss- and gain-of-function 
and rescue experiments. Targeting FZD10 by sh-RNA results in a reduction in the size 
of the spinal cord due to the significant decrease in proliferative cells in the ventricular 
zone (Fig. 6.1 and Fig. 6.2). In addition, the dorsal progenitor domains were slightly 
affected after FZD10 knockdown. Neurogenesis was affected as the expression of 
Lhx1/5 and Tuj-1 was reduced (Fig. 6.3). 
 
We next investigated the requirement of FZD10 for Wnt1 and/or Wnt3a activity in the 
spinal cord. We previously showed that Wnt1 overexpression up-regulated FZD10 
expression (Chapter 5). Here we found that FZD10 is required for the biological activity 
of Wnt1 as FZD10 knockdown by sh-RNA rescued the Wnt1-induced phenotype 
whereas the Wnt3a-induced phenotype was not affected (Fig. 6.5 and Fig. 6.6).  
 
Overexpression of FZD10 led to inhibitory effects in neural progenitors and 
neurogenesis. The expression domains of Pax6 and Pax7 were reduced and dorsally 
shifted and neurogenesis was inhibited as differentiated neuron markers, Lhx1/5, Islet-1 
and Tuj-1, were repressed (Fig. 6.9, Fig. 6.10 and Fig. 6.11). These results could 
suggest that full-length FZD10 may act in a dominant negative fashion and inhibit 
proliferation and differentiation in the spinal cord. This is supported by a study 
reporting that misexpression of full-length cFZD1 or cFZD7 mimics the effect of 
misexpression of putative dominant negative forms of these two FZDs, which results in 
a severe reduction in the size of the cartilage element in the developing chick wing 
(Hartmann and Tabin, 2000). This study has suggested that changing FZDs levels may 
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disturb Wnt signalling that may need balanced levels of FZDs.   
 
We also found that FZD10 overexpression led to reduced phalloidin staining, which 
was evident on the apical side of cells, abutting the lumen of the spinal cord. In contrast, 
expression of laminin was not altered in basal cells (Fig. 6.12). This could suggest that 
overexpressed FZD10 may affect microfilament movement and neural cell division.   
 
We also showed that misexpression of hLRP6 on its own did not seem to affect 
patterning in the spinal cord (Fig. 6.13). On the other hand, we found that co-
electroporation of hLRP6 with Wnt1 and FZD10 resulted in a striking expansion of the 
dorsal neural progenitor domains and that the spinal cord was dorsalized (Fig. 6.14 and 
Fig. 6.15). 
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Discussion 
 
 
 
 
 
 
 
 
	 129	
7-1 Introduction  
The canonical Wnt ligands belong to a family of secreted glycoproteins that bind to the 
N-terminal extracellular cysteine-rich domain of the frizzled (FZD) receptor family of 
seven-pass transmembrane proteins and activate β-catenin/TCF (Komiya and Habas, 
2008; Logan and Nusse, 2004; MacDonald et al., 2009). Canonical Wnt signalling is 
also called Wnt/β-catenin signalling because β-catenin is a major player in this pathway 
(Komiya and Habas, 2008).  
Wnt signalling controls several developmental processes in both invertebrates and 
vertebrates, from fruit flies to humans. Wnt signalling has been shown to be involved in 
the regulation of a wide variety of biological processes, such as cell proliferation, cell 
polarity, cell differentiation and cell fate specification (Moon et al., 2004; Logan and 
Nusse, 2004). It also plays several roles in the development of the central nervous 
system (CNS), such as in neural induction, neurulation, patterning, neuronal 
differentiation in the spinal cord, neural stem cells, axon guidance and synaptogenesis 
(Yoshikawa et al., 1997; Pöpperl et al., 1997; Davidson et al., 2002; Muroyama et al., 
2004; Muroyama et al., 2002; Chenn and Walsh, 2003; Lyuksyutova et al., 2003; Hall 
et al., 2000). 
7-2 Wnt1 and Wnt3a expression and function during spinal cord development 
Canonical Wnt signalling has been shown to be involved in dorsal-ventral patterning of 
the spinal cord, including cell proliferation and specification (Le Dréau and Martí, 
2012; Ulloa and Marti, 2010). Elevating β-catenin levels by electroporating a 
constitutively active form of β–catenin cell autonomously accelerates cell proliferation 
and activates dorsal genes in chick spinal cords, whereas reducing β-catenin activity by 
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introducing dominant-negative forms of Tcfs results in a reduction in cell proliferation 
and dorsal genes were repressed (Alvarez-Medina et al., 2008; Megason and McMahon, 
2002). Consistent with this, we also found that blocking canonical Wnt signalling using 
a dominant-negative form of Wnt3a resulted in a marked reduction in spinal cord size 
and that dorsal marker (Pax7) was inhibited (Appendix B. Fig. B.1). This indicates that 
canonical Wnt signalling is required for spinal cord development.  
Some Wnt genes are expressed in the neural tube including Wnt1 and Wnt3a (Alvarez-
Medina et al., 2008; Galli et al., 2014; Megason and McMahon, 2002; Parr et al., 1993). 
Wnt1 and Wnt3a are known to function through canonical Wnt signalling and they are 
implicated in neural tube development (Dickinson et al., 1994; Megason and McMahon, 
2002; Muroyama et al., 2002; Alvarez-Medina et al., 2008). Wnt1 and Wnt3a control 
cell cycle regulators and promote cell proliferation in the spinal cord (Megason and 
McMahon, 2002). They also regulate neural specification through patterning of the 
spinal cord along the dorsal ventral axis (Muroyama et al., 2002; Alvarez-Medina et al., 
2008). 
Here, we followed Wnt1 and Wnt3a expression patterns during chick embryo 
development using in situ hybridization to observe any changes in their expression. We 
performed careful analysis of their expression patterns from HH14 to HH25; 
overlapping expression was shown throughout the chick dorsal neural tube (Appendix 
A. 1, 2, 3). Moreover, it was apparent that Wnt1 and Wnt3a are highly expressed during 
the initiation of neurogenesis of the dorsal neural tube, but their expression was 
restricted to the dorsal midline after neurogenesis (Appendix A. 2, 3). Our results 
confirmed that Wnt1 and Wnt3a expression was restricted to the domain surrounding 
the roof plate at all stages examined. Wnt1 and Wnt3a function is required for dorsal 
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neural tube development, as seen from several studies. We here questioned whether 
Wnt1 and Wnt3a have the same capacity to regulate patterning in the spinal cord. 
Therefore, we individually electroporated Wnt1 and Wnt3a in the neural tube and the 
effects were assessed using DV neural markers (Chapter 5). We found that both Wnts 
were able to activate Pax6 and Pax7 expression more ventrally within the dorsal 
domain, whereas Nkx2.2 was more restricted to the ventral domain of the spinal cord 
(Chapter 5). Both Wnts also promoted neurogenesis of dorsal interneuron 3, as Islet-1 
expression was increased (Chapter 5). These results indicate that Wnt1 and Wnt3a have 
the same biological activities in chick spinal cord even though they only share 43% 
amino acid identity (Chapter 5; Alvarez-Medina et al., 2008; Megason and McMahon, 
2002). In addition their functions have been studied in mice, their mutations result in 
different phenotypes because they are expressed in different tissues. In Wnt1 knockout 
mice, the midbrain was lost and the hindbrain was affected, whereas in Wnt3a knockout 
mice, the anterior-posterior axis was truncated, there were defects in somitogenesis and 
the hippocampus was lost (reviewed in Amerongen and Berns, 2006). In Wnt1–/–; 
Wnt3a–/– double mutant mice, dorsal neural specification and neural crest expansion 
were affected (Ikeya et al., 1997; Muroyama et al., 2002). 
In this study, we also sought to explain how Wnt1 and/or Wnt3a initiate canonical Wnt 
signalling in the chick spinal cord and through which receptors. Thus, we performed 
expression analysis for all known FZDs in order to identify which FZDs are expressed 
in the spinal cord. 
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7-3 FZDs are expressed during spinal cord development 
FZD receptors are involved in neural tube development. For example, neural tube 
closure was affected in FZD1 and/or FZD2 knockout mice (Yu et al., 2010). Also, the 
neural tube failed to close along the anterior-posterior axis in FZD3-/-; FZD6-/- double 
mutants (Wang et al., 2006). FZD3 knockout mice show severe defects in axon 
development in the central nervous system (Hua et al., 2013; Wang et al., 2001; Wang 
et al., 2006). In addition, some neurons fail to migrate and cluster in the midline of the 
spinal cord of this mutant (Wang et al., 2006).  
In chicks, all FZDs are expressed during the early stage of development and they are 
detected in different tissues, including the developing brain (Chapman et al., 2004; 
Fuhrmann et al., 2003; Stark et al., 2000; Quinlan et al., 2009; Theodosiou and Tabin, 
2003). Here, we were particularly interested in FZD expression patterns during chick 
spinal cord development. We established a complete expression profile of cFZD 
receptors in chick spinal cord and identified FZDs that could be involved in the dorsal-
ventral patterning of the spinal cord (Fig. 3.1 and Table. 3.1). Through in situ 
hybridization, we identified that six out of ten FZDs were expressed in the spinal cord 
and showed specific and different expression patterns at stage HH14-15. FZD1 and 
FZD10 expression was seen in the dorsal neural tube and FZD10 was strongly and 
specifically detected in the dorsal part of the neural tube (Chapter 3). Whereas FZD2 
and FZD7 were found in the intermediate ventral spinal cord and their expression 
patterns seemed to overlap, FZD7 showed stronger expression in the neural progenitors. 
FZD3 and FZD9 transcripts were found throughout the dorsal ventral spinal cord. FZD3 
expression was specific in the ventricular zone where proliferation occurs, while FZD9 
expression was ubiquitous. We also observed that FZD7 and FZD10 were expressed 
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during spinal cord neurogenesis (Chapter 3). The expression profile of cFZDs could 
suggest potential interactions of these receptors with Wnt ligands that are expressed 
during spinal cord development. Moreover, it could be proposed that dorsal FZDs, such 
as FZD10, may mediate signalling that is activated by Wnt ligands expressed in the 
dorsal spinal cord, whereas ventral FZDs may transduce the signals of Wnt ligands in 
the ventral spinal cord. 
 
7-4 FZD10 expression during spinal cord neurogenesis 
FZD10 is one of the FZD family receptors that has been detected in different species, 
including zebrafish, Xenopus, chick and mouse (Galli et al., 2014; Kawakami et al., 
2000a; Moriwaki et al., 2000; Wheeler and Hoppler, 1999; Nikaido et al., 2013; Yan et 
al., 2009). In chicks, FZD10 is expressed at the early stage of development as it is found 
in the pre-streak stages, and by stage 4, is detected in the posterior of the primitive 
streak (Chapman et al., 2004). FZD10 expression continues throughout embryonic 
development and it has been detected by in situ hybridization in several developing 
tissues, such as the central nervous system, limb buds and branchial arches (Kawakami 
et al., 2000a).  
In this report, full-length cFZD10 was cloned and its expression profile was established 
during chick embryo development as well as in the spinal cord using an in situ 
hybridization approach (Chapter 4). At stage HH9, FZD10 was expressed in the 
midbrain and in the posterior region during secondary neurulation. FZD10 expression 
was found in the developing central nervous system, in the midbrain, the hindbrain and 
the spinal cord in all stages examined throughout development (Fig. 4.1). In addition, at 
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stage HH24, FZD transcripts were found in the limb bud and the branchial arches. 
FZD10 also showed very strong expression in the tail bud throughout the developmental 
stages. 
We followed FZD10 expression during spinal cord development from HH14 to HH24 
and it was apparent that FZD10 is expressed in the dorsal spinal cord and continues to 
be expressed at different times during neurogenesis. FZD10 expression was detected in 
the region of neural progenitors and overlapped with well-known dorsal progenitor 
markers, such as Pax3/6/7 and Ngn1. FZD10 is also expressed during dorsal interneuron 
formation as shown by the differentiated neural markers; Islet-1 and Lhx1/5 (Chapter 
4). 
Importantly, we conducted a careful analysis for the expression patterns of Wnt1, 
Wnt3a and FZD10 during spinal cord development (Chapter 4 and Appendix A). As 
seen in the expression profiles, Wnt1, Wnt3a and FZD10 are expressed in the spinal 
cord and their expression overlapped (Chapter 4; Galli et al., 2014). FZD10 expression 
was detected in the entire dorsal domain of the spinal cord and may interact with dorsal 
Wnts including Wnt1 and Wnt3a. Wnt1 and Wnt3a are required for spinal cord 
development (Alvarez-Medina et al., 2008; Megason and McMahon, 2002; Muroyama 
et al., 2002).  
 
7-5 Dorsally expressed Wnts (Wnt1/Wnt3a) regulate the expression of FZD7 and 
FZD10 in the spinal cord 
Wnt1 and Wnt3a are expressed in the dorsal spinal cord, function through canonical 
Wnt signalling and play important roles during development. We previously showed 
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that FZD7 is expressed in the intermediate-ventral spinal cord, whereas FZD10 
expression is detected in the dorsal spinal cord (Chapter 4). Here, we investigated 
whether dorsally expressed Wnts regulate the expression of FZDs in the spinal cord. 
Therefore, Wnt1 and Wnt3a were co-electroporated in chick neural tubes and the 
embryos were analysed after 24 hours. The transfected embryos were hybridized with 
probes detecting FZDs. In situ hybridization followed by cryosections revealed that 
FZD10 expression was ventrally expanded on the experimental side of the spinal cord in 
electroporated embryos. This indicates that FZD10 expression is up-regulated by 
canonical Wnt signalling (Wnt1/3a) potentially enhancing the ability of cells to respond 
in a positive feed-back loop. This result might also suggest that FZD10 may be involved 
in mediating canonical Wnt signalling in the chick spinal cord.  
Conversely, FZD7 expression was lost in the intermediate-ventral spinal cord on the 
transfected side of the spinal cord after Wnt1 and Wnt3a co-electroporation. This 
suggests that ventrally expressed FZDs are negatively regulated by secreted Wnts from 
the dorsal spinal cord.  
Wnt/FZD interactions and selectivity are not fully understood and this is a current topic 
of interest, especially in some aspects of pharmacology and pathophysiology. For 
example, Wnt–FZD selectivity, receptor complex stoichiometry and signal initiation 
still need to be studied at the molecular level (Schulte, 2015). Recently, Wnts have 
shown selective binding to FZDs and Wnt-FZD pairs drive different biological 
outcomes in different cell lines (Dijksterhuis et al., 2014). We here introduced the chick 
spinal cord as a tool to dissect Wnt-FZD interaction and selectivity in vivo. 
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7-6 Wnt1 up-regulates FZD10 expression in the spinal cord 
Recently, it was shown that FZD10 seems to interact with Wnt1 and Wnt3a in vitro as 
demonstrated by an in situ proximity ligation assay (Galli et al., 2014). We also found 
that FZD10 expression was strongly up-regulated and ventrally expanded in spinal 
cords co-electroporated with Wnt1 and Wnt3a. Thus, we attempted to determine which 
Wnts affect FZD10 expression in vivo; embryos were electroporated with Wnt1 and 
Wnt3a individually. We found that FZD10 expression was upregulated and ventrally 
extended after Wnt1 overexpression but it was not affected following Wnt3a 
overexpression (Chapter 5). This demonstrates that FZD10 expression in the dorsal 
spinal cord responds exclusively to Wnt1 and thus FZD10 may mediate Wnt1 function 
in vivo in this context. These data encouraged us to examine FZD10 function and 
interactions during spinal cord development (see 7-7). Many in vivo and in vitro studies 
have found no interaction between Wnt3a and FZD10; FZD10 did not seem to 
synergise with Wnt3a in the Xenopus animal cap assays (Kawakami et al., 2000b). 
Research from the Wheeler lab showed that FZD10 synergises with Wnt1 and Wnt8 
(but not with Wnt3a) and induces axis duplication in Xenopus embryos (Garcia-Morales 
et al., 2009). In addition, FZD10-CRD was not able to interact with Wnt3a, as shown by 
a co-immunoprecipitation experiment (Carmon and Loose, 2010). Thus, our findings as 
well as those of others suggest that FZD10 does not seem to bind Wnt3a. Therefore, 
Wnt3a may activate different FZDs, such as FZD1 and FZD3, in the spinal cord. Due to 
time limitations, we were unable to conduct any further experimentation to test this, 
however, it has been shown that Wnt3a can mediate canonical Wnt signalling through 
FZD1 in hippocampal neurons and PC12 cells (Chacon et al., 2008). 
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7-7 FZD10 function during spinal cord neurogenesis 
FZD10 has the ability to function through canonical Wnt signalling as injection of 
human or Xenopus FZD10 into the ventral marginal zone (VMZ) results in partial axis 
formation in early Xenopus embryos (Garcia-Morales et al., 2009; Terasaki et al., 2002). 
Also FZD10 can interact with Wnt1 and the phenotype of FZD10 knockdown can be 
rescued by β-catenin in Xenopus embryos (Garcia-Morales et al., 2009). Additionally, 
we showed that FZD10 expression is up-regulated by Wnt1 in chick spinal cord 
(Chapter 5). 
Loss of function in Xenopus shows that FZD10 is required for generation of sensory 
neurons (Garcia-Morales et al., 2009). Furthermore, in mouse P19 cells, in which neural 
differentiation is induced by retinoic acid, overexpression of Xenopus FZD10 results in 
an increase in the number of neurons generated, while siRNA knockdown of 
endogenous mouse FZD10 inhibits neurogenesis (Garcia-Morales et al., 2009). Here, 
we further investigated FZD10 function in the dorsal ventral patterning of the spinal 
cord in vivo. 
 
7-7-1 FZD10 knockdown reduces cell proliferation and inhibits neurogenesis in 
spinal cord 
Different approaches, such as loss and gain of function experiments and rescue 
experiments, were applied in vivo in order to study how FZD10 is involved in spinal 
cord development and in Wnt signal transduction (Chapter 6). shRNA was used to 
knock-down FZD10 in the spinal cord. Chick neural tubes were electroporated with 
FZD10 shRNA vectors and then they were assessed. We found that targeting FZD10 by 
	 138	
shRNA vectors reduced FZD10 expression. Furthermore, the electroporated side of the 
spinal cord was smaller compared to the control. We found that the reduction in the size 
of the spinal cord was a consequence of a significant decrease in the number of 
proliferative cells in the ventricular zone, demonstrated by pH3 staining and cell 
counting (Fig. 6.1 and Fig. 6.2). This is consistent with the role of canonical Wnt in cell 
proliferation. In addition, domains of dorsal progenitors were slightly affected after 
FZD10 knockdown as judged by Pax6 and Pax7 expression. Neurogenesis was affected 
as Lhx1/5 and Tuj-1 expressions were reduced (Fig. 6.3). Our results demonstrate that 
FZD10 knockdown inhibits proliferation of neural progenitors, which results in a 
reduction in interneuron differentiation.  
 
 
7-7-2 FZD10 knockdown rescues the Wnt1-induced phenotype 
We previously found that Wnt1 overexpression up-regulated FZD10 expression but it 
was not affected by Wnt3a overexpression (Chapter 5). We further investigated FZD10 
requirements for Wnt1 and/or Wnt3a activity in the spinal cord. Therefore, we 
performed rescue experiments by electroporating Wnt1 or Wnt3a with FZD10 shRNA 
in neural tubes. Then, the embryos were analysed using neural markers Pax6 and Pax7. 
We found that FZD10 is required for Wnt1-induced dorsalisation of the neural tube as 
FZD10 knockdown by shRNA rescued the Wnt1 overexpression phenotype. In this 
experiment, the ventral expansion of the expression domains of Pax6 and Pax7 was 
reduced in the electroporated half of the spinal cord. Moreover, a vast majority of the 
embryos (80%) were rescued by FZD10 shRNA electroporation. In contrast, the Wnt3a 
overexpression phenotype was not affected, as ventral expansion of dorsal genes Pax6 
and Pax7 was not altered after FZD10 knockdown (Fig. 6.5 and Fig. 6.6). These results 
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showed that FZD10 maidates Wnt1 signalling in vivo in the spinal cord. They also 
confirmed our previous observations that demonstrate that FZD10 only interacted with 
Wnt1 in the spinal cord, but it does not seem to interact with Wnt3a in vivo (Fig. 7.1).  
	
Fig.	7.1	proposed	model	for	Wnt1	and	Wnt3a	signalling	in	the	spinal	cord. 
 
 
7-7-3 FZD10 overexpression affects neural progenitors and neural differentiation 
markers 
 
To further investigate the role of FZD10 in spinal cord development, a full-length 
cDNA of FZD10 was subcloned into expression vector (pCAB-IRES-GFP) and was 
introduced into chick neural tubes by in vivo electroporation. Embryos were analysed 
after 48 or 72 hours post-electoporation (Chapter 6). The effects were assessed using 
neural markers for different neural cells. Overexpression of FZD10 led to cell-
autonomous inhibitory effects in neural progenitors and neurogenesis. The expression 
domains of Pax6 and Pax7 were reduced and dorsally shifted on the experimental side 
of the spinal cord as compared to the control (Fig. 6.9). This suggests that the size of the 
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dorsal progenitor domain was reduced. In contrast, the Nkx2.2 expression domain (a 
ventral marker) was moderately expanded on the electroporated half of the spinal cord 
(Fig. 6.9). 
 
We also found that neurogenesis was inhibited as differentiated neuron markers were 
repressed (Fig. 6.10 and Fig. 6.11). Lhx1/5 expression was severely reduced and it was 
lost in the ventral interneurons. There were fewer Islet-1 positive cells on the 
electroporated side of spinal cord, but motorneurons were not affected in the ventral 
spinal cord. In addition, Tuj-1 expression was repressed along the dorsal-ventral spinal 
cord in embryos electroporated with FZD10. 
  
These results show inihibtory effect  after  FZD10 overexpression, it was anticipated 
that if FZD10 activated canonical Wnt signalling, its overexpression would promote 
proliferation and neurogenesis in the dorsal spinal cord. However, it has been shown 
that Wg signalling was attenuated by dFZD3 up-regulation in Drosophila  (Sato et al., 
1999) and this is similar to our observation. Thus, our results may suggest that full-
length cFZD10 interferes in a dominant negative manner, leading to inhibition of the 
pathway and inhibition of proliferation and differentiation in the spinal cord. This is 
supported by a study reporting that overexpression of full-length cFZD1 or cFZD7 
mimics the effect of overexpression of putative dominant- negative forms of these two 
FZDs, which results in a severe reduction in the size of the cartilage element in the 
developing chick wing (Hartmann and Tabin, 2000). Other possibilities are that 
overexpressed FZD10 may interfere with non-canonical Wnt or that FZD10 requires co-
receptors to activate canonical Wnt signaling effectively (see 7-7-3 and 7-7-4).  
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7-7-3 FZD10 overexpression severely affects the actin cytoskeleton in the spinal 
cord 
We sought to further explore FZD10 function in the cell structure cytoskeleton of the 
spinal cord and to explain inhibitory effects of FZD10 overexpression in vivo (Chapter 
6). Therefore, FZD10 was electroporated in chick neural tubes and markers for apical 
and basal cell surfaces were used. We found that FZD10 overexpression led to a 
reduction in phalloidin staining, which was severely disrupted on the apical lumen of 
the spinal cord. Interestingly, Laminin expression was not altered on the basal side of 
the spinal cords in embryos electroporated with FZD10 (Fig. 6.12). It was clear that 
phalloidin staining was disrupted in the apical surface of the lumen in the spinal cord 
following FZD10 overexpression, suggesting that F-actin failed to accumulate on the 
apical side. These data indicate that overexpressed FZD10 could affect the polarity of 
cells in the spinal cord. This might also suggest that overexpressed FZD10 may disrupt 
non-canonical Wnt signalling, in particular the PCP pathway. Consistent with our data, 
Fukukawa and colleagues (2009) showed that overexpressed FZD10 severely disrupts 
the assembly of actin stress fibres in HuBM-Bmi1-hT-immortalized mesenchymal stem 
cells and in 1273/99 cells. Furthermore, it inhibits RhoA activity in a synovial sarcoma 
cell line (SYO-1 cells), enhances the phosphorylation of Dvl2 and Dvl3 and activates 
the Rac1–JNK pathway (Fukukawa et al., 2009). These researchers proposed that 
overexpressed FZD10 affects the actin cytoskeleton as a result of its interference with 
non-canonical Wnt signalling and by regulating RhoA activity. Therefore, our data and 
that of others suggest that FZD10 can also function through non-canonical Wnt 
signalling. FZDs are known to signal through multiple Wnt pathways including Wnt/β-
catenin and Wnt/PCP signalling. For example, FZD1, 2 and 7 are shown to be involved 
in both types of Wnt signalling (Gros et al., 2009; Linker et al., 2003; Medina et al., 
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2000; Sumanas et al., 2000; Yu et al., 2010).  
7-7-4 FZD10 interacts with Lrp6 to mediate Wnt1 activity in vivo in the spinal 
cord 
 Lrp6 is a FZD co-receptor, binds Wnt1 and is necessary for the activation of Wnt 
signalling (He et al., 2004; MacDonald and He et al, 2012; Tamai et al., 2000). 
Importantly, it is expressed in neural tube and its mutations result in neural tube defects 
including effects in patterning, failure of neural tube closure and disruption in cell 
polarity (Allache et al., 2014; Gray et al., 2013; Houston and Wylie, 2002; Pinson et al., 
2000). Therefore, we studied the function of Lrp6 and tested its requirement for FZD10 
and Wnt1-induced patterning defects in chick spinal cords (Chapter 6). We found that 
hLrp6 misexpression did not have any pronounced effects on Pax3 and Pax7 expression 
domains, which are dorsal markers and are activated by canonical Wnt in the spinal 
cord (Fig. 6.13). This could suggest that hLrp6 gain of function did not seem to affect 
patterning on its own in chick spinal cord. This is consistent with experiments 
performed on mice in which the hLrp6 gain of function did not seem to regulate neural 
specification, whereas hLrp6 loss of function resulted in a reduction in neural fold size 
and affected the Pax6 expression domain (Gray et al., 2013). However, we observed 
that hLrp6 co-electroporation with FZD10 resulted in a positive effect on Pax7 
expression, suggesting that hLrp6 partially rescues the inhibitory effects of FZD10 
overexpression. We also found that FZD10 co-electroporation with Wnt1 led to a 
reduction in the Wnt1 phenotype, but when hLrp6 was co-electroporated with Wnt1 and 
FZD10 there was a striking ventral expansion of the dorsal neural progenitor domains 
and the spinal cord was strongly dorsalized (Fig. 6.14 and Fig. 6.15). Moreover, the 
overall size of the spinal cord was much larger and the overgrowth was apparent on the 
electroporated side of the spinal cord in the electroporated embryos. We also compared 
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the ventral expansion of Pax7 expression in spinal cords electroporated with Wnt1 alone 
to spinal cords co-electroporated with Wnt1, FZD10 and hLrp6. We found that the 
expansion of Pax7 expression doubled in size and increased 1.9-fold in the spinal cords 
that were co-electroporated with Wnt1 and both receptors (FZD10/Lrp6) (Chapter 6; 
Fig. 6.14). These results indicate that Lrp6 is required for FZD10 to mediate Wnt1 
biological activity in vivo in the spinal cord. This also suggests the mechanism by 
which Wnt1 regulates proliferation and patterning in the spinal cord involves an 
interaction with both FZD10 and Lrp6 (Fig. 7.2). It would be good to investigate this 
mechanism more by performing luciferase assay experiments  (Wnt signalling reporter; 
Top-flash) in the neural tube in the future as shown in Alvarez-Medina et al., 2008. 
 
Fig.	7.2	Schematic representation of	Wnt1/FZD10/Lrp6	signalling	model.		Wnt1	binds	to	FZD10	and	Lrp6	which then activate a downstream pathway (canonical Wnt 
signalling) to regulate proliferation, patterning and neural differentiation in chick spinal 
cords.	
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7-8 Conclusion 
We established a complete expression profile for all chick FZDs in the spinal cord and 
identified six FZDs that are expressed in the spinal cord (Chapter 3). FZD10 expression 
was established in the dorsal domain of the spinal cord (Chapter 4). Wnt1 and Wnt3a 
activate dorsal genes, including FZD10, whereas they inhibit ventral FZD (FZD7) 
(Chapter 5). Wnt1 overexpression up-regulates FZD10 expression in the dorsal spinal 
cord. FZD10 knockdown significantly decreases cell proliferation and neurogenesis as 
well as rescues the Wnt1-induced phenotype (Chapter 6). Interestingly, FZD10 
overexpression results in cell-autonomous effects in the spinal cord, leading to a 
reduction in the dorsal progenitor domains in the dorsal spinal cord. It also inhibits the 
differentiation of interneurons and disrupts the actin cytoskeleton of the spinal cord 
(Chapter6). We uncovered a potential role for FZD10 in non-canonical Wnt signalling, 
as its overexpression affects F-actin accumulation in the apical surface of the spinal 
cord. We also demonstrated in vivo that Wnt1 mediated effects on dorso-ventral neural 
tube patterning involves FZD10 and Lrp6, which then activate a downstream pathway 
(canonical Wnt signalling) to regulate proliferation, patterning and neural differentiation 
in chick spinal cords (Fig. 7.2). 
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Appendix A 
 
Fig. A.1 - Whole mount in situ hybridization for Wnt3a, FZD10 and Wnt1 at 
different stages. Wnt3a (A,B,C and D). FZD10 (E,F,G and H). Wnt1 (I,J,K and L). 
(M and N) show double in situ for Wnt3a and FZD10.	
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Fig. A.2 In situ expression profile of Wnt1 in the developing spinal cord at 
different stages HH14 to HH25. Dorsal-ventral sections show Wnt1 expression (A-H). 
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Fig. A.3 In situ expression profile of Wnt3a at different stages. A-D show whole 
mount in situ at HH14 to HH20. E-J shows the expression pattern of Wnt3a during the 
development of the spinal cord at stage HH14 to HH25.  
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Appendix B 
 	
Fig B.1 DnWnt3a affects spinal cord size and reduces Pax7 expression domain 
(48hours PE).  (A) Whole mount picture of electroporated embryo with dnWnt3a and 
pCS2-GFP. (B) Transverse section of spinal cord showing GFP expression in the 
electroporated side. (C) Elctroporated side is smaller when compared to the control and 
Pax7 expression is inhibited as well as its expression domain is reduced. (D) GFP 
expression in the electroporated side of the spinal cord. Embryos number was 3/4.  
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Appendix C 
 
Fig. C.2 comparing human Lrp6 protein sequence to predicted chick Lrp6. Human 
Lrp6 were blasted against chick genomic sequence in NBCI; it was found that they 
share 93% amino acid identity, suggesting that Human and chick Lrp6 are conserved 
and may play same roles.   	
 
PREDICTED: LOW QUALITY PROTEIN: low-density lipoprotein receptor-related protein 6 [Gallus gallus] 
Sequence ID: ref|XP_417286.3|Length: 1625Number of Matches: 1 
Related Information 
Gene-associated gene details 
Map Viewer-aligned genomic context 
Range 1: 26 to 1625GenPeptGraphics 
Next Match 
Previous Match 
 
Identities Positives Gaps 
1489/1601(93%) 1555/1601(97%) 1/1601(0%) 
 
Query  13    FCVLLRAAPLLLYANRRDLRLVDATNGKENATIVVGGLEDAAAVDFVFSHGLIYWSDVSE  72 
             +CVLLR+APLLLYANRRDLRLVDA NGKENAT++VGGLEDAAAVDFVF  GLIYWSDVSE 
Sbjct  26    YCVLLRSAPLLLYANRRDLRLVDAANGKENATVIVGGLEDAAAVDFVFVKGLIYWSDVSE  85 
 
Query  73    EAIKRTEFNKTESVQNVVVSGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVL  132 
             EAIKRTEFNK+ SVQNVV+SGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVL 
Sbjct  86    EAIKRTEFNKSGSVQNVVISGLLSPDGLACDWLGEKLYWTDSETNRIEVSNLDGSLRKVL  145 
 
Query  133   FWQELDQPRAIALDPSSGFMYWTDWGEVPKIERAGMDGSSRFIIINSEIYWPNGLTLDYE  192 
             FWQELDQPRAIALDP+ GFMYWTDWGEVPKIERAGMDGSSR II+N++IYWPNGLTLDYE 
Sbjct  146   FWQELDQPRAIALDPARGFMYWTDWGEVPKIERAGMDGSSRSIIVNTDIYWPNGLTLDYE  205 
 
Query  193   EQKLYWADAKLNFIHKSNLDGTNRQAVVKGSLPHPFALTLFEDILYWTDWSTHSILACNK  252 
             EQKLYWADAKLNFIHKSNLDG++RQAVVKGSLPHPFALTLF D LYWTDW+THSILAC+K 
Sbjct  206   EQKLYWADAKLNFIHKSNLDGSHRQAVVKGSLPHPFALTLFGDTLYWTDWNTHSILACSK  265 
 
Query  253   YTGEGLREIHSDIFSPMDIHAFSQQRQPNATNPCGIDNGGCSHLCLMSPVKPFYQCACPT  312 
             Y+GE LREIHS+IFSPMDIHAFSQ+RQPNATNPCGI+NGGCSHLCLMSP KP YQCACPT 
Sbjct  266   YSGEDLREIHSNIFSPMDIHAFSQKRQPNATNPCGINNGGCSHLCLMSPTKPSYQCACPT  325 
 
Query  313   GVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLQLEDIRHAIAIDYDPVEG  372 
             GVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVL LEDIRHAIAID+DP+EG 
Sbjct  326   GVKLLENGKTCKDGATELLLLARRTDLRRISLDTPDFTDIVLPLEDIRHAIAIDFDPLEG  385 
 
Query  373   YIYWTDDEVRAIRRSFIDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRL  432 
             YIYWTDDEVRAIRRSF+DGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRL 
Sbjct  386   YIYWTDDEVRAIRRSFVDGSGSQFVVTAQIAHPDGIAVDWVARNLYWTDTGTDRIEVTRL  445 
 
Query  433   NGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRVVLVNTSLGWP  492 
             NGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDR+VLVNTSLGWP 
Sbjct  446   NGTMRKILISEDLEEPRAIVLDPMVGYMYWTDWGEIPKIERAALDGSDRIVLVNTSLGWP  505 
 
Query  493   NGLALDYDEGKIYWGDAKTDKIEVMNTDGTGRRVLVEDKIPHIFGFTLLGDYVYWTDWQR  552 
             NGLALDY E KIYWGDAKTDKIEVMN DGTGRRVLVEDK+PHIFGFTLLGDYVYWTDWQR 
Sbjct  506   NGLALDYAESKIYWGDAKTDKIEVMNADGTGRRVLVEDKLPHIFGFTLLGDYVYWTDWQR  565 
 
Query  553   RSIERVHKRSAEREVIIDQLPDLMGLKATNVHRVIGSNPCAEENGGCSHLCLYRPQGLRC  612 
             RSIERVHKR+AERE+IIDQLPDLMGLKATNVH++IG+NPCAE+NGGCSHLCLYRPQGLRC 
Sbjct  566   RSIERVHKRTAEREIIIDQLPDLMGLKATNVHQIIGTNPCAEDNGGCSHLCLYRPQGLRC  625 
 
Query  613   ACPIGFELISDMKTCIVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFDVT  672 
             ACPIG ELI+DMKTCIVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDF    
Sbjct  626   ACPIGLELINDMKTCIVPEAFLLFSRRADIRRISLETNNNNVAIPLTGVKEASALDFXCD  685 
 
Query  673   DNRIYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVS  732 
                 YWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVS 
Sbjct  686   RQSNYWTDISLKTISRAFMNGSALEHVVEFGLDYPEGMAVDWLGKNLYWADTGTNRIEVS  745 
 
Query  733   KLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRAAMDGSERTTLVPNVGR  792 
             KLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRA+MDGSERTTLVPNVGR 
Sbjct  746   KLDGQHRQVLVWKDLDSPRALALDPAEGFMYWTEWGGKPKIDRASMDGSERTTLVPNVGR  805 
 
Query  793   ANGLTIDYAKRRLYWTDLDTNLIESSNMLGLNREVIADDLPHPFGLTQYQDYIYWTDWSR  852 
             ANGLTIDYAKRRLYWTDLDTNLIESSNMLGL+RE+IADDLPHPFGLTQYQDYIYWTDWSR 
Sbjct  806   ANGLTIDYAKRRLYWTDLDTNLIESSNMLGLDREIIADDLPHPFGLTQYQDYIYWTDWSR  865 
 
Query  853   RSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQSGWNECASSNGHCSHLCLAVPVGGF  912 
             RSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQ+GWNECASSNGHCSHLCLAVPVGGF 
Sbjct  866   RSIERANKTSGQNRTIIQGHLDYVMDILVFHSSRQAGWNECASSNGHCSHLCLAVPVGGF  925 
 
Query  913   VCGCPAHYSLNADNRTCSAPTTFLLFSQKSAINRMVIDEQQSPDIILPIHSLRNVRAIDY  972 
             VCGCPAHYSLN+DNRTCSAPTTFLLFSQK+AINRMVIDEQQSPDIILPIHSLRNVRAIDY 
Sbjct  926   VCGCPAHYSLNSDNRTCSAPTTFLLFSQKNAINRMVIDEQQSPDIILPIHSLRNVRAIDY  985 
 
Query  973   DPLDKQLYWIDSRQNMIRKAQEDGSQGFTVVVSSVPSQNLEIQPYDLSIDIYSRYIYWTC  1032 
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             DPLDKQLYWIDSRQN+IRKAQEDGSQ  TVV+S VP+QNL++QPYDLSIDIYSRYIYWTC 
Sbjct  986   DPLDKQLYWIDSRQNIIRKAQEDGSQSLTVVISPVPNQNLDMQPYDLSIDIYSRYIYWTC  1045 
 
Query  1033  EATNVINVTRLDGRSVGVVLKGEQDRPRAVVVNPEKGYMYFTNLQERSPKIERAALDGTE  1092 
             EATNVINVTRLDGR +GVVLKG+QDRPRA+VVNPEKGYMYFTNLQERSPKIERAALDGTE 
Sbjct  1046  EATNVINVTRLDGRPMGVVLKGDQDRPRAIVVNPEKGYMYFTNLQERSPKIERAALDGTE  1105 
 
Query  1093  REVLFFSGLSKPIALALDSRLGKLFWADSDLRRIESSDLSGANRIVLEDSNILQPVGLTV  1152 
             REVLFFSGLSKPIALA+DS+LGKLFWADSDLRRIESSDLSGANR+VLEDSNILQPVGLTV 
Sbjct  1106  REVLFFSGLSKPIALAIDSQLGKLFWADSDLRRIESSDLSGANRVVLEDSNILQPVGLTV  1165 
 
Query  1153  FENWLYWIDKQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNLQEYRQHPCAQDNG  1212 
             FENWLYWID+QQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELN+QEYRQHPC+QDNG 
Sbjct  1166  FENWLYWIDRQQQMIEKIDMTGREGRTKVQARIAQLSDIHAVKELNVQEYRQHPCSQDNG  1225 
 
Query  1213  GCSHICLVKGDGTTRCSCPMHLVLLQDELSCGEPPTCSPQQFTCFTGEIDCIPVAWRCDG  1272 
             GCSHIC+VKGDGTTRCSCP+HLVLLQDELSCGEPPTCSPQQFTCFTGEIDCIPVAWRCDG 
Sbjct  1226  GCSHICIVKGDGTTRCSCPVHLVLLQDELSCGEPPTCSPQQFTCFTGEIDCIPVAWRCDG  1285 
 
Query  1273  FTECEDHSDELNCPVCSESQFQCASGQCIDGALRCNGDANCQDKSDEKNCEVLCLIDQFR  1332 
             FTECEDHSDE NCPVCS++QFQC SGQCID ALRCNG+ANCQD SDEKNCEVLCL  QFR 
Sbjct  1286  FTECEDHSDEKNCPVCSDTQFQCESGQCIDSALRCNGEANCQDNSDEKNCEVLCLTSQFR  1345 
 
Query  1333  CANGQCIGKHKKCDHNVDCSDKSDELDCYPTEEPAPQATNTVGSVIGVIVTIFVSGTVYF  1392 
             CA+GQCIGK KKCDHN+DCSD SDE  CY TEEPAPQ  NT+GS+IGVI+T+FV G +YF 
Sbjct  1346  CASGQCIGKSKKCDHNLDCSDSSDEQGCYTTEEPAPQPNNTIGSIIGVILTLFVVGAMYF  1405 
 
Query  1393  ICQRMLCPRMKGDGETMTNDYVVHGPASVPLGYVPHPSSLSGSLPGMSRGKSMISSLSIM  1452 
             ICQR+LCPRMKGDGETMTNDYVVHGPASVPLGYVPHPSSLSGSLPGMSRGKS+ISSLSIM 
Sbjct  1406  ICQRVLCPRMKGDGETMTNDYVVHGPASVPLGYVPHPSSLSGSLPGMSRGKSVISSLSIM  1465 
 
Query  1453  GGSSGPPYDRAHVTGASSSSSSSTKGTYFPAILNPPPSPATERSHYTMEFGYSSNSPSTH  1512 
             GGSSGPPYDRAHVTGASSSSSSSTKGTYFP ILNPPPSPATERSHYTMEFGYSSNSPSTH 
Sbjct  1466  GGSSGPPYDRAHVTGASSSSSSSTKGTYFPPILNPPPSPATERSHYTMEFGYSSNSPSTH  1525 
 
Query  1513  RSYSYRPYSYRHFAPPTTPCSTDVCDSDYAPSRRMTSVATAKGYTSDLNYDSEPVPPPPT  1572 
             RSYSYRPYSYRHFAPPTTPCSTDVCDSDYAPSRR+T+   AKGYTSDLNYDSEPVPPPPT 
Sbjct  1526  RSYSYRPYSYRHFAPPTTPCSTDVCDSDYAPSRRVTAT-MAKGYTSDLNYDSEPVPPPPT  1584 
 
Query  1573  PRSQYLSAEENYESCPPSPYTERSYSHHLYPPPPSPCTDSS  1613 
             PRSQYLSAEENYESCPPSPYTERSYSHHLYPPPPSPCTDSS 
Sbjct  1585  PRSQYLSAEENYESCPPSPYTERSYSHHLYPPPPSPCTDSS  1625 
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APPENDIX D 
-Vectors used in this study: 
 
 
	
E.1 Schematic shows pGEM-T easy vector used for cloning and generating in situ 
probes. 				
	
E.2 Schematic representation of the pCIG-IRES-GFP vector used for overexpression of 
Wnt1 and Wnt3a in chick neural tube. (Adapted from Megason and McMahon, 2002). 	
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E.3 Schematic representation of the pRFP-C-RS vector used to knock FZD10 down in 
chick neural tube. (Adapted from Origene).				
	
E.4 Schematic representation of the pCAB-IRES-GFP vector used for overexpression 
of dnWnt3a and FZD10 in chick neural tube.  
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E.5 Schematic representation of the pCS2 vector used for overexpression of LRP6 in 
chick neural tube. (Adapted from Addgene).  	
 
 
 
 
 
 
 
 
